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Abstract of the Dissertation 
Mass Spectrometry-Based Strategies for Biomolecular Structure Analysis: Steroid Metabolites 
Structures and Protein-Protein Interactions 
by 
Yuetian Yan 
Doctor of Philosophy in Chemistry 
Washington University in St. Louis, 2015 
Professor Michael L. Gross, Chair 
Professor Timothy E. Holy, Co-Chair 
 
 Mass spectrometry is an important method for studying the structure of both small molecules 
and large biomolecules (e.g., proteins). The majority of the applications prior to 1970 were 
focused on small molecules, owing to the limited ionization methods which posed difficulties in 
producing gas-phase ions for large biomolecules then. Beginning in the 1980’s, with the 
introduction of new ionization methods (ESI and MALDI), the applications have gradually 
switched to biological science measuring large bioorganic molecules. Today, with the 
developing interest in metabolomics and proteomics, and ongoing improvement in MS-based 
techniques, mass spectrometry is extensively applied in the study of both small and large 
molecules. 
The research presented in this thesis falls into two main parts, which focus on the application of 
MS in (1) structural analysis of steroid metabolites and (2) characterization of protein-protein 
interactions. In the first part, combinations of different MS methods are adopted and used to 
solve the structures of unknown steroid metabolites, which are the pheromones responsible for 
mouse communication in mouse urine. This part includes three chapters, the first two of which 
discuss the method development of using MS to study the structure of steroid metabolites; and 
the third chapter presents the application of the MS methods in solving a newly discovered 
steroid pheromone, which is determined as a sex-specific hormone. In the second part, two MS-
xiv 
 
based strategies, namely, hydrogen-deuterium exchange (HDX) and fast photochemical 
oxidation of proteins (FPOP), are applied in two studies of protein-protein interactions, including: 
(1) dimerization of SecA, which is a motor protein in bacteria translocation pathway; and (2) 
interface mapping of EGFR binding to Adnectin1. In the first chapter in Part 2, we used HDX 
MS to characterize the dimer interface of SecA, and, meanwhile, detected a conformational 
change from open to closed forms at the pre-protein binding domain upon dimerization. This 
conformational change provided leads for the active form of SecA. In the second chapter in Part 
2, we applied FPOP, which is modified to suit therapeutic protein formulation conditions, to map 
the epitope of Adnectin1-EGFR interaction at amino acid residue level. The epitope identified 
agrees with that from both HDX study and crystallography results, presenting more evidence of 
the capability of FPOP in epitope mapping. 
These five studies on characterization of steroid metabolites and protein-protein interactions 
show the successful application of mass spectrometry in the structural study of both small 
molecules and large proteins. Furthermore, there’s a great potential for study of more complex 
systems. 
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Chapter 1  
Introduction: Mass Spectrometry Assists Structural 
Analysis of Steroid Metabolites Important in Mouse 
Communication 
 
2 
 
1.1 Abstract 
Among mice, social behavior, such as sex, social status, and identity is organized via 
pheromones and other odor cues in chemical signaling. The molecular identity of these signals, 
however, remains largely unknown. Recently, a group of steroid conjugates in mouse urine was 
found to serve as important ligands for the pheromone-sensing neurons. Although two of those 
steroid metabolites were structurally analyzed with NMR and mass spectrometry, many more 
remains structurally unresolved. These steroid metabolites, which occur in trace amounts in 
mouse urine and elsewhere and, therefore, are difficult for NMR study, are challenging to 
characterize. In the first part of this thesis, we explored the application of a combination of MS 
tools for determining structure of steroid metabolites. In the area of steroid conjugates analysis, 
mass spectrometry dates back to the 1950s, first using electron ionization (EI). With further 
development of mass spectrometry, other suitable methods for structure characterization became 
available for the study of steroid conjugates, including different types of tandem mass 
spectrometry. In this chapter, we give an introduction to the techniques and instrumentation in 
mass spectrometry that can be applied in structural study of steroid metabolites; we also review 
the history of steroid conjugates study by mass spectrometry.   
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1.2 Social Communication of the Mouse 
Animals are social. They use their sense of smell to identify and learn the status of other 
animals. Natural cues such as urine-containing metabolites inform about reproductive status, 
social dominance, and levels of stress(1). By investigating various bodily fluids, such as urine, an 
animal can discriminate between individuals and “communicate”.  
For many mammals, olfactory sensations derive from at least two anatomically and 
molecularly distinct neural pathways, the main and accessory olfactory systems. The main 
olfactory system is composed of main olfactory epithelium (MOE) that contains olfactory 
sensory neurons (OSNs). Chemical cues are detected in the MOE after they bind to G protein-
coupled receptors on the cilia of OSNs. For a long time, the main olfactory system was believed 
to utilize only volatile chemical cues and trigger innate physiological or behavior responses(2-4). 
Recently, evidence appeared showing that murine OSNs can also respond to small, nonvolatile 
major histocompatibility complex (MHC) peptide ligands that lead to changes in behavior(5). 
Similarly, the accessory olfactory system is composed of the vomeronasal organ (VNO) 
epithelium, which contains vomeronasal sensory neurons (VSNs). Odorants that are dissolved in 
nasal mucous gain access to the VNO via an active pumping mechanism(6) and then bind to the G 
protein-coupled receptors located on VSNs. Although it was presumed that the VNO 
preferentially responds to large-molecular-weight, nonvolatile molecules, it has also been shown 
to respond to volatile chemosensory stimuli in vitro(7, 8).  
Unlike the main olfactory system, the accessory olfactory system plays a more narrowly 
specialized role for social communication. Previous studies showed that VNO lesions lead to 
deficits in reproductive and territorial behaviors in mice(9-13). More than two decades ago, 
Wysocki and his colleagues studied the importance of VNO by using a dental burr to enlarge the 
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incisive foramen and then remove the entire VNO (VNX)(14). Many following-up studies(9) have 
been published from the same group, reporting VNX impaired abilities including ultrasonic 
vocalizations in males, hormone surges in response to cues from females, male-mouse courtship 
and sexual behavior, territorial marking and inter-male aggression, and maternal behaviors in 
females. More recently, several other groups genetically mutated mice to form a homozygous 
deficiency in Trp2, a cation channel expressed in the VNO. These Trp2 mutants reveal a striking 
reduction in the electrophysiological response to pheromones in the VNO, and, therefore afford 
the opportunity to examine the role of VNO in the generation of innate social behaviors in mice. 
The studies(10, 11, 13) showed that Trp2 mutant males and nursing females fail to display 
aggression on intruder males, Trp3 mutant female showed reduction in lactating behavior, and 
trp2 mutant male also lost sex discrimination and initiated sexual behaviors toward both males 
and females. All these findings suggest that VNO-mediated pheromone input regulates important 
sexual and social behaviors in mice. 
1.3 Vomeronasal Agonists Carry Pheromone Information 
Pheromones are chemical cues that are released by animals to regulate their social 
interactions within the same species. Although there are many known ligands found for main 
olfactory sensory neurons, only a small number of agonists carrying pheromone information for 
VSNs have been identified thus far, in contrast to the many chemosensory receptors found in the 
rodent nose. Behaviorally, the most well characterized source of VSN ligand is urine, because 
mice employ urine investigation as a tool to discriminate between individuals and urine also 
comes available in relatively large quantities. Among the known chemicals carrying pheromonal 
information, several volatile molecules(8, 15) were identified to be VSN agonists. In addition, 
nonvolatile major histocompatibility complex (MHC) class I peptides(16) and major urinary 
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proteins (MUPs)(17) have been reported to activate selectively VSNs. Altogether, these identified 
vomeronasal agonists are far less numerous than the amount of chemosensory receptors found in 
the rodent nose (more than 1300(18)). Also, these molecules at saturating concentrations were 
reported together to stimulate fewer than 15% of the neurons, whereas hundred-fold diluted urine 
stimulated 30-40% of the neural population(7). Both facts indicate that there are more compounds 
that are responsible for most of the activity in mouse urine unidentified.  
In an effort to search for the unidentified source responsible for most of the activity in 
dilute urine, Nodari et al.(19) adopted a de novo screen of active constituents of mice urine by 
presenting chromatographic fractions of urine to VSNs and recording their neuronal firing 
responses. As a result, a large family of compounds that collectively accounts for much of the 
activity in female mouse urine was identified, most of which contain a sulfate group and two are 
structurally characterized as sulfated steroids(20) by using nuclear magnetic resonance (NMR) 
and mass spectrometry (MS). Indeed, several lines of evidence suggest that urine contains other 
active, but unknown, sulfated steroids. In fact, the urine from female mice of the BALB/c strain, 
contains sulfated compounds estimated to produce 80% of the total activation of these sensory 
neurons(19).  
Unfortunately, like many metabolites, many of the unknown cues in natural stimuli are 
present in very low abundance, restricting the possibility of using NMR analysis for structure 
identification. Therefore, more sensitive methods are needed, and the first part of this thesis 
describes the exploration of various combinations of MS methods to determine steroid-
metabolite structure, and demonstrates its successful application to solve one unknown and 
putative female sex pheromone.  
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1.4 Mass Spectrometry 
Mass spectrometry (MS) is a microanalytical technique that can be used to determine the 
elemental and isotopic signature of an analyte and provide some aspects of its molecular 
structure. The simplest mass spectrometer is composed of an ion source, a mass analyzer, and a 
detector. In a typical MS procedure, a sample, which might be solid, liquid, or gas, is ionized to 
form ions in gas phase before they are separated according to their mass-to-charge ratios (m/z). 
The majority of applications prior to 1970 were analysis of small molecules, because only 
analytes having significant vapor pressure could produce gas-phase ions by the only commonly 
available ionization techniques at that time, electron ionization (EI) and chemical ionization (CI). 
After 1970, the capabilities of MS were expanded by the development of desorption/ionization 
(D/I) techniques, which enables generating gas-phase ions directly from a condensed phase. 
However, it was not until the late 1980’s, when John Fenn invented electrospray ionization 
(ESI)(21), Fanz Hillenkamp and Michael Karas developed matrix-assisted laser desorption 
ionization (MALDI)(22), that MS become vastly applied in biological science for measuring 
bioorganic molecules, including peptides, proteins, carbohydrates, and DNA or RNA fragments.  
Today, EI and CI continue to play very important roles when combined with gas 
chromatography (GC/MS), whereas ESI and MALDI are mainly responsible for the dominant 
role of MS in the biological sciences. GC/MS now is a mature technique in analysis of small 
molecules, supported by several large online databases. ESI and MALDI are even more routinely 
used in both small and large molecule analysis owing to easy sample handling and the 
requirements for only small sample quantity.  
Besides the availability of various ionization techniques, the success of MS in science 
today is also attributable to combining different mass analyzers to afford hybrid mass 
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spectrometers that provide high-mass resolving power measurements. In conducting this thesis 
research, three hybrid mass spectrometers were mainly used; they all involve ESI (including 
nanospray) combined with linear ion trap/Orbitrap, GC-quadrupole/time-of-flight (TOF), and 
MALDI-TOF/TOF.  These are described in the following sections. 
1.4.1 Quadrupole/Time-of-Flight Mass Spectrometers 
1.4.1.1 Quadrupole Mass Analyzer 
As indicated by its name, a quadrupole mass analyzer (sometimes called quadrupole mass filter 
or QMF) is composed of four parallel rods that ideally form a hyperbolic cross section. Each 
opposing rod pair is connected together and held at the same polarity. A radio frequency (RF) 
and direct current (DC) voltage are applied between one pair of rods and the other. Extracted 
ions from an ion source travel down the quadrupole between the rods along the longitudinal axis 
toward the detector. Only ions of a certain m/z will reach the detector for a given U (magnitude 
of the DC potential) and V (magnitude of the RF signal), given a constant AC frequency, and 
other ions will collide with the rods owing to unstable trajectories. This is mathematically 
modeled with the use of the Mathieu differential equation(23). And this property of the QMF 
enables a quadrupole either to function as a mass selector in which only ions with specific m/z 
can be transmitted, or to scan a mass spectrum by increasing or decreasing U and V at a fixed 
ratio from a pre-established minimum to a maximum value.   
Selective transmission of ions over a narrow m/z by the quadrupole is most often used in tandem 
MS (MS/MS) analysis mode to select a precursor ion for study. One example instrument 
designed for such analysis is a triple quadrupole mass spectrometer, which is composed of a 
linear set of three quadrupoles in series. The first (Q1) and third (Q3) quadrupoles act as mass 
filters, and the second (Q2) quadrupole is operated in the RF-only mode (transmits ions of all m/z 
8 
 
values) to serve as a collision cell(24, 25). Q1 is used for selection of the precursor ions and 
transmitting them to Q2, where collisions of the precursor ions with an appropriate concentration 
of collision gas (Ar, He, or N2) occurs, and product ions are formed. These product ions are 
passed to Q3 where they may be fully scanned to give a mass spectrum or transmitted over a 
narrow range to achieve “selected reaction monitoring” whereby duty cycle and sensitivity are 
increased (Figure 1-1).   
In modern mass spectrometry, quadrupoles are very often used in hybrid mass spectrometers. 
The tandem quadrupole-TOF (QTOF) mass spectrometer uses a time-of-flight device as the 
second mass analyzer and has the advantage of improved mass accuracy to the nearest 0.1 
millimass unit vs. using a quadrupole for the second mass analyzer.  
1.4.1.2 Time-of-flight Mass Spectrometry 
Time-of-flight (TOF) mass spectrometry is a method that separate and detect ions of different 
m/z in a field-free drift path after the application of a constant acceleration voltage (U) for all 
ions. After the initial acceleration with a high electrical potential, we can equate two types of 
energies as:  
E = qU = ½ mv2 = Ek           Eq. 1 
 
Figure 1- 1. A schematic of a triple quadrupole mass spectrometer (QQQ-MS). Q1 and Q3 
represent two mass filters for precursor and fragment ion selection while Q2 (collision cell) 
creates fragment ions via collision-induced dissociation (CID). Taken from 
http://www.particlesciences.com/news/technical-briefs/2009/mass-spectrometry-
bioanalysis.html. 
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The velocity (v) of the ion in the flight tube, therefore, can be obtained. 
v2qUm                              Eq. 2 
Because the field-free drift tube is at a fixed length (l), the time that an ion takes to reach the 
detector depends on its velocity, and, therefore, its mass-to-charge ratio.  By measuring this time 
and using the known experimental parameters, the m/z of the ion can be determined from the 
following equation deduced from Eq. 2: 
m
z  = 
2U
v2 	 2U
l/t2                     Eq. 3 
If the TOF is coupled with a reflectron, the kinetic energy dispersion in the direction of ion flight 
can be corrected, and as a result the mass resolving power is significantly improved.  A modern 
Q-TOF instrument can have mass resolving 
power of 60,000 over a wide mass range.  
1.4.2 Linear Ion Trap/Orbitrap 
Mass Spectrometers 
1.4.2.1 Linear Ion Trap  
The linear ion trap, or linear quadrupole ion 
trap (LIT or LTQ, Figure 1-2a), uses a set 
of quadrupole rods to confine ions radially 
(by employing an RF potential) and a static 
electrical potential applied to end electrodes 
to confine the ions axially(26). A common 
instrument from Thermo Fisher, the LTQ, 
 
Figure 1- 2. a. The linear ion trap. b. The 
chamber of the 3D quadruple trap. Taken from 
http://employees.csbsju.edu/hjakubowski/classe
s/ch331/protstructure/olcompseqconform.html. 
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makes use of a transmission quadrupole that can be used as a selective mass filter, but unlike a 
transmission quadrupole, it can also function as an actual trap by creating a longitudinal potential 
well for the ions(27). The LTQ has the advantages of larger ion storage capacity than the 3D 
quadrupole trap (Figure 1-2b). These properties allow LTQ to exceed the triple quadrupole in 
MS/MS analysis to achieve a better signal-to-noise ratio by accumulating ions in MS2 before 
acquiring a mass spectrum of the product ions. Furthermore, this trapping property of the LTQ 
makes MS3 or further possible without further complex construction, but this is also true of 3D 
traps. This advantage in tandem mass spectrometry is especially advantageous in the structural 
analysis of small molecules, which will be the focus of the first part of my thesis.  
1.4.2.2 Orbitrap Mass Spectrometry 
The orbitrap, which is a modification based on the Kingdon trap(28), is a type of Fourier 
transform mass spectrometer. The orbitrap is 
composed of two coaxial axisymmetric 
electrodes, the inner spindle-shaped electrode and 
an outer barrel-shaped surface (Figure 1-3). A 
constant electric potential is imposed between the 
two electrodes, and, therefore, ions can be 
trapped in the space between them by balancing 
the electrostatic attraction to the inner electrode 
by the centrifugal force of the spinning ions. 
Furthermore, the opposing surfaces of the 
axisymmetric coaxial electrodes are nonparallel, 
leading to varying electric field between the two 
 
Figure 1- 3. Cutaway view of the 
Orbitrap mass analyzer. Ions are injected 
into the Orbitrap at the point indicated by 
the red arrow. Taken from Perry et al. 
2008. Mass Spectrometry Reviews. Page 
664. 
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surfaces along the z-axis, reaching a minimum at the center of the orbitrap. The electric-field 
vectors are nonparallel, with decreasing projection of the electric field onto the z-axis toward the 
center of the trap, which is the force driving the ions toward the center of the trap along the z-
axis. Therefore, besides cycling around the inner electrode, the ions also have a natural tendency 
to oscillate axially (along the z-axis) in the orbitrap. Owing to properties of quadro-logarithmic 
potential(29), this axial motion is harmonic, with its angular frequency dependent on its m/z: 
ωz=k q
m
                             Eq. 4 
where k is the force constant/ field curvature. This oscillation feature allows the orbitrap to 
function as a mass spectrometer, and the ion signal is detected as a time-domain signal by using 
image current detection as sensed by the halves of the barrel electrode; the image current is then 
Fourier transformed to frequency-based signal. Image current detection is also at the heart of FT 
ICR mass spectrometers, and was first utilized with that instrumentation over 40 years ago. 
The orbitrap analyzer can be interfaced to a linear ion trap, which together provide very high 
resolving power (100,000 at m/z 400) and efficient MS/MS capability. Therefore, much of the 
research reported here in this thesis (both the first and second parts) was conducted with LTQ-
Orbitrap interfaced to capillary HPLC. 
1.5 Gas-Phase Fragmentation 
Mass Spectrometry studies its subjects in their ionic forms in the gas phase. In the ion source, an 
atom or molecule is converted into an ion in the gas phase by adding or removing charged 
particles, such as electrons or protons.  The neutral substance is either admitted to the gas phase 
prior to or accompanying ionization. In Electron ionization (EI) and chemical ionization (CI), the 
excess energy introduced upon ionization almost always leads to fragmentation of the molecule. 
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This fragmentation pattern can be viewed as a “chemical fingerprint” and is useful in the study of 
molecular structure. In other soft ionization processes, such as electrospray ionization (ESI), very 
often only molecular ions are formed. In such situations, the molecular ions can be purposefully 
fragmented by collision-induced-dissociation with collision gas in a collision cell, which is built 
before the mass analyzer, to help understand the structure. Such gas-phase fragmentation remains 
very important and widely used in modern mass spectrometry for study of both small molecules 
and large biomolecules.  
1.5.1 Electron Ionization  
Electron ionization (EI) is a widely used ionization method in mass spectrometry that uses 
energetic electrons to interact with gas-phase molecules to produce ions. In an EI ion source, 
electrons are produced by electrically heating a thin metal filament to a temperature at which 
thermionic emission occurs. The electrons are then accelerated to 70 eV, concentrated into a 
beam, and directed toward the sample gas which is introduced in the ion source perpendicular to 
the beam. The electric field around the sample neutral molecules undergoes large fluctuation 
because of the close passage of highly energetic electrons, and, therefore, causes the sample 
molecules to ionize and fragment. The following gas phase reaction describes the ionization 
process.  
M + e-  M+• + 2e-                        Eq. 5 
The ionization process is often followed by predictable fragmentation. The fragmentation pattern 
of the molecular ion can be used to deduce the structural features of the analyte.  Knowledge in 
organic chemistry, such as electron-triggered cleavages and rearrangements and chemical bond 
stability, are used to suggest or to rationalize the fragmentation pathways. Many analytes have a 
unique “chemical fingerprint”, therefore EI has been widely used in structure studies of natural 
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products and, more recently, in metabolism. Furthermore, there are commercially available 
libraries containing hundreds of thousands of reference EI mass spectra which can be used to 
facilitate identification of unknown compounds.  
Today, EI is mostly used in GC-MS instruments because it is most easily adapted to gas-phase 
sample ionization. In the study of small molecule structure characterization, we used one such 
instrument to show the application of EI in the structural study of unknown steroid metabolites 
and its value in structure elucidation.  
1.5.2 Tandem Mass Spectrometry 
Desorption/ionization (D/I) has greatly advanced mass spectrometry in several application areas, 
the most important of which is the identification of large bioorganic molecules. Now 
electrospray ionization (ESI) and matrix-assisted laser desorption/ionization coupled mass 
spectrometers are the two most popular instruments in a mass spectrometry lab. These ionization 
methods produce protonated molecules ([M + H]+) in the positive-ion mode and deprotonated 
molecules ([M - H]-) in the negative-ion mode  of the instrument, or in some cases 
cationized/decationized molecules. Most of the ions formed by such soft ionization techniques 
are even-electron species and, therefore, do not undergo fragmentation when formed by soft 
ionization. Thus, although they are useful in providing the molecular mass of the analyte, they 
are also disappointing in not providing much, if any, structural information. This problem is 
solved by combining tandem mass spectrometry with the soft ionization technique, like ESI or 
MALDI.  
There are many methods used to fragment ions, and they result in different types of 
fragmentation. In the following, we will introduce the two tandem mass spectrometry methods 
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that were used in the research presented in this thesis; they are low-energy collision-induced 
dissociation and high-energy charge-remote fragmentation.  
1.5.2.1 Collision-induced Dissociation 
Collision-induced dissociation (CID) is most often what is being used in a tandem mass 
spectrometry experiment. It is achieved by introducing neutral target molecules or atoms into the 
collision cell and inducing collisions with the accelerated analyte ions in the gas phase. As a 
result, energy is added to the ions as internal energy that leads to subsequent bond breakage and 
fragmentation of the ions.  
CID of Peptides and Proteins 
The ability to generate fragment ions in 
tandem mass spectrometry (or MS/MS) is very 
important for the identification of an analyte 
with high confidence. MS/MS is now widely 
used in protein mass spectrometry, and is 
almost indispensable for identification of 
peptides and proteins. Peptide ions that are fragmented with CID produce a series of product 
ions, namely b ions if the charge is retained on the N-terminus and y ions if the charge is retained 
on the C-terminus (Figure 1-4). Other fragment ions, indicated by a, c, x, or z in Figure 1-4, can 
also be formed in gas-phase with other fragmentation methods, but these methods were not 
utilized in this thesis. This application of CID MS/MS in peptide identification is important in 
the second part of this thesis.  
CID of Small Molecules 
 
Figure 1- 4. The fragmentation sites of 
peptide during gas-phase fragmentation. 
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The application of CID for small molecules, especially in structure identification, however, 
remains limited. This is partly because structural chemists turn to NMR in structure studies in 
cases where sample quantity is not limited.  More importantly, structural elucidation with CID is 
complicated and sometimes incomplete. Although some basic theories and rules of fragmentation 
have been proposed, the deduction of fragmentation remains difficult when facing complicated 
molecules including steroids. Despite such difficulties in data analysis, CID mass spectrometry is 
an important tool in studying complex biological samples including biological fluids.  A subject 
for our study in this thesis, mouse urine, is a challenging sample from which fractionating and 
obtaining sufficient analyte  for NMR analysis is most times difficult. In the first part of this 
thesis, we focused on MS/MS and MS/MS/MS of steroid sulfates to understand their general 
fragmentation patterns, and discovered several fragmentation rules that we applied to the 
characterization of one unknown steroid metabolite. 
1.5.2.2 Charge-remote Fragmentation 
Charge-remote fragmentation (CRF) is a class of gas-phase decompositions that occurs remote 
from the charge site(30-32). The two important criteria that enable charge-remote fragmentation are 
(1) a charge fixed at one end of the molecule and (2) high-energy collisional activation (> 10,000 
eV in the laboratory frame). The ionization method is not a prerequisite for CRFs, although the 
mostly frequently used ionization method for generating precursor ions was fast atom 
bombardment (FAB). Provided sufficient energy is deposited on a molecule, other 
complementary ionization methods can also be utilized to ionize samples prior to CRF.  
Although it is generally agreed that CRF proceeds similarly to gas-phase thermal reactions and 
the charge is not involved in the fragmentation, the detailed mechanisms and energetic are still 
debated. For fatty acids, charge-remote cleavage of C-C bonds can be explained by a 1,4-H2 
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elimination mechanism (Scheme 1-1(33) ). On the other hand, a radical mechanism initialized by a 
homolytic C-C bond cleavage may also be operative (Scheme 1-2(34, 35)). Other mechanisms(36, 37) 
were also proposed later. However, none of them can explain all the data on CRF. 
Charge-remote fragmentation has been proven useful in the structure characterization of long-
chain or poly-ring molecules(38-42). Early CRF experiments were performed mostly on sector 
instruments that are capable of providing high collision energies. However, there has been a 
marked decline in the application of high-energy CID with the demise of magnet sector 
instruments and the current dominance of ion traps, QTOFs, and hybrid ion-trap FT 
spectrometers that employ low-energy CID. Recently, interest resumed in CRF with the 
introduction of TOF/TOF instruments that provide high collision energies(43-46). The introduction 
of a first TOF and an accelerating voltage before the collision cell in the design of the TOF/TOF 
instruments enabled precursor ions to gain a high kinetic energy, which is usually between 1 to 
20 kV (e.g., 20 kV accelerating voltage 
equals to 20 keV kinetic energy for a 
singly charged species).  As a result, the 
precursor ions have high kinetic energy 
and high-energy collision is allowed 
with neutral gases when entering the 
collision cell. As part of the research in 
the first part of the thesis, we showed 
the application of MALDI TOF/TOF 
instrumentation to induce CRF and 
 
Scheme 1- 1. 1,4-H2 elimination mechanism 
proposed by Gross and co-workers. X may 
correspond to O- or OLi2+. 
 
 
Scheme 1- 2. Homolytic bond-fragmentation 
mechanism. X may correspond to O- or OLi2+. 
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enable structural characterization of steroid metabolites. 
1.6 MS-Based Structural Analysis of Steroid Conjugates 
Biological MS dates back to the 1950s, when steroid was one of the first class of biomolecules 
analyzed by MS(47). In the early studies of steroids, EI was the dominant ionization method and 
later was coupled with GC. GC/MS offers very good chromatographic separation of analytes 
even those with minor structural differences (e.g., isomers). Meanwhile, EI produces informative 
and often characteristic fragmentation, therefore the structural information is forthcoming. 
However, for the majority of the steroid analysis, derivatization is required to form volatile 
compounds to be analyzed by GC(48).  Because the sample injection volume (1-5 µL typically) is 
small, intense analyte cleanup and concentration prior to analysis are often required to provide 
sufficient intensity of analyte signals for detection. EI spectra are often complicated, and made 
even more so with derivatization that leads to more fragments of the derivative itself. Despite the 
difficulties, GC/MS is still routinely used in structure analysis, partly due to the availability of a 
vast EI online data base for structural identification of analytes.  
The introduction of the desorption-ionization techniques of fast atom bombardment(49, 50) and 
ESI(51, 52) bypassed the problems of analyte volatility and thermal stability, and allowed direct 
coupling with liquid chromatography (LC) for analyte separation. The development of tandem 
mass spectrometry (MS/MS)(53, 54) about the same time (1980a) afforded a new approach for 
structural characterizations of steroid conjugates with mass spectrometry. This approach used 
FAB ionization on magnetic-sector instruments and high collision energies to generate charge-
remote fragmentation.  The approach was demonstrated effective in resolving structures of bile 
salt conjugates and other steroids(40-42, 55). Today, we are using direct-inlet ESI rather than FAB, 
and sector instruments have been replaced with ion traps, QTOFs, and hybrid ion-trap FT 
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spectrometers that employ low-energy CID. Over the years, low-energy CID has seen some 
application in structure characterization of steroid sulfates(56), but the data interpretation often 
stops at accurate mass and functional group fragmentation to deduce known steroid metabolites 
in a sample mixture. Recently, high-energy CID(43, 44) has been resumed with TOF/TOF 
instruments, and applied in some areas for structural characterization(45, 46, 57, 58).   
1.7 Purpose of this Study 
In the first part of the thesis research, we utilized all the different MS approaches mentioned 
above for the structure characterization of steroid metabolites in Chapter 2 and Chapter 3. We 
then applied this combination of MS methods in Chapter 4 in the study of mouse urine to solve 
the structure of an unknown steroid sex pheromone that is important in mouse communication.  
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Chapter 2* 
Mass Spectrometry Combinations for Structural 
Characterization of Sulfated-Steroid Metabolites 
 
 
 
 
 
 
 
 
 
 
 
* This chapter is based on recent publication: Yan, Y., Rempel, D. L., Holy, T. E., Gross, M. L.. 
Mass spectrometry combinations for structural characterization of sulfated-steroid metabolites. J 
Am Soc Mass Spectrom, 2014, 25(5), 869-79. 
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2.1 Abstract 
Steroid conjugates, which often occur as metabolites, are challenging to characterize.  One 
application is female-mouse urine, where steroid conjugates serve as important ligands for the 
pheromone-sensing neurons. Although the two with the highest abundance in mouse urine were 
previously characterized with mass spectrometry (MS) and NMR to be sulfated steroids, many 
more exist but remain structurally unresolved. Given that their physical and chemical properties 
are similar, they are likely to have a sulfated steroid ring structure.  Because these compounds 
occur in trace amounts in mouse urine and elsewhere, their characterization by NMR will be 
difficult. Thus, MS methods become the primary approach for determining structure. In this 
chapter, we show that a combination of MS tools is effective for determining the structures of 
sulfated steroids.  Using 4-pregnene analogs, we explored high-resolving power MS (HR-MS) to 
determine chemical formulae; HD exchange MS (HDX-MS) to determine number of active, 
exchangeable hydrogens (e.g., OH groups); methoxyamine hydrochloride (MOX) derivatization 
MS, or reactive desorption electrospray ionization with hydroxylamine to determine the number 
of carbonyl groups; and tandem MS (MSn), high-resolution tandem MS (HRMS/MS), and GC-
MS to obtain structural details of the steroid ring. From the fragmentation studies, we deduced 
three major fragmentation rules for this class of sulfated steroids. We also show that a combined 
MS approach is effective for determining structure of steroid metabolites, with important 
implications for targeted metabolomics in general and for the study of mouse social 
communication in particular. 
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2.2 Introduction 
Determining the structure of steroid conjugates is a major challenge in metabolomics.  A 
particular need is to understand animal communication.  Mammals use their sense of smell to 
identify and learn the status of other animals. Natural cues such as urine contain metabolites 
informative about reproductive status, social dominance, and levels of stress(1). In most cases, 
however, the identity of the signaling compounds remains unknown. A recent study(2) used the 
responses of olfactory neurons in the mouse vomeronasal organ, specializing in the detection of 
“social odors” or “pheromones” produced by other animals, to assay the activity of purified urine 
fractions. The structures of two active compounds were determined(3), by using a combination of 
mass spectrometry (MS) and nuclear magnetic resonance (NMR), were shown to be sulfated 
steroids of the glucocorticoid family. Because steroids are among the main regulators of 
mammalian physiology(4), their metabolites are attractive candidates for conveying many aspects 
of an animal’s status. Indeed, several lines of evidence suggest that urine contains other active, 
but unknown, sulfated steroids. For the urine from female mice of the BALB/c strain, sulfated 
compounds account for an estimated 80% of the total activation of these sensory neurons(2). 
Unfortunately, like many metabolites, many of the unknown cues in natural stimuli are present in 
much lower abundance than the two compounds identified by Hsu et al.(3), and consequently 
present a greater challenge for structural analysis. MS is particularly apt for obtaining structural 
information from small sample quantities, but we felt that a single MS method would not be 
adequate.  Thus, the purpose of the research reported in this chapter is to explore the effectives of 
various combinations of MS methods to determine steroid-sulfate structure. 
For many years, steroidal hormones have been analyzed by gas chromatography-mass 
spectrometry (GC-MS) since Sweeley and Horning’s(5) first success in 1960.  More recently, 
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steroids were also analyzed by using HPLC coupled with tandem mass spectrometry (LC-
MS/MS)(6-12). GC has the advantages over LC of higher chromatographic resolution, affording 
specificity for minor structural differences, as well as a vast EI online database for structural 
identification of analytes. GC-MS, however, requires some knowledge of the analytes’ structure, 
because GC’s reliance on volatility often necessitates functional-group-specific derivatization. In 
contrast, LC-MS/MS requires less initial knowledge of the structure of the sample, as 
derivatization is not a requirement for ionization. This eases the handling requirement for the 
sample and reduces possible losses of material during sample preparation. 
In this chapter, we describe a combination of methods, taking advantage of both GC-MS and 
LC-MS/MS, which constitute a MS-based “tool box” for studying structures of sulfated steroids.  
Although each tool is not new, we wished to explore whether a combination would offer an 
effective approach to steroid identification.  To demonstrate, we focused on a set of six 
commercial or custom-synthesized 4-pregnene steroids, a key class of compounds because they 
are central in steroid biosynthetic pathways in the mouse(13). The 4-pregnenes sulfates were 
chosen because they are structurally similar to previously identified sulfated steroids found in 
mouse urine and active for mouse communication.  We also anticipate that more unknown 
sulfated steroids belonging to this category exist in mouse urine. The combination we selected 
include different MS-based approaches including 1) high mass-resolving-power MS (HR-MS) to 
determine chemical formula; 2) HD exchange MS (HDX-MS) to determine number of active 
hydrogens (e.g., –OH groups); 3) methoxyamine hydrochloride (MOX) derivatization MS, or 
online derivatization with hydroxylamine by reactive desorption electrospray ionization, to 
determine the number of carbonyl groups; and 4) tandem MS (MSn),  high-resolution tandem MS 
(HRMS/MS), and 5) GC-MS to probe details of the steroid-ring structure. From the 
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fragmentation studies, we can draw some generalized fragmentation rules for sulfated-steroid 
CID MS/MS. This combination of MS-based methods provides an opportunity to “footprint” 
steroid sulfates metabolites, providing a foundation for sequel studies of mouse social 
communication.  
2.3 Materials and Methods 
2.3.1 Materials 
Sulfated steroids, including 4-pregnen-11β, 21-diol-3, 20-dione 21-sulfate (termed SS425, 
standing for sulfated steroid 425, the number of which is the molecular mass of [M - H]-), 4- 
pregnen-11β, 17, 21-triol-3, 20-dione 21-sulfate (SS441) and 4- pregnen-17, 21-diol-3, 11, 20-
trione 21-sulfate (SS439), and steroids, including 5β- pregnan-11β, 21-diol-3, 20-dione, 5α- 
pregnan-3α, 11β, 21-triol-20-oneand 4- pregnen-11β, 20β, 21-triol-3-one were purchased from 
Steraloids Inc (Newport, RI), and dissolved in methanol to 5 mM as stock solution. Strata-X 33u 
polymeric reversed phase 60 mg/3 m for solid phase extraction (SPE) was purchased from 
Phenomenex (Torrance, CA). All other chemicals and reagents were purchased from Sigma 
Aldrich (St. Louis, MO). 
2.3.2 Sulfation of Steroids 
Sulfation methods to synthesize sulfated steroids from steroids were modified from that of  
Kornel et al.(14) to suit for micro-synthesis. Acidified pyridine was prepared by adding 0.3 mL 
chlorosulfonic acid dropwise to 5 mL dry pyridine while cooling on an ice bath. To sulfate 
steroids 5β- pregnan-11β, 21-diol-3, 20-dione, 5α- pregnan-3α, 11β, 21-triol-20-one and 4- 
pregnen-11β, 20β, 21-triol-3-one, 5 µL of 5 mM stock steroid solution was dried by using a 
SpeedVac at room temperature, and the residue redissolved in 80 µL pyridine. Acidified pyridine 
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(30 µL) was then added, and the mixture was shaken for 5 min, as optimized, following which 
saturated NaHCO3 solution was used to neutralize the reaction solution, which was then dried in 
a SpeedVac at room temperature. The residue was redissolved in 3 mL H2O and desalted with 
SPE columns, and the final product was eluted with 1 mL methanol. Sulfation of 5β- pregnan-
11β, 21-diol-3, 20-dione and 4- pregnen-11β, 20β, 21-triol-3-one occurred at C21, as indicated 
by LC-MS/MS results (data not shown), leading to single products named SS427 (standing for 
sulfated steroid 425, the number of which is the molecular mass of [M - H]-) and iSS427 
(standing for isomer SS427), respectively; sulfation of 5α- pregnan-3α, 11β, 21-triol-20-one 
happened at either C3 or C21, referred to as 3-SS429 and 21-SS429 respectively, which were 
separated with a custom-packed C18 column before infusion into ESI source for MS/MS 
analysis. 
2.3.3 Mass Spectrometry 
2.3.3.1 Electrospray Ionization Mass Spectrometry (ESI-MS):  
Sample stock solutions were diluted to 1 µM and infused to an ESI source at 3 µL/min. Both 
low-mass-resolving power and high-mass-resolving power ESI-MS were conducted in the 
negative-ion mode on a LTQ Orbitrap Velos and a LTQ Orbitrap from Thermo Scientific (West 
Palm Beach, FL), equipped with the Xcalibur operating system. Spray voltage in the negative ion 
mode was set to 3.5 kV; capillary voltage and temperature was at -32 V and 275 ºC; and the tube 
lens was -222 V. Tandem MS (MSn) experiments were carried out after low energy CID by using 
a relative collision energy ranging from 30 to 40% of the maximum and high energy HCD with 
150 eV collision energy.  
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2.3.3.2 Reactive Desorption Electrospray Ionization (Reactive DESI):  
All DESI experiments were carried out by using an electrosonic spray ionization (ESSI) source 
to generate charged microdroplets, and a silica capillary to introduce the sample(15, 16). The ESSI 
sprayer was aimed to the outlet of the sample introduction capillary at an angle of 30°-45°, and 
the horizontal distance between the two was ~0.5 mm. The solvent for ESSI consisted of 
methanol/water in DESI and methanol/water/5% hydroxylamine/0.05% acetic acid in reactive 
DESI, and was injected at 10 µL/min, comparing to 4 µL/min of the sample flow rate. The 
control DESI experiments were done in the negative-ion mode, whereas the reactive DESI 
experiments were done in the positive-ion mode. The spray voltage was set at 5 kV for positive 
ions and -5 kV for negative ions; the nebulizing gas (N2) pressure for ESSI was 80 psi.  MS 
detection was on a Thermo Finnigan LCQ DecaXP plus. Capillary temperature and voltage was 
set at 250 ºC and 21 V, and the tube lens was 10 V for positive ions; they were set to 250 ºC, -47 
V, and -50 V, respectively, for negative ions. 
2.3.3.3 Gas Chromatography-Mass Spectrometry (GC-MS):  
The sulfate group of sulfated steroids was removed by solvolysis as described in(17), under 
conditions for micro-synthesis. Acidified ethyl acetate was prepared by shaking 1 M sulfuric acid 
in water and ethyl acetate (V:V= 1:2) vigorously for 2-3 min and then discarding the water phase. 
The dried sample was dissolved in acidified ethyl acetate to a concentration of 1 µM to give a 
total of 5 mL and incubated for ~ 6 h at 38 ºC, followed by neutralization with ammonium 
hydroxide. The reaction time was optimized for both SS425 and SS441 to 6 h. The desulfated 
sample was then dried, and redissolved in 15 µL pyridine, to which 15 µL of N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% TMS was added and incubated at 70 ºC 
for  1 h for SS425 and 2 h for SS441. Derivatized samples were then loaded into an Agilent 
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(Santa Clara, CA) 7693 autosampler, and 1 µL injections were analyzed on an Agilent 7890A 
gas chromatograph system interfaced to an Agilent 7200 accurate-mass Q-TOF mass 
spectrometer. The samples were injected with a 10:1 split. The GC column was a DB-5MS (12 m, 
0.25 mm i.d., 0.33 um film coating, P.J. Cobert St. Louis, MO). A linear temperature gradient 
was used:  the initial temperature of 80° was held for 2 min and increased to 280 at 15°/min. The 
temperature was held at 280° for 5 min. The samples were ionized by electron ionization (EI), 
and the source temperature, electron energy, and emission current were set at 280 °C, 70 eV and 
300 uA, respectively. The injector and transfer line temperatures were also 280°C.  
2.3.4 Hydrogen Deuterium Exchange (HDX) and Methoxyamine 
Hydrochloride (MOX) Derivatization 
HDX of sulfated steroids was initiated by dissolving a dried sample in D2O, to give a sample 
concentration of ~ 2 µM, at neutral pH. The same volume of acetonitrile was added prior to 
conducting ESI MS and MS/MS. MOX derivatization involved 18 h incubation of dried sample 
(20 µL × 1 uM) in 100 µL MOX reagent (2% in pyridine) at 60 ºC.  The product solution was 
then dried under nitrogen and re-dissolved in 20 µL MeOH and infused to the ESI source for 
analysis. 
2.4 Results and Discussion  
2.4.1 Electrospray Ionization (ESI-MS), HDX, and MOX Derivatization 
Given that these sulfated steroids contain a negative charge on the sulfate group, all ESI mass 
spectra and product-ion spectra (MSn) spectra were obtained in the negative-ion mode to give an 
[M - H]- molecular ion.  High-resolving-power mass measurement gave mass accuracy within 5 
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ppm for both 32S and 34S isotopic peaks, based on the molecular ion formulae (Table 2-1), as 
expected.  
Upon HDX, the molecular ion profile cleanly shifted 1 Da for SS425, indicating the existence of 
one exchangeable proton in the compound.  For SS441, the shift is 2 Da, indicating two 
exchangeable protons. For an unknown, its accurate mass would reveal the number of oxygens; 
that number, minus those in the sulfate group, indicates the maximum number of exchangeable 
sites, provided there are no nitrogens in the molecule.  Under neutral conditions, hydrogens alpha 
to a carbonyl group exchange very slowly and will not be “counted” here.  
MOX derivatization converts the carbonyl group to an oxime (C=NOCH3), leading to an 
increase of 29 Da in mass for every carbonyl of the compound.  Thus, HDX and MOX 
derivatization afford a count of the number of ketone or aldehyde groups (Table 2-1 indicates 
two carbonyl groups in both SS425 and SS441).  
Table 2- 1. Outcomes of the application of HRMS, HDX, MOX derivatization, reactive DESI, 
and HCD MS/MS of SS425 and SS441 
Sulfated 
steroids 
Structure 
HR/MS HDX 
MS 
(# of     
–OH) 
MOX 
deriv. 
(# of 
C=O) 
Reactive 
DESI 
(# of C=O) 
HCD 
MS/MS 
(-SO4-?) 
32S                        
(error) 
34S
(error) 
SS425 
 
425.1641 
(3 ppm) 
427.1670 
(3 ppm) 
426 
(1) 
483 
(2) 
491/492/493 
(2) 
97 
(yes) 
SS441 
 
441.1584 
(1 ppm) 
443.1549 
(3 ppm) 
443 
(2) 
499 
(2) 
507/508/509 
(2) 
97 
(yes) 
 
2.4.2 Reactive Desorption Electrospray Ionization (Reactive DESI)  
34 
 
As an alternative to MOX derivatization in counting carbonyl groups in sulfated steroids, we 
followed Huang et al.(18) in performing reactive DESI on steroids in the positive-ion mode, 
utilizing hydroxylamine and ambient-pressure ionization to derivatize steroidal carbonyl groups. 
Hydroxylamine was used instead of methoxyamine because it is more volatile than the latter and 
is compatible with on-line derivatization and detection. Unlike traditional DESI, we introduced 
the sulfated steroid samples in a capillary with a constant flow instead of depositing them on a 
plate. In this process, protonated hydroxylamine ions are formed during electrospray and carried 
in microdroplets toward the substrate where they react. The proposed product ions include a 
positively charged tetrahedral intermediate (hydroxylamine adduct, with a mass increase of 34 
Da) and an oxime formed by loss of water from the tetrahedral intermediate (Scheme 2 in 
literature(18)). Because the reaction with hydroxylamine ions give a more readily protonated 
group in lieu of the 
origianal carbonyl group, 
the derivatization adds a 
positive charge to the 
molecule, counterbalanced 
in part by the negative 
charge of the highly acidic 
sulfate group.  Provided 
there is more than one 
carbonyl group in the 
compound, we expect the 
products to be zwitterions 
 
Figure 2- 1. DESI mass spectra in the negative-ion mode for (a) 
SS425, (b) SS441.  Reactive DESI mass spectra in the positive-ion 
mode of (c) SS425, (d) SS441. 
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both in solution and in a mass spectrometer ion source operating in the positive-ion mode. 
As shown in Table 1 and Figure 2-1, product ions from reactive DESI on SS425 and SS441 are 
of m/z 493 and 509, respectively, both with mass increases of 68 Da, indicating the presence of 
two carbonyl groups in each compound. Unlike Huang et al.’s study(18), the oxime product 
wasn’t observed in either reaction, and the tetrahedral intermediate product was accompanied by 
an oxidation reaction that resulted in products with 1 or 2 Da decrease in mass, such as those at 
m/z 491/492 and m/z 507/508 in reactive DESI of SS425 and SS441, respectively. These 
differences likely result from the different instrumentation and DESI setup (we used ESSI 
instead of DESI). Although the mechanisms for the formation of the oxidized species of the 
tetrahedral intermediates is not a focus of this study, a possible explanation is that the ESI 
capillary (in this case, DESI capillary) is an electrolytic half-cell where redox reactions occur 
under the conditions of DESI(19).   
2.4.3 HCD MS/MS of ESI Produced Steroid Sulfates 
Verifying the presence of a sulfate group to account for at least one sulfur atom in the 
compounds is straightforward. With HCD 
MS2, the product-ion spectra of SS425 and 
SS441 are dominated by ions of m/z 97, 
HOSO3-, confirming that one sulfur atom is 
part of a sulfate group. One example is the 
HCD product-ion spectrum (MS2) of SS425 
(Figure 2-2). Aside from the ion of m/z 97, 
the ion of m/z 80 is SO3-, offering more 
 
Figure 2- 2. HCD fragmentation of the [M – 
H]- of m/z 425 of SS425. 
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confirmation for the presence of a sulfate group. The formation of HSO4- and SO3- is expected 
and was reported previously in product-ion spectra of many steroidal sulfates(20-23). The proton-
transfer mechanism as proposed in(24), occurs with the elimination of a ketene and a ketone. 
However, other vinyl or phenyl sulfates, such as estron-3-yl 3-sulfate, do not undergo bisulfate 
elimination to form HSO4- in mass spectrometric fragmentation(22, 23, 25), because that reaction 
would form a prohibitively high-energy benzyne. We term the formation of the product ion 
HOSO3- of m/z 97 upon HCD MS/MS as the “97” rule, which indicates the presence of a sulfate 
as a signature product ion. Although HCD gives highly obvious evidence for a sulfate substituent 
via the abundant product ions of m/z 80 and 
97, the other product ions, requiring higher 
dynamic range, provide incomplete structural 
details of the sulfated steroid. Therefore, we 
utilized an alternative tandem MS method 
with CID fragmentation in an ion trap, which 
prevented observation of the m/z 80 and 97 
ions and provided higher dynamic range for 
product ions arising from ring cleavages.  
2.4.4 Multi-stage CID (MSn) of ESI-
Produced Steroid Sulfates 
Today’s MS/MS technology allows the low-
energy, negative-ion CID spectra of 
metabolites such as SS425 and SS441 
 
Figure 2- 3. Product-ion spectra of the [M - 
H]- ions of SS425 of (a) m/z 425 (32S 
isotopolog) (b) m/z 427 (the 34S isotopolog),  
(c) the ion of m/z 426 (2H isotopolog) after 
HDX. 
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(presented in Figures 2-3a and 2-4a) to be 
obtained with accurate m/z measurement 
(Table 2-2). We were able to obtain product-
ion (MS2) spectra (Figure 2-3b and 2-4b) 
from precursor ions of m/z 427 for SS425 and 
443 for SS441, which are a mixture of 
isotopologs containing approximately 53% 
34S.  These spectra also confirm the 
presence/absence of sulfate group. For 
example, the single ion of m/z 410 in Figure 
2-3a must contain the sulfate group, 
consistent with the calculated elemental 
composition and the shift of 2 Da to m/z 412 
in Figure 2-3b.  More significantly, the 
product ions of m/z 325 and 343 must be 
formed by losses including the sulfate groups as the m/z 325 ion now appears as both m/z 325 
(losses of H234SO3 + H2O) and 327 ions (losses of H232SO3 + H2O); the latter retaining two 13C 
atoms. This is consistent with accurate mass measurements for ions of m/z 343 and 325 (Table 2-
2). 
To assign with more confidence the compositions of the product ions, MS2 was also conducted 
on samples where the -OH group has become deuterated (Figure 2-3c and 2-4c). By comparing 
product ions in Figure 2-3a and 2-3c, or Figure 2-4a and 2-4c, any mass shift indicates, in the 
absence of HD scrambling, the number of –OH groups retained in the related product ion.  
 
Figure 2- 4. Product-ion spectra of the [M - 
H]- ions of SS441 of (a) m/z 441 (32S 
isotopolog) (b) m/z 443 (34S isotopolog), and 
(c) m/z 443 after H/DX (2H isotopolog). 
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Noteworthy is the lack of any significant shifts of the m/z 325 and 343 ions (Figure 2-3c), 
indicating that the loss of H2SO3 and H2O now occur as those of HDSO3 and H2O. The results 
suggest that the loss of H2SO3 involves the H transfer from –OH on C11 to the sulfate group 
while transferring the charge from the sulfate group to the oxygen on C11. 
Table 2- 2. Calculated fragment-ion elemental compositions based on accurate mass detection of 
CID fragmentations with HRMS2 for SS425 and SS441. 
a. SS425  b. SS441  
m/z Calc. mass Comp. m/z Calc. mass Comp. 
410.1374 410.1394 C20H26O7S 426.1354 426.1354 C20H26O8S 
343.1890 349.1904 C21H27O4 423.1479 423.1483 C21H27O7S 
325.1785 325.1798 C21H25O3 411.1479 411.1483 C20H27O7S 
315.1943 315.1955 C20H27O3 343.1909 343.1915 C21H27O4 
310.1552 310.1563 C20H22O3 331.1909 331.1915 C20H27O4 
297.1839 297.1849 C20H25O2 315.1596 315.1602 C19H23O4 
285.1475 285.1485 C18H21O3 313.1803 313.1809 C20H25O3 
271.1684 271.1693 C18H23O2 297.1487 297.1496 C19H21O3 
257.1529 257.1536 C17H21O2 282.1256 282.1261 C18H18O3 
241.1582 241.1587 C17H21O 189.0921 189.0921 C12H13O2 
189.0911 189.0910 C12H13O2 138.9710 138.9709 C2H3O5S 
 
 
 
 
 
 
Figure 2- 5. Sites of fragmentation for the (a) molecular ion and (b-d) various product ions of 
SS425. Sites of fragmentation for the (e) molecular ion and (f-h) various product ions of SS441.  
Those parts of the structures drawn in fainter lines represent the regions lost as neutrals in the 
MS/MS-induced fragmentation. 
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This combination of isotopic labeling 
and accurate m/z measurement in the 
product-ion spectra permits a 
fragmentation pathway scheme to be 
proposed. Those schemes (Scheme 2-
1a and b), and reiterated in a simpler 
form in Figures 2-5a and 2-5e) are 
informative of the steroid-ring 
structure (the carbons are 
numerically labeled according to 
convention on structure of SS425 in 
Scheme 1a for convenience). 
Additional support and 
complementary information to 
characterize the steroid ring were 
found in a MS3 experiment and are 
reiterated in Figures 2-5b, c, d, f, g, and h. The fragmentation pathways proposed here for either 
MS2 or MS3 are not validated by molecular orbital theory or isotope labeling. Instead, the ion 
structures are proposed according to their accurate masses to be consistent with the 
fragmentation. The purpose is to show correlations in the fragmentation patterns of compounds 
from the same class of sulfated steroids and to provide insights on how CID fragmentation can 
be applied to track functional groups and their changes on the ring. One outcome is that the ring 
topology of steroid sulfates of this type can be characterized by the rich fragmentation seen in 
Scheme 2- 1. Proposed fragmentation pathways for 
(a) SS425 and (b) SS441 upon CID MS/MS. Ion 
structures are consistent with fragmentation and 
accurate masses of product ions, and they are 
proposed to facilitate the interpretation of the mass 
spectra and are not based on standard ion-chemistry 
criteria. 
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both MS2 and MS3 experiments, as illustrated in Figure 2-5. Collisional activation, however, does 
not always produce all possible fragmentations of the ring, in which case, the specific functional 
group location cannot be made. For example, the location of C17-OH in SS441 cannot be 
established because there’s no cleavage for C16-C17 bond; in which case if SS441 were an 
unknown compound, the –OH group can only be vaguely assigned to C16 or C17. 
2.4.5 Functional Group Location based on CID MS/MS  
One goal of interpreting tandem MS and accurate m/z data is to locate a functional group on the 
steroid ring.  The fragment ions of m/z 189 found for both SS425 and SS441 are depicted to 
contain steroid rings A and B, as well as C11. The formation of ions of m/z 189 is not simply due 
to the two homolytic cleavages of C11-C12 and C8-C14 bonds (scheme 2-1), but also must 
involve a proton transfer from C11-OH to the weak SO3- base, possibly followed by loss of the 
H2 and C9H14O5S. Although the reasoning to assign structure is similar to that used by Hsu et 
al.(3),and also supported by chemical composition from accurate mass and the lack of a sulfate 
group by 34S-MS2, we want to emphasize that we are not conducting a mechanism study but 
rather to use pathways to study substitutions on C11. To determine whether there is a correlation 
between the presence of a hydroxyl group on C11 and the occurrence of this product ion of m/z 
189 in MS2, four more sulfated steroids, namely, iSS427, SS427, 21-SS429 and SS439, were 
prepared, and their product-ion spectra were studied to search for similar cleavages. As expected, 
three of the four compounds, all of which possess a hydroxyl group at C11, gave product ions of 
m/z 189, 191 and 193 (Figure 2-6 a, b, and c), respectively, as a result of the cleavage of the C11-
C12 and C8-C14 bonds. By contrast, the product-ion spectrum of SS439 contains no such 
product ion, theoretically of m/z 187, owing to this cleavage, because C11 is now a carbonyl 
group (Figure 2-6d). Thus, we summarize this correlation between the presence of C11-OH and 
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the product ion of m/z 189/191/193 as the 
“C11-OH” rule, indicating that only when 
there’s a hydroxyl group on C11 will this 
fragmentation happen in sulfated steroids. On 
the other hand, when interpreting product-ion 
spectra of unknown sulfated steroids, MS3 
should be conducted to fragment the m/z 
189/191/193 ion, if present, to confirm its 
structure before invoking this rule and 
making conclusions. Although there are 
many other carbon sites on the steroid ring to 
accommodate a hydroxyl group and likely 
other fragmentation rules for steroids with 
hydroxyl group at those sites, C11, based on 
biological relevance, is an important position 
on the steroid ring structure because it is often hydroxylated by 11β-hydroxylase during steroid 
hormone synthesis in mouse, and sometimes followed by further oxidation(26). These differences 
are readily detected by MS2.  
Another important functional group, located at C20, is similarly deciphered by tandem MS. A 
derivative of many cholesterol steroids formed in steroid hormone synthesis involves reduction 
of cholesterol side-chain length and the hydroxylation of C21(13) by two important steroid 
enzymes, cholesterol 20–22 desmolase and 21-hydroxylase. C20 retains a -OH or =O after C20-
C22 cleavage with 20-22 desmolase action(27), and hydroxylated C21 could be then sulfated by a 
 
Figure 2- 6. CID fragmentation in the 
negative-ion mode of the [M – H]- of (a) 
iSS427, (b) SS427, (c) 21-SS429, and (d) 
SS439. 
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sulfatase to form sulfated steroids. As a result, sulfated steroids occurring biologically often 
differ at C20 as either a C=O or a C-OH. Again, this difference can be revealed by a product ion 
formed by the cleavage of bond C20-C21 and loss of a neutral molecule CH2SO4 to give a 
product [M - H+- 110]-, which only occurs when C20 is C=O. For example, as in Figure 2-3a, the 
loss of 110 from the precursor ion of m/z 425 leads to a product ion of m/z 315 (relative 
abundance of more than 20%). Accurate mass of the m/z 315 ion from HRMS2 (Table 2-2) and 
34S-MS2 (Figure 2-3b) indicates this ion forms by the loss of CH2SO4, allowing us to write an ion 
structure (Scheme 2-1a). The same fragmentation occurs for SS441. More support for this 
fragmentation chemistry comes from the product-ion spectra of iSS427, SS427, 21-SS429 and 
SS349, for which the loss of 110 occurs for the latter three (Figure 2-6 b, c, d), all of which have 
an C20 oxidized to C=O. In contrast, when C20 retains a hydroxyl group, this cleavage is 
inhibited. As shown in Figure 2-6a, no obvious product ion at m/z 317 is present. Thus, we 
summarize this as the “-110” rule, which addresses the correlation between C20 =O and 
fragmentation C20-C21 upon CID.  
2.4.6 Gas Chromatography Mass Spectrometry (GC-MS)  
GC combined with EI-MS is a powerful approach for the identification of unknown compounds, 
steroids being one important class of them. GC is particularly advantageous because it provides 
effective separation, which is needed for the analysis of complex biological mixtures in 
metabolomics.  Further, EI mass spectra has always been informative in structure studies, but it 
is even more so with today’s high-resolving power MS instruments that give accurate m/z for all 
fragments at speeds sufficient for GC separation. Exhaustive studies were reported by others to 
characterize the EI mass spectra of steroids and delineate fragmentation(28). Furthermore, online 
databases of EI mass spectra have expanded tremendously during the past three decades. For 
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example, Wiley Registry 9th 
edition contains approximately 
662,000 EI mass spectra of 
592,000 compounds; and Wiley 
also published a database “Mass 
Spectra of Physiologically Active 
Substances: Including drugs, 
steroid hormones, and endocrine 
disruptors” and contains 4182 
mass spectra and chemical 
structures of steroids. Thus, 
structural studies of unknown 
steroids can again take advantage 
of GC-MS, and, thus, we 
included it in our MS approach 
for unknown sulfated steroids.  
To utilize GC-MS, we had to remove chemically the sulfate group from the two standards, 
SS425 and SS441, and we then derivatized the products for GC/MS analysis. Solvolytic removal 
of the sulfate group was successful for nanomoles of samples, and the product yields were 
greater than 50% for both SS425 and SS441 (as determined by LC/MS). Removing the sulfate 
group on sulfated steroids is important for GC/MS analysis because the resulting samples are 
considerably more volatile. It is noteworthy, however, that solvolysis may convolute quantitative 
analysis for complex biological fluids for which a requirement may be to compare free versus 
 
Figure 2- 7. Mass spectra in the GC-MS mode for 
derivatized (a) SS425 and (b) SS441. 
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sulfated steroids. For that 
purpose, the combination of 
LC/MS and GC/MS for may be 
more suitable for quantitative 
analysis. After BSTFA/TMS 
derivatization of the desulfated 
steroids, we analyzed 0.1 nmol 
of sample. This low requirement 
of sample is compatible with 
studying low-abundance, urinary 
sulfated steroids, an application 
of this methodology. Accurate-mass mass spectra for SS425 and SS441 (Fig 2-7a and b) were 
searched in NIST MS database. A match of corticosterone bis(trimethylsilyl) ether was found for 
SS425, with a high probability score of 93%. However, no match was found for SS441. 
Although this structure may appear in other databases, we turned to the EI fragmentation 
pathway of SS441, based on accurate masses of fragments, to extract signature fragmentations 
that assist in identification. As before, the ion structures in this scheme are not established but 
only proposed to be consistent with accurate masses and fragmentation outcomes, and to 
organize our conclusions on how EI fragmentation might report on the structural details of a 
steroid ring.  Scheme 2-2 shows that under EI fragmentation, cleavages in the ring, mostly near 
the functional groups, reveal more detailed information about the ring structure. Therefore, the 
rich fragmentation from EI-MS complements that from ESI-MSn, and, taken together, allows one 
or several structure candidates to be proposed for an unknown.  
Scheme 2- 2. EI fragmentation pathways of derivatized 
SS441. Ion structures are proposed only to be consistent 
with accurate masses and fragmentation outcomes. 
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2.5 Conclusions 
A difficulty in assigning the structures of steroid sulfate 
metabolites as constituents in natural stimuli is their low 
abundance, precluding the application of most structural 
tools. To deal with this problem, we implemented a 
combined approach including HRMS to give the 
chemical formula, and HDX, MOX derivatization and 
reactive DESI to count various functional groups. The 
combination also includes MSn and GC-MS to resolve 
the arrangement of the functional groups and ring structure. Three major fragmentation rules 
were deduced in this study (Figure 2-8), the “97” rule, the “C11-OH” rule and the “-110” rule, 
collectively addressing the three metabolic important carbon sites for this family of compounds 
from the mouse. Proper chemical manipulation and derivatization permit the analysis of sulfated 
steroids by GC-MS to take advantage of its highly effective separation and the availability of 
online database searching to confirm structural assignments, taking advantage of the 
complementary and rich EI fragmentation. This MS-based combined approach consumes 
approximately 0.1 nmol of sample for ESI-MS with direct infusion when analyzed in the 
negative-ion mode and 1 nmol was required for simple chemical modification and derivatization 
for GC-MS. An outcome is that the ring topology of steroid sulfates of this type can often be 
well characterized, except when an important fragmentation is missing and only vague 
assignments can be made. In addition, although the fragmentation “rules” will likely change for 
other classes of steroids, this approach should be general for rare steroid metabolites, affording 
 
Figure 2- 8. Three fragmentation 
rules of sulfated steroids under low 
energy CID. 
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one or several putative structure that can be synthesized and its MS properties compared with 
those of the unknown.   
Another important application may be premarin, a pharmaceutical from urine of female pregnant 
horses, which is comprised of a large number of steroid sulfates, many still resisting 
identification. 
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Chapter 3* 
High-Energy Collision-Induced Dissociation by MALDI 
TOF/TOF Causes Charge-Remote Fragmentation of Steroid 
Sulfates  
 
 
 
 
 
 
 
 
 
 
* This chapter is based on recent publication: Yan, Y., Ubukata, M., Cody, R. B., Holy, T. E., 
Gross, M. L.. High-energy Collision-induced Dissociation by MALDI TOF/TOF Causes Charge-
Remote Fragmentation of Steroid Sulfates. J Am Soc Mass Spectrom, 2014, 25(8), 1404-11. 
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3.1 Abstract 
A method for structural elucidation of biomolecules dating to the 1980s utilized high-energy 
collisions (~10 keV, laboratory frame) that induced charge-remote fragmentations (CRF), a class 
of fragmentations particularly informative for lipids, steroids, surfactants, and peptides. 
Unfortunately, the capability for high-energy activation has largely disappeared with the demise 
of magnetic sector instruments. With the latest designs of tandem time-of-flight mass 
spectrometers (TOF/TOF), however, this capability is now being restored to coincide with the 
renewed interest in metabolites and lipids including steroid-sulfates and other steroid 
metabolites. For these metabolites, structure determinations are required at concentration levels 
below that appropriate for NMR. To meet this need, we explored CRF with TOF/TOF mass 
spectrometry for two groups of steroid sulfates, 3-sulfates and 21-sulfates. We demonstrated that 
the current generation of MALDI TOF/TOF instruments can generate charge-remote-
fragmentations for these materials. The resulting collision-induced dissociation (CID) spectra are 
useful for positional isomer differentiation and very often allow the complete structure 
determination of the steroid. We also propose a new nomenclature that directly indicates the 
cleavage sites on the steroid ring with carbon numbers.  
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3.2 Introduction 
Steroids are among the main regulators in mammalian physiology(1), and as a result, their 
metabolites are attractive candidates for conveying many aspects of an animal’s status. Steroid 
sulfates were first recognized as naturally occurring metabolites in 1938 when Schachter and 
Marrian(2) isolated estrone sulfate from the urine of pregnant mares. Since then, many more 
steroid sulfates have been isolated from different biological sources and identified. Until the 
1960s, they were considered as biologically inactive end-products of metabolism appropriate for 
elimination(3). Many efforts have been made since then to search for the physiological role for 
steroid sulfates, and these efforts revealed the significance of sulfated steroids for structural, 
signaling and regulatory functions(4-8).That they are biologically active is made clear by the 
commonly used drug Premarin, which is a complex mixture of steroid sulfates. Recently, with 
the emergence of lipidomics and metabolomics, the interest in steroid conjugate analysis is again 
growing. An example is the work of one of the authors (T. Holy), who found steroid sulfates of 
the glucocorticoid family as “social odors” or “pheromones” in mouse urine(9, 10). Given the low 
levels of these materials in mammalian fluids (at sub-micro molar concentration in mouse 
urine(9)), we need improved methods for structure determinations of steroid sulfates to deal with 
materials at concentrations below the levels at which NMR can be used.  
In early studies of analysis of steroids and their conjugates, GC/MS with electron ionization (EI) 
was the dominant approach(11-13). Although EI affords rich fragmentation, its utility is limited 
because most steroids require derivatization to form volatile, thermally stable analytes(14-17), 
sometimes compromising sensitivity. In the 1980s, the introduction of fast atom bombardment 
(FAB)(18) and tandem mass spectrometry (MS/MS)(19, 20), afforded a new approach for structural 
characterizations of steroid conjugates with mass spectrometry, but the approach required 
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magnetic-sector instruments and high collision energies to generate charge-remote 
fragmentation. The concept of charge-remote (originally called remote-site fragmentation) was 
first described in 1983 as observed on a unique three-sector mass spectrometer(21, 22). This 
instrumentation was later used to demonstrate the charge-remote fragmentations of a series of 
bile acids and bile salt conjugates(23) and other steroids(24, 25). Tomer and Gross(26) then reported 
in 1988 that both charge-remote and charge-proximate fragmentations occur for bile salts, steroid 
sulfates, and glucuronides, showing that nearly complete structure determination of steroid rings 
could be achieved. Unfortunately, there has been a marked decline in the application of high-
energy CID with the demise of sector instruments and the current dominance of ion traps, 
QTOFs, and hybrid ion-trap FT spectrometers that employ low-energy CID. Although the latter 
has been applied over years in structural characterization of organic compounds, including 
steroid sulfates(10, 27), the structural elucidation is complicated and incomplete because the major 
fragment ions usually result from losses of small molecules, and MS3 is often required to get a 
more complete set of fragment ions. Furthermore, low-energy CID spectra tend to show more 
rearrangement reactions and are not as reproducible as high-energy spectra. Because low-energy 
CID strongly depends on instrument characteristics and settings, the prospects of building an 
MS2 database for structure searches has become more complex(28).  
The introduction of TOF/TOF instruments, specifically designed for high-energy CID(29, 30), has 
triggered a “renaissance” of interest in high-energy fragmentation processes. MALDI coupled to 
an appropriate TOF/TOF-instrument can accommodate the need for sufficient mass resolving 
power, precursor-ion selection, and high collision energies for the structural analysis of 
biomolecules(31-34). The first evidence comes from Trimpin et al.(31) who showed that metal-
cationized fatty acids desorbed from a solvent-free preparation undergo CRF in a TOF/TOF. 
55 
 
Additional evidence is from Allmeier and Pittenauer(33, 34) who induced CRF of trialkylglycerols 
(TAGs). Other applications of MALDI TOF/TOF were also reported for carbohydrates and 
peptides(35, 36). Whereas fatty acids have been investigated by MALDI TOF/TOF and their CID 
spectra are well understood, steroids and their conjugates have been far less investigated(37). In 
this chapter, we demonstrate, for the first time to our knowledge, the application of MALDI 
TOF/TOF instrumentation to induce CRF and enable structural characterization of sulfated 
steroids. The results are comparable to those obtained on the older tandem magnetic sector 
instruments and strongly suggest that TOF/TOF instruments offer a new opportunity for lipid 
and steroid structure-determination studies and for lipidomics in general.  
3.3 Experimental Procedure  
3.3.1 Materials 
All steroids and sulfated steroids, cholesteryl sulfate, 3β-hydroxy-5-pregnen-20-one-3-sulfate 
(termed SS395, for sulfated steroid 395, the number of which is the molecular mass of [M - H]-), 
etiocholan-3α-ol-11,17-dione sulfate (SS383), 4-pregnen-11β,21-diol-3,20-dione-21-sulfate 
(SS425), 4- pregnen-11β, 17,21-triol-3,20-dione-21-sulfate (SS441), 4-pregnen-17,21-diol-
3,11,20-trione-21-sulfate (SS439), 5β-pregnan-11β,21-diol-3,20-dione, and 4-pregnen-11β, 
20β,21-triol-3-one were purchased from Steraloids Inc (Newport, RI), and dissolved in methanol 
to give a 5 mM stock solution. SS427 and iSS427 were prepared by sulfating 5β-pregnan-11β, 
21-diol-3,20-dione and 4-pregnen-11β,20β,21-triol-3-one as described previously(38). The 
structures of all steroid sulfates used are listed in Figure 3-1. All other chemicals and reagents 
were purchased from Sigma Aldrich (St. Louis, MO). 
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3.3.2 Mass Spectrometry 
A MALDI-TOF/TOF mass spectrometer (SpiralTOF™, JEOL Ltd., Tokyo, Japan) was used for 
all measurements. This MALDI-TOF/TOF mass spectrometer has unique multi-turn spiral ion 
optics with a 17 m long flight path to provide ultrahigh mass resolving power for MALDI-TOF 
measurements(39-41). An ion gate positioned at the 15 m point in the spiral ion flight path 
provided mono-isotopic precursor-ion isolation for tandem mass spectrometry upon high-energy 
CID(42, 43).  Selected monoisotopic precursor ions undergo 20 kV collisions with the helium 
collision gas at a pressure of 1.7x10-4 Pa. Ions exiting the collision chamber underwent 9 kV 
post-acceleration and focusing to ensure efficient detection of low m/z fragments.  
A 349 nm Nd-YLF laser operated at a laser repetition rate of 1 kHz was used to desorb and 
ionize the samples. The extraction delay was optimized to 50 nsec. α-Cyano-4-hydroxycinnamic 
acid (CHCA) matrix was dissolved in 1:1 water/acetonitrile containing 0.1% trifluoroacetic acid 
at a concentration of 10 mg/mL (Trifluoroacetic acid, normally removed for the negative-ion 
 
Figure 3- 1. Structures of steroid sulfates investigated.  
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mode detection,  caused the signal intensity to decrease by two fold compared to its absence . It 
was utilized here to show its compatibility with negative-ion mode detection and to keep open 
the possibility for adoption when analyzing a biological sample mixture in both the positive- and 
negative-ion modes.). The steroid sulfate and matrix solutions were mixed together 1:1 by 
volume.  A 1.0 µL aliquot of this mixture was deposited onto the MALDI target plate for 
analysis with the MALDI-TOF/TOF mass spectrometer. 
3.4 Results and Discussion  
We used MALDI TOF/TOF to investigate the fragmentation of two groups of steroid sulfates, 
namely 3-sulfates and 21-sulfates. These two groups were chosen because hydroxyl sites on 
neutral steroids suitable for sulfonation by steroid sulfotransferase are commonly present at 
carbons 3 and 21 (or 17) for C-21 steroids (or C-19 steroids).  Furthermore, they have the sulfate 
group fixed at either end of the steroid(44), allowing us to demonstrate the charge-remote nature 
of the fragmentation. The fixed charge at one end of the precursor ion after ionization should 
allow CRF to be induced 
remotely as the predominant 
reaction channel under high-
energy CID for both 3-sulfates 
and 21-sulfates. With the fixed 
sulfate group, these steroid 
sulfates can be readily desorbed 
and ionized by MALDI as [M – 
H]- species (Figure 3-2a shows 
 
Figure 3- 2. Monoisotopic precursor-ion selection of 
SS441 for TOF/TOF Measurements in Spiral TOF. 
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one example of the negative-ion mass spectrum of SS441). With the SpiralTOF, accurate mass 
measurements are achieved in MS1 scans, and monoisotopic precursor-ion selection is made 
possible for fragmentation (Fig 3-2b), allowing straightforward interpretation of the product-ion 
spectra (TOF/TOF). The major fragmentations for members of each subclass are similar and 
often involve through-ring cleavages, as is described below. 
Table 3- 1. Major fragment ions from high-energy CID of [M - H]- ions of 3-sulfates 
 
 
 
Steroid sulfate SO3- HSO3- 2,3A 5,10B 6,10B 7,10B 8,9C 8,11C 13,14D 13,15D 17,18S 
Cholesteryl sulfate 80,97 123 N/A N/A 217 243 257 311 325 337 
SS395 80,97 123 N/A N/A 217 243 257 311 N/A 337 
SS383 80,97 123 191 204 N/A 245 N/A 327 341 N/A 
 
3.4.1 Fragmentation Nomenclature 
Given that this fragmentation by through-ring cleavages may be general, we provide a new 
nomenclature designating the steroid ring cleavages. Shown for cholesteryl sulfate (Table 3-1) is 
the nomenclature, where each cleavage is named for the ring in which it occurs and the positions 
of two carbon atoms constituting the two bonds that must be broken to cause a through-ring 
cleavage (the designated carbon atoms are to the left of the cleavage, and ring A is on the left, 
ring D on the right, as per convention). For example, a cleavage that breaks ring B at C9-C10 
and C7-C8 is designated as 7,10B. In addition to major ring cleavages, high-mass ions are formed 
by cleavages of the side chain attached to ring D, remote from the charge site (Figure 3-3). 
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Cleavages occurring at the 
side chain are named by using 
the two carbon positions at the 
C-C bond being cleaved. For 
example, the cleavage at bond 
C20-C22 is named as 20,22S 
(“S” refers to the side-chain). 
Note that the cleavages are 
denoted with a simple dashed 
line, because in charge remote 
fragmentations the charge is 
fixed and the product ion 
always contains the charge. 
3.4.2 3-Sulfates 
We investigated three steroids 
substituted with sulfate at the 
3-position (A ring) by MALDI 
TOF/TOF and obtained highly informative MS/MS data, with rich fragmentation occurring 
through the steroid ring (Table 3-1). As indicated in the product-ion spectra (Table 3-1 and 
Figure 3-3), 3-sulfates undergo predominantly charge-remote fragmentation upon high-energy 
collisions, providing information about the nature of the substituent and its location, especially if 
the substituent is an alkyl chain. Taking cholesteryl sulfate as an example, we find rich 
fragmentation of the ring structure and the side chain at C17 (Figure 3-3a) to give a detailed 
 
Figure 3- 3. High-energy CID fragmentation in the negative-
ion mode of 3-sulfates: a. cholesteryl sulfate, b. SS395, and  
c. SS383.  The highly broadened [M – H]- signals indicate 
this precursor is off scale presumably because the product-
ion yield is low and dispersed over many fragments. 
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“foot-print” of the ring junctions and the side-chain branching of this compound. For example, 
the mass difference for the B-ring cleavage, 7,10B, and the C ring cleavage, 8,9C, is 26 Da, which 
corresponds to C2H2 and shows that the ring junction is unsubstituted.  Comparing the three 3-
sulfates, we find that processes 2,3A, 8,9C, and 13,14D occur for the three compounds, and the mass 
differences between 2,3A and 8,9C are 120 Da (C9H12) for cholesteryl sulfate and SS395 whereas 
for SS383, the difference is 122 Da (C9H14), consistent with the absence of a double bond in the 
latter. Similarly, the differences between 8,9C and 13,14D are consistent with the substitution 
patterns (Table 3-1 and Figure 3-3). For cholesteryl sulfate and SS383, the differences between 
13,14D and 13,15D are 14 Da, as expected whereas for SS395, the 13,15D  fragment is missing, and  
replaced by an ion m/z 323 formed by loss of C4H8O by an unknown mechanism. On the 
contrary, the appearance of product ions from cleavages across the B ring are significantly 
different for SS383 and the other two, mainly because the C5-C6 bond is a single bond for 
SS383 and a double bond for the other two (Figure 3-3 a, b). A fragment ion is formed by the 
nearby cleavage, 7,10B, of both cholesteryl sulfate and SS395, although this fragment is missing 
in the product-ion spectrum of SS383 (Figure 3-3c). Besides B-ring cleavages, cleavages of the 
C ring show the expected differences among the three compounds. For example, 8,11C is absent 
in SS383 fragmentation, consistent with the presence of the C11 keto group that prevents this 
cleavage (Table 3-1), and the differences between 8,9C and 8,11C for cholesteryl sulfate and 
SS395 is 14 Da, consistent with a CH2 group at position 11. This detailed analysis of ring 
cleavages was not presented in the early papers on CRF of steroids, and the prospects for a 
nearly complete structural analysis were not understood. Importantly, branching sites on the side 
chain are easily determined by examining the pattern for CnH2n+2 eliminations, because cleavages 
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happening at either side of a branch point are more facile than those occurring via double 
cleavages at a branch point.    
Table 3- 2. Major fragment ions from high-energy CID of [M - H]- ions of 21-sulfates 
 
 
Steroid 
sulfate 
2,3A 1,3A 1,4A 5,10B 6,10B 7,10B 8,9C 8,11C 8,12C 13,14D 13,15D 17,20S 20,21S 
iSS427 383 371 N/A 317 303 291 263 235 221 180 167 139 110 
SS427 383 371 357 315 301 288 261 233 219 178 165 N/A 110 
SS425 381 369 N/A 315 301 289 261 233 219 178 165 N/A 110 
SS441 381 367 N/A 331 317 305 N/A N/A 235 N/A N/A 139 110 
SS439 395 383 N/A 329 N/A 303 N/A N/A 235 N/A 181 139 110 
Note: * All 21-sulfates produce fragment ions at m/z 80 and 97, representing SO3- and HSO4- respectively. 
          ** 2,3A and 1,3A product ions from SS441 associated with a consecutive lost of H2O, as revealed in m/z. 
 
In addition to the common fragment ions due to ring or side-chain cleavage, some unexpected 
fragments are also formed; these are consistent with our early findings on CRF of steroid sulfates 
(26). For example, besides the losses of neutral molecules in which the C17 substituent is cleaved 
with H-transfer, cleavages also occur to eliminate directly a CH3 radical, presumably forming a 
distonic ion, rather than H transfer and elimination of neutral molecules (this cleavage is termed 
17,18S, as shown in Table 3-1). The mechanism for this cleavage was previously proposed to 
occur through a six-member transition state (Scheme 1 in ref 26). Although obtaining detailed 
mechanistic data is not the purpose of this paper and must await future work, we show the 
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fragmentation for clarity. Another example is the fragmentation of the three 3-sulfates to undergo 
a CH4 loss upon CID. This process most likely arises from the loss of an angular methyl group 
(C18 or C19) with H rearrangement and indicates the presence of methyl substituents. 
3.4.3 21-Sulfates 
We investigated five different compounds with different substitutions on the ring or the side 
chain, as listed in Table 3-2. Similar to 3-sulfates, 21-sulfates give rich charge-remote 
fragmentation as cross-ring cleavages and of the side chain upon high-energy CID (Figure 3-4). 
Ions of m/z 80 and 97 are also abundant in product-ion spectra of 21-sulfates, representing 
SO3- and HSO4- from releases of small, charged sulfur-containing groups. Although we adopted 
 
Figure 3- 4. High-energy CID fragmentation in the negative-ion mode of 21-sulfates: 
a. iSS427, b. SS427, c. SS425, d. SS441, and e. SS439. The highly broadened [M – 
H]- signals indicate this precursor is off scale presumably because the product-ion 
yield is low and dispersed over many fragments. 
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the same nomenclature for all the cleavages of 21-sulfates as for the 3-sulfates, the designations 
for 21-sulfates are of portions of the steroid that are lost as neutrals whereas for the 3-sulfates, 
they are part of the fragment ion. The scheme in Table 2 shows an example of the cleavages of 
SS427. 
The CID spectra of [M - H]- ions can be used to delineate clearly the locations and type of 
different substitutions. For example, the positional isomers, iSS427 and SS427 differ in the 
position of a double bond; iSS427 has the double bond between C4 and C5, whereas SS427 has 
the unsaturation located at C20 as a keto group. As a result, their product-ion spectra (Figure 3-4 
a, b) show that ions formed by 1,4A cleavage are among the most abundant fragments formed 
from SS427 but undetectable for iSS427. The same types of fragmentations involving rings B, C, 
and D occur for both compounds, but they show a consistent mass shift of 2 Da. In addition, the 
C20 keto groups in SS427 and in SS425 (Figure 3-4 b, c) prevent the 17,20S cleavage, but 
replacement of the keto group with C20-OH in iSS427 promotes this fragmentation and gives the 
ion of m/z 139 (Figure 3-4a). An m/z 139 ion is observed, however, although less abundant, in 
the product-ion spectra of SS441 and SS439 (Figure 3-4 d, e), indicating that the effect of a C20 
keto group on 17,20S is eased when substituted by a hydroxyl group at C17 (the only difference 
between SS441 and SS425). Although SS441 differs from SS425 only by the C17 hydroxyl 
group, it undergoes fewer cleavages of the C and D rings, suggesting that a C17 hydroxyl group 
suppresses cleavages of the C and D ring. Likewise, SS439 also undergoes nearly no cleavages 
across the C and D ring under CID.  
Expulsions of neutral molecules, CH4 or CO, are dominant reactions for most 21-sulfates being 
studied. The loss of CH4 is similar to that in 3-sulfates, which likely involves an angular methyl 
group. Loss of CO is also a charge-remote cleavage on the A ring of 21-sulfates, which occurs 
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similarly at the D ring of SS383, a 3-sulfate steroid. The other two 3-sulfates undergo no such 
fragmentation owing to the lack of keto groups on the ring system. Besides losses of CH4 and 
CO, SS441 also gives abundant ions by the loss of H2O, which are followed by other consecutive 
fragmentations such as 2,3A and 1,3A, as indicated in Table 3-2. 
We wish to note that the cleavages are not always as simple as indicated by the dashed lines.  
Sometimes the cleavage occurs as designated (e.g., 1,3A, 1,4A, 7,10B, 8,11C, 8,12C, and 13,15D) 
whereas other cleavages occur as designated but are accompanied by additional H transfer(s).  
Consider, for example, 2,3A. A simple through-ring cleavage would give loss of C2H2O, but the 
actual fragmentation is to lose C2H4O.The mechanistic reasons for these differences are 
interesting and remain to be elucidated.  Nevertheless, structural assignments can still be made in 
the absence of a complete understanding of the ion chemistry. 
3.4.4 Approximate Detection Limits 
In addition to studying the effectiveness of MS/MS fragmentation for structure elucidation, we 
evaluated the detection limit of the 3- and 21-sulfates on this MALDI TOF/TOF instrument, 
requiring sufficient fragmentation information for structure characterization. We took one 
example from each group of steroids, cholesteryl sulfate and SS425, and evaluated the signal-to-
noise ratio (S/N) of the base peaks in their product-ion spectra when different amounts of sample 
were applied to the MALDI plate. As shown in Table 3-3, S/N of the base peak at m/z 311 in the 
product-ion mass spectrum of cholesteryl sulfate decreased from 200 to 80 when the applied 
sample amount is reduced from 25 pmol to 4 pmol. Further reduction of the sample applied to 1 
pmol caused the S/N for detecting the ion of m/z 331 to decrease to 20. Although the intensity for 
the base peak detection is still acceptable with 1 pmol of sample application, some of lower-
abundance product ions disappeared below the S/N at this condition (e.g., the ion of m/z 217), 
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making a structure assignment incomplete. Similarly, for SS425, S/N of the base peak at m/z 219 
decreased from 500 to 60 in the product-ion spectrum when the sample applied was decreased 
from 25 to 1 pmol; further, the lower abundance fragment ions began to disappear with 1 pmol of 
sample application. Although the S/N tracks only approximately the applied sample quantity, we 
can conclude that the approximate detection limit sufficient for structure assignment of steroid 
sulfates is low pmol levels, with some variations for different samples. This low sample-size 
requirement demonstrates the applicability of MALDI TOF/TOF for analyzing biological 
samples where only trace amounts can be isolated (e.g., SS425 was shown to exist in mouse 
urine at micro-molar concentrations in a previous study(9)).  
Table 3- 3. Signal-to-noise ratios of base peaks in the product-ion spectra of 
cholesteryl sulfate and SS425 as a function of the amount of sample applied. 
Steroid sulfate Cholestery sulfate SS425 
Base peak (m/z) 311 219 
Applied amount (pmol) 25 10 4 1 25 10 4 1 
S/N 200 100 80 20 500 400 200 60 
 
3.5 Conclusion 
The effectiveness of charge-remote-fragmentation for primary structure identification of lipids 
and steroids has been known for some time. The approach can determine locations of double 
bonds, identify various functional groups, locate branching and ring junctions directly from 
product-ion spectra. Instrumentation and ionization methods traditionally used for CRF, 
however, have become rare, diminishing the importance of CRF in structural studies.  It 
continues to be recognized and invoked, however, as one class of fragmentation, a “thermal-like” 
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process that occurs with little or no involvement of a charge or radical site. Low-energy MS/MS 
fragmentation of steroid sulfates(45) produce fewer cross-ring cleavages and is less informative 
than the spectra from high-energy activation, which induces extensive fragmentation across the 
steroid ring at the ring junctures. 
The ability to induce CRF coupled with the advantage of monoisotopic precursor-ion selection 
afforded by new TOF/TOF instruments, permits relatively straight-forward interpretation of 
product-ion spectra because all product ions are monoisotopic. These characteristic ions formed 
under high-energy CID are nearly identical to those observed many years ago on tandem sector 
instruments when the sample was introduced by FAB ionization. Cleavages through the steroid 
rings occur whether the steroid is a 3- or a 21-sulfate, consistent with the classification that the 
processes are “charge-remote” as would be expected because the intervening rigid steroid ring 
makes it impossible for the charge site to interact with the reaction site. Although the earlier 
measurements on steroids proved that the fragmentation is indeed charge-remote and showed the 
nature of the remote side chain, the work in this chapter also shows that there is more 
information in these spectra (e.g., on ring junctions and substituent locations). 
In spite of the commonality of ring cleavages, 3-sulfates can be easily differentiated from 21-
sulfates by the low m/z product ions. For example, 3-sulfates give a product ion of m/z 123 by 
2,3A cleavage, whereas 21-sulfates give product ions of m/z 110 arising from the side-chain 
cleavage, 20,21S.  3-Sulfates containing alkyl side chains on the D ring can also be differentiated 
from 21-sulfates, because the former is rich in fragments in the high mass range, owing to 
cleavages of the side chain, to give product ions that reflect its structure and locate the branch 
points. Locating functional groups is also straightforward by considering the mass differences 
between nearby cleavages. An important caveat is that certain substitutions on the ring (e.g., a 
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C11 keto group) can prevent nearby fragmentations. In this case, the absence of cleavages is also 
informative and should be taken into account when elucidating unknown steroid structures.   
We project that an important application of this approach will be in imaging steroids, lipids, and 
related materials. 
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Chapter 4 
Structural Characterization of A Novel Steroid Metabolite: 
A Molecular Code for Identity in the Vomeronasal System 
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4.1 Abstract  
In social interactions, individuals are recognized by visual, auditory, or olfactory cues, but the 
fundamental basis of recognition is poorly understood. Olfactory recognition exploits emitted 
chemical cues, but identifying the key signals among thousands of compounds remains a major 
challenge. To address this need, Holy et al. developed a new technique, Component-Activity 
Matching, to select candidate ligands that “explain” patterns of bioactivity across diverse 
complex mixtures. Using this technique, 23 components from mouse urine were found as 
candidates to explain firing rates in seven of eight functional classes of vomeronasal sensory 
neurons. And one putative female sex pheromone, was identified to stimulate a class of neurons 
selective for females. This compound accounted for much of the neuronal activity of some 
female strains, and greatly enhanced investigatory behavior of males. Here, we report the 
structural characterization of this unknown compound. Mass spectrometric approaches, including 
high-resolution mass spectrometry, HDX and other chemical derivatization followed by ESI 
mass spectrometry, and tandem mass spectrometry are used to identify this compound, which we 
named as cortigynic acid. The structural identity of the compound is later confirmed with custom 
synthesis based on the proposed structure.   
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4.2 Introduction 
Mammals explore the chemical world with several olfactory modalities(1). The accessory 
olfactory system (AOS) emphasizes the detection of social cues, sometimes called pheromones, 
which regulate behavior among members of the same species(2, 3). Behavioral data have shown 
that pheromones are present in several scent sources: secretory glands (lacrimal, salivary, and 
preputial), urine, and feces(2, 4). Mouse urine excites widespread activity among vomeronasal 
sensory neurons (VSNs)(5-8) and is the best behaviorally characterized source of chemical cues 
for mammalian social communication(2). Although recent progress has been made toward 
identifying the molecular nature of pheromone cues by purifying individual ligands from mouse 
urine(9-11), the identities of olfactory ligands inside urine cues are largely unknown.  
Recently, Holy lab developed a novel approach, Component-Activity Matching (CAM), for 
systematically and exhaustively defining a “short list” of candidate vomeronasal ligands that 
encode identity. This approach exploits the striking differences among natural stimuli across 
different sexes and strains of mice(8) in a forward screen for compounds that may drive activity in 
vomeronasal neurons, without the need for laborious sample purification. The hypothesis is that 
these different neuronal activity patterns could be caused by different ligands present in one or 
more of urine samples. Thus, the molecular correlates of identity might therefore be discoverable 
by seeking compounds whose abundance could “explain” these patterns of physiological 
responses. Using this approach, a small set of constituents whose concentrations match a pattern 
of neuronal responsiveness across samples were identified. Later, they focused on a class of 
neurons that responded to urine from females of all strains, which did not respond to any male 
strains. One best CAM candidate that explains this pattern of neuronal activity was purified. It is 
proven to account for one-fourth of neuronal activity of female C57BL/6J mouse urine. 
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In this chapter, we report the structural characterization of this best CAM candidate, which we 
call M377, with mass spectrometry. Different mass spectrometry methods are used, including 
high-resolution MS, tandem MS and HDX MS. Based on the proposed structure, a standard 
compound was custom-synthesized and used to confirm the identity of the unknown compound. 
Preliminary behavior studies indicate that this M377 (cortigynic acid) is a sex pheromone that is 
unique in female mouse urine. The identification of its strucuture introduces a new type of 
molecular cues for identity in a mammalian olfactory system.  
4.3 Experimental 
4.3.1 Materials 
1, 4-pregnadien-11β, 17, 20-triol-3-one 21-carboxylic acid were purchased from Steraloids inc 
(Newport, RI), All other chemicals and reagents were purchased from Sigma Aldrich (St. Louis, 
MO). 
4.3.2 Hydrogen/Deuterium Exchange (H/DX) 
H/DX of M377 was initiated by dissolving a dried sample in D2O at neutral pH, to give a sample 
concentration that, based on ion count of similar structures, was ~ 2 µM. The same volume of 
acetonitrile was added prior to conducting ESI MS.  
4.3.3 Periodic Acid Reaction 
The periodic acid reaction with M377, as well as a comparison standard 1, 4-pregnadien-11β, 17, 
20-triol-3-one 21-carboxylic acid (Steraloids, Newport, RI), was initiated by mixing 20 µL of 
sample (~1 µM in MeOH) with 80 uL of 0.5% periodic acid. The reaction mixtures were then 
shaken for 20 minutes before nanoLC/MS analysis.  
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4.3.4 Mass Spectrometry 
Stock solution of M378 and synthetic compound was diluted to ~1 µM and infused to an ESI 
source at 3 µL/min. ESI-MS were conducted in both the negative-ion mode on a LTQ Orbitrap 
Velos and the positive-ion mode on a LTQ Orbitrap from Thermo Scientific (West Palm Beach, 
FL), equipped with the Xcalibur operating system. In the negative ion mode, spray voltage was 
set at 3.5 kV; capillary voltage and temperature was at -32 V and 275 ºC; and Tube lens was -
222 V. In the positive ion mode, spray voltage was set at 4.5 kV; capillary voltage and 
temperature was at 49 V and 250 ºC; and Tube lens was 100V. Tandem MS (MSn) experiments 
were carried out after low energy CID by using a relative collision energy ranging from 30 to 
40% of the maximum. 
4.4 Results and Discussion 
4.4.1 Chemical Formula 
Deduction of M377 with High 
Resolution MS  
High-resolution mass spectra (HR-
MS) and H/DX mass spectra were 
obtained to determine elemental 
composition and the presence of 
particular chemical groups. HR-MS in 
the negative-ion mode gave an 
 
Figure 4- 1. HRMS mass spectra for M377 (A) in the 
negative ion mode (B) in the negative ion mode after 
HDX (C) in the positive ion mode after HDX. 
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accurate mass of 377.1968 for molecular ion [M-H]- (Figure 4-1A), consistent within 1ppm with 
the formula C21H29O6−. This chemical formula is also supported by the isotopic peak distribution, 
with the 13C peak being ~20% of the 12C peak. H/DX MS was performed in both negative and 
positive ion modes, showing that the maximum mass shift after hydrogen/deuterium exchange is 
3Da in negative ion mode and 4 Da in positive ion mode. This indicates that there are four 
exchangeable sites (hydroxyl groups) in the molecule, of which one gets ionized in the negative 
ion mode for detection, suggesting the presence of a carboxylic group (Figure 4-1B and C). 
4.4.2 Structural Characterization of M377 with Tandem MS 
For further structural elucidation of M377, 
low-energy negative-ion collision-induced-
dissociation (CID) spectra were acquired at 
both low and high resolving power (Figure 4-
2A and B), allowing elemental composition to 
be calculated for product ions (Table 4-1). For 
example, one of the product ions at m/z 
189.0922 is calculated to be (C12H13O2−), with 
mass accuracy within 1ppm. Interestingly, this 
product ion was also observed in a previous 
study (11), so here we performed MS3 on this 
product ion. The result (Figure 4-3A) showed 
an identical MS3 spectrum. Thus, the ion of 
m/z 189 (C12H13O2−) has the structure depicted 
 
Figure 4- 2. CID fragmentation in the 
negative ion mode of (A) M377, (B) M377 
with accurate mass detection, and (C) 4-
pregnadien-11β, 16, 20-triol-3-one 21-
carboxylic acid. 
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in Scheme 4-1. Another example is one of 
product ions at m/z 331.1909 (C20H27O4−) 
(Figure 4-3B), formed by the loss of CH2O2 by 
cleavage of the C20-C21 bond. This fragment 
ion supports our hypothesis of a -COOH group 
at this position. Similarly, an ion of m/z 
301.1805 (Figure 4-3C) is attributed to the loss 
of C2H4O3, from the cleavage of the C17-C20 
bond, which could be explained by a 
consecutive C20-CH(OH)- group next to the 
C21–COOH group. This interpretation is also 
supported by the MS3 data of ions at m/z 331, 
which led to fragment ions at m/z 301 (Figure 
4-3B). Also, given the known structure of the 
ion of m/z 189 (C12H13O2−), the fragment ion 
of m/z 203 (C13H15O2−) can be assigned as the cleavage in C ring which differs by one carbon 
site from that producing m/z 189. Similarly, fragment ions of m/z 243 (C16H19O2−) and m/z 257 
(C17H21O2−) were formed by cleavages of the D ring. When compared to ions of m/z 189, this 
indicated that there were no –OH group substitutions on C12, C13, C14 or C15 (Scheme 4-1).  
Thus, the location of each functional group can be assigned as indicated in Scheme 4-1, with one 
exception: the –OH group located either on C16 or C17. Based on the difference (C2H4O) of 
product ions of m/z 257 and 301, the cleavage sites that led to them can only be separated by two 
carbons, C16 and C17, one of which bears the last unassigned –OH group. This interpretation is 
 
Figure 4- 3. MS3 in the negative ion mode of 
(A) product ion at m/z 189 from M377 MS2 
(B) product ion at m/z 331 from M377 MS2 
(C) product ion at m/z 301 from M377 MS2. 
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also supported by MS3 analysis of an ion of m/z 301 (Figure 4-3C), which showed an abundant  
fragment of m/z 257. However, due to the lack of additional fragmentation between the C16 and 
C17, MS2 gave little indication of which of these locations should be preferred. Therefore, we 
carried out a chemical degradation with periodic acid, which reacts with 1,2-diols by cleaving the 
C-C bond and forming an aldehyde. Consequently, periodic acid would react with M377 if the –
OH was on C17 (forming a 1,2-diol at C17 and C20), but not if the –OH was on C16. Both 
M377 and a standard compound 1, 4-pregnadien-11β, 17, 20-triol-3-one 21-carboxylic acid 
(P0750-000, Figure 4-4A) were reacted with periodic acid. P0750-000 served as a positive 
Table 4- 1. High-resolution Mass Measurements of Major Fragment ions.  
measured mass (Da)  calculated mass (Da)  elemental composition 
of ion  
Elemental composition 
of lost molecule  
377.1963  377.1970  C21H29O6-  N/A  
359.1857  358.1864  C21H27O5-  H2O  
331.1909  331.1915  C20H27O4-  CH2O2  
313.1804  313.1809  C20H25O3-  CH4O3  
301.1805  301.1809  C19H25O3-  C2H4O3  
295.1699  295.1704  C20H23O2-  CH6O4  
287.1648  287.1653  C18H23O3-  C3H6O3  
269.1543  269.1547  C18H21O2-  C3H8O4  
257.1544  257.1547  C17H21O2-  C4H8O4  
243.1388  243.1391  C16H19O2-  C5H10O4  
203.1078  203.1078  C13H15O2-  C8H14O4  
189.0922  189.0921  C12H13O2-  C9H16O4  
161.0975  161.0972  C11H13O-  C10H16O5  
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control, and the chemical derivatization products were detected by positive-ion mode MS. As 
expected, P0750-000 reacted with periodic acid and generated a reaction product of m/z 
301.1798 (C19H24O3)+ (Figure 4-4A).  In contrast, M377 did not react with periodic acid, with 
only the unreacted [M+H]+ of m/z 379.2115 present (Figure 4-4B). Therefore, we confirmed that, 
unlike P075-000, M377 has a 1,3–diol instead of a 1,2–diol. Since C20 has a –OH group (as 
described above), the unassigned –OH group must be positioned at C16 instead of C17. 
Therefore, we proposed the structure of M377 to be 4-pregnadien-11, 16, 20-triol-3-one 21-
carboxylic acid, also known as 16-hydroxycorticosterone 20-hydroxy-21-acid. 
To test the validity of this structural interpretation, we obtained a custom synthesis of this 
proposed compound, as a epimeric mixture at carbon 20. Product-ion mass spectra of the 
synthetic and endogenous compounds are nearly indistinguishable (Figure 4-2A and C), and MS3 
on major MS2 fragment ions from both compounds are also consistent (data not shown), 
indicating identical structures of the two. Further, the two stereoisomeric components of the 
synthetic epimeric mixture were quantified by HPLC as having a concentration ratio of 10:1; of 
which the less abundant component matched the endogenous compound in elution time and 
Scheme 4- 1. Fragmentation processes proposed for the [M-H]- ion of M377. 
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showed the same neuronal 
activity as endogenous M377.  
The structure of M377 has 
several distinctive features. To 
our knowledge, biological 
activity of a steroid carboxylic 
acid has not been previously 
reported. As a 21-carbon 
steroid with a hydroxyl group at 
the 11th position, this structure 
likely derives from metabolism 
of a glucocorticoid(12). 
However, the hydroxyl group at 
position 16 is a motif characteristic of a female sex steroid, estriol, which in humans is only 
produced in significant amounts during pregnancy(13). We therefore named this new VSN ligand 
“cortigynic acid.”  
4.5 Conclusion 
The structural elucidation of M377 as a vomeronasal code for identity helped support the newly 
developed strategy, CAM, as a validated fast unbiased screen for VNO ligands. Without 
requiring any purification, CAM identified a single compound, out of 1,634 possibilities, to 
explain responses of a neuronal type selective for urine from BALB/c females. Structural 
analysis of this compound, M377, to be a novel ligand, cortigynic acid. One of the most 
intriguing aspects of this structure is the presence of a hydroxyl group on C16, a motif known 
 
Figure 4- 4. HRMS mass spectra for products of periodic 
reaction with (a) 1, 4-pregnadien-11β, 17, 20-triol-3-one 
21-carboxylic acid, (b) M377. 
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from the estrogen compound estriol. Unlike the C17 position, a hydroxyl group at C16 is less 
common among urinary metabolites. One possible source for the enzymatic activity that adds 
this hydroxyl to C16 of a steroid is a P450 16 hydroxyl enzyme(14). In fact, this 16α-hydroxylase 
activity in mouse liver microsomes was found in many female inbred mice, including the 
BALB/c and C57BL/6J mouse strains used in our current study. 
Preliminary behavioral study showed cortigynic acid to be a potential first cue for encoding 
“sex” from urinary cues for the mouse vomeronasal system. Cortigynic acid was present at high 
concentration only in intact adult female mice urine, and was relatively constant across strains. In 
behavioral tests, cortigynic acid substantially and significantly increased male investigatory 
behavior. When added to male urine, this one ligand increased the duration of investigation bouts 
by more than two-fold. Based on results with a close structural analog, we speculate that the 
specific interest in this compound integrates multiple structural features, including the 16-
hydroxyl moiety specific to female mice. This is the first known female-selective ligand in 
mouse urine. These results take a major step towards a comprehensive understanding of the 
molecular code for identity in the vomeronasal system. 
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Chapter 5 
Introduction: Protein-Protein Interactions, 
Hydrogen/Deuterium Exchange, Fast Photochemical 
Oxidation of Proteins for Mass Spectrometry-Based Protein 
Biophysics  
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5.1 Abstract 
Knowledge about the structural and biophysical properties of proteins when alone or in 
complexes with other ligands in solution is important in understanding many biological 
processes. Such knowledge is also needed for therapeutic drug development. Recent evolution 
and improvement of MS-based approaches are making it powerful for the study of protein 
chemistry. Two most popular MS-based protein footprinting strategies are hydrogen deuterium 
exchange and fast photochemical oxidation of proteins, which enable the study the biophysical 
properties of proteins in solution as well as their interactions with binding partners. The 
principles of these two techniques are introduced in this chapter as a prelude to the Chapter 6 and 
7, where we report their application in some protein biophysics studies.  
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5.2 Protein-Protein Interaction 
Protein-protein interactions (PPIs) play a central role in regulating many biological processes. 
The interactions are fundamentally characterized as stable or transient, both of which can be 
weak or strong. The most common stable protein interactions are between the subunits of a 
protein complex, which in many cases can now be isolated and purified. The transient 
interactions often require changes in conditions, such as phosphorylation or external factors that 
affect conformations, to trigger the interaction. When in contact with their binding partners, 
transiently interacting proteins control many cellular processes(1), including protein modification, 
transport, folding, signaling, and cell cycling.  
Proteins bind to each other via a combination of chemical forces, including van der Waals forces, 
hydrophobic interactions, and salt bridges. The binding interfaces could occur over large surfaces 
spanning hundreds of residues or be represented by a small peptide formed by proteolysis. The 
binding affinity is influenced by, but not limited to, the types of interaction and the size of the 
binding domain. Other factors, such as ionic strength, pH, and presence of other ligands, may 
also affect the binding affinity.  
Malfunction of the protein-protein interactions can result in disease(2, 3). Because PPI plays a 
significant role in life cycles, considerable efforts have been made to discover what features of a 
protein are “druggable”; and modulation of PPI has emerged as a promising strategy to treat 
human diseases and is receiving growing attention by the scientific community.  Many of the 
drugs on the market were developed by using these principles, and they treat a multitude of 
diseases.  
As the foundation of drug design, PPI and its understanding are key to drug development. In 
recently years, the technologies to characterize protein-protein interactions have rapidly matured, 
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one of which being mass spectrometry-based approaches(4). These methods not only facilitate 
drug development, but also help to improve our knowledge in biological networks.  
5.3 MS-Based Protein-Protein Interaction Studies  
A common strategy that is adopted in mass spectrometry-based methods for investigating the 
conformational properties of proteins in solution is to introduce covalent modifications into 
proteins and use ESI or MALDI MS, often coupled with separation, to read out the results(5). 
More specifically, this strategy involves measuring the labeling reaction rate at local regions of a 
protein to ascertain information about the 
local solvent accessibility and 
conformation. This approach can probe 
protein conformational changes 
associated with protein-protein or protein-
ligand interactions and protein dynamics. 
In the last decade, a variety of different 
covalent labeling techniques have been 
developed and applied in this area of study(6-8). The work described here in the second part of the 
thesis focuses on two covalent labeling methods combining with MS in studying protein 
biophysics, namely, hydrogen deuterium exchange (HDX) and fast photochemical oxidation of 
proteins (FPOP).  
5.4 Hydrogen Deuterium Exchange 
Hydrogen deuterium exchange measures the integration of deuterium into a protein(s) by relying 
on the natural phenomenon of hydrogen exchange.  It was traditionally used in conjunction with 
     
Figure 5- 1. Three types of hydrogens in 
proteins. (1) black: amide hydrogens; (2)white: 
hydrogens attached to sidechain functional 
groups; (3) hydrogens bonded to carbons.  
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NMR analysis(9), and its use with MS was implemented shortly after the development of ESI(10, 
11). Important developments in HDX MS have followed through the years(7, 12-19), now it is well-
established and more useful than expected in protein biophysics studies, offering unparalleled 
limits of detection, low sample consumption, and the promise of single amino-acid resolution. 
HDX monitors the exchange rate of amide hydrogens on the protein backbone. There are three 
types of hydrogens(20) in the protein, namely the amide hydrogen, the hydrogens attached to the 
functional groups of side chain, and the hydrogens covalently bonded to carbon (Figure 5-1(21)). 
The exchange rates of these three types of hydrogens are significantly different. Hydrogens 
attached to the functional groups of side chains exchange fastest (half lives of ms), and are easily 
back-exchanged to hydrogen in HDX by returning the protein to a protic solvent. On the contrary, 
hydrogens bonded to carbon atoms are essentially not exchangeable with deuterium in D2O. The 
exchange rate of amide hydrogens is in the middle (half lives of seconds to hours); therefore, 
they are measurable on a lab time-scale. The characteristics of HDX allow us to measure readily 
the extent of deuterium uptake of amide hydrogens on the backbone and monitor protein 
dynamics. 
5.4.1 Effect of pH and Temperature on HDX rates   
The HDX reaction can be catalyzed by either acid or base. Thus, the rate of HDX is sensitive to 
pH -- one unit change in pH leads to ten-fold change in the exchange rate(22). Although the 
intrinsic exchange rates of backbone hydrogens are different and dependent on solvent 
accessibility and hydrogen bonding, the overall exchange rate reaches the slowest value near pH 
2.5 (Figure 5-2A). Furthermore, like most other reactions, temperature also affects the rate of 
HDX(23, 24), which decreases ten-fold by lowering temperature from room temperature (25 ºC) to 
0 ºC at pH 2.5. Therefore, HDX can be “quenched” by adding acidic solution to the exchanging 
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medium to bring down its pH to 2.5 while cooling in ice water.  This slows considerably back 
exchange and allows capture of the HDX information while conducting digestion and MS 
analysis. The use of quench conditions is important because analysis of the deuteration is almost 
always performed in protic media. After the quench, the overall half life of HDX is longer but 
still much shorter than other covalent labeling strategies. Therefore, MS analysis following HDX 
is often kept short, within approximately10 min, to minimize the amount of back-exchange and 
yet obtain sufficient deuterium uptake to assure reliable measurement of it.   
5.4.2 Exchange Kinetics of HDX (EX1 vs. EX2) 
Key to the application of HDX in structural studies is that conformational properties of the 
protein modulate the N-H to N-D conversion rate. Two important factors limiting HDX of amide 
sites are hydrogen bonding and solvent protection. In protected regions, the overall rate constant 
kHDX is much smaller than kch, which is the rate constant for exchange in unstructured peptides. 
Nevertheless, those buried amide hydrogens can still undergo HDX with measurable rates by 
exchanging during short-lived, transitional “open” conformations, which are created by 
 
Figure 5- 2. The rates of H/DX depend on pH (A) and temperature (B). Taken 
from HXMS website: http://www.hxms.neu.edu/research/tutorial_theory.htm 
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kcl 
conformational fluctuations of the protein. Such structural fluctuations can either be determined 
globally or localized for a protein segment by conducting proteolysis prior to analysis. The 
model for most hydrogen exchange of native proteins in D2O is:  
N − Hcl	 ⇌ N-Hop kch→ N − D	                         Eq. 5-1 
where kop is the rate constant of protein unfolding/opening motion and kcl is the rate constant of 
protein folding/closing motion. Eq. 5-1 is typically discussed with two limiting regimes referred 
to as EX1 and EX2(25, 26).  
EX1 is characterized by kch >> kcl, so that kHDX is given by the unfolding/opening rate constant: 
kHDX = kop. EX1 kinetics can be seen as a cooperative unfolding event involving several residues 
in a protein region, all of which exchange before refolding/closing. In such situations, the protein 
or protein regions give multiple groups of deuterium uptake distribution after HDX, making data 
interpretation difficult.  
EX2 is characterized by kch << kcl, leading to kHDX = (kop/kcl)kch. Under this condition, the 
probability of HDX occurring during a single opening event is small, many opening/closing 
cycles may occur before an isotope exchange happens on a given amide. Proteins undergoing 
this behavior show a single major group of deuterium uptake distribution after HDX in the mass 
spectra and that distribution broadens and moves to higher m/z with time of exchange. Under 
physiological conditions, most proteins, including those discussed in this thesis, undergo EX2 
exchange kinetics and only a few undergo EX1 kinetics naturally. Intermediate cases that exhibit 
aspects of both regimes are also known(26, 27).  
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5.4.3 HDX MS-Based Protein Structure and Dynamics Study 
Continuous labeling is the strategy most often applied in studying protein structure, dynamics, 
and interaction. In continuous labeling, a native protein is exposed to D2O, and the deuterium 
uptake level is monitored as a function of exchange time (often ranging from seconds to hours). 
As the exchange time increases, the extent of deuterium labeling gradually increases in the 
protein. Protein regions that spend more time in open conformations undergo faster exchange 
than those more tightly folded. Based on Eq. 5-1, HDX primarily monitors protein structural 
dynamics, and dynamics is closely connected to protein structure (folded regions are generally 
less dynamic than disordered regions).  
Because deuterium is one unit in mass higher than hydrogen, the amount of D incorporation can 
be calculated by measuring the mass increase of a protein/peptide after HDX. Therefore, the 
relative D uptake level can be calculated by Eq. 5-2: 
D% = {[m(P) – m(N)]/[m(F) – m(N)]} × 100%                     Eq. 5-2 
where m(P), m(N) and m(F) are the centroid values of partially deuterated protein/peptide, 
nondeuterated protein/peptide, and fully deuterated protein/peptide, respectively. By plotting D% 
against T (time), a HDX kinetic curve for protein/peptide is generated, and can be used for 
comparison among different states.  
HDX kinetics can be measured either at the global level or, more commonly, at the peptide level. 
Peptide-level analysis is especially important because protein conformational changes occur at 
small regions, such as at protein-protein interaction site, where one may seek to locate the 
specific interface with higher spatial resolution than observing changes at the global level. HDX 
coupled with enzymatic digestion (using acidic proteases) prior to mass spectrometry analysis 
affords such peptide-level resolution. Subsequently, similar analysis with HDX kinetic curves at 
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peptide-level can be used to compare among different states (i.e., apo vs. holo) to locate the 
regions that undergo conformational changes (i.e., protection) in different states (Figure 5-3).  
Residue-level HDX analysis is sometimes performed with electron-transfer dissociation to refine 
the spatial resolution to the amide level. However, this application is difficult and limited by 
instrumentation and fragmentation efficiently. It is not considered further in this thesis.   
Today, HDX MS is widely used in protein biophysics and in drug development, such as epitope 
mapping, protein-stability studies, and protein-ligand binding studies (for reviews, see(28-30)). For 
a protein-protein interaction study, usually two treatments of the protein, bound and unbound, are 
prepared and subjected to continuous labeling. The kinetic curves of most abundant peptides 
from both treatments are plotted together and compared, as depicted in Figure 5-3. Regions that 
undergo no conformational change upon binding will show no difference in extent of deuterium 
incorporation. Regions that show significant protection against D labeling are likely to be located 
at or near the binding interface.  
Furthermore, this traditional continuous labeling technique, HDX MS-based ligand binding and 
protein stability experiments can be used in other applications. For example, Gross et al.(31-34) 
 
Figure 5- 3. H/DX workflow that provides “peptide-level” information. Taken 
from Chalmers et al. 2011. Expert Review Proteomics. 
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developed a method for monitoring protein-ligand interactions by MS, titration and hydrogen 
deuterium exchange (PLIMSTEX). PLIMSTEX curves show the amount of exchanged 
hydrogens against ligand concentration at a fixed exchange time. From the shape of the curve, 
binding affinity and stoichiometry can be uncovered through least-squares fitting analysis of the 
PLIMSTEX titration curve. Fitzgerald and coworkers(35-42) developed a method in studying 
protein stability, namely, stability of unpurified proteins from rates of HD exchange (SUPREX). 
SUPREX uses denaturant to affect protein thermodynamic stability, and its curves display the 
number of exchanged hydrogens as a function of denaturant concentration for a fixed exchange 
time. SUPREX profiles have a sigmoidal appearance resembling unfolding curves as measured 
by optical methods. These two methods are not applied in studies in this thesis, and therefore are 
not further discussed. 
5.5 Fast Photochemical Oxidation of Proteins 
The concept of applying oxidative 
labeling coupled with MS 
footprinting in protein biophysics 
study is very similar to that of 
continuous labeling HDX MS. 
However, more elaborate means than 
just sample dilution with a solvent 
are required to initiate the labeling 
reaction. Oxidative labeling utilizes 
hydroxyl radicals, which can be 
 
Figure 5- 4. Flow system for Fast Photochemical  
Oxidation of  Proteins (FPOP). The frequency of the 
pulsed laser beam and the sample flow rate are 
adjustable to control the single labeling of the sample. 
Cross 
Section 
of Laser 
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OH OH
248 nm
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generated by different means, to react with certain amino acids in the protein(43-46). Fast oxidative 
labeling (millisec time scale) was first established by Chance and coworkers(44) by radiolytic 
modification.  Photochemical labeling initiated by laser irradiation of H2O2 was later developed 
by different groups(47-49). Of those methods, only fast photochemical oxidation of proteins 
(FPOP), developed by Hambly and Gross(49), uses a flow system and controls the radical life to ~ 
1 µs by introducing a radical scavenger to prevent excessive labeling (Figure 5-4).  
FPOP labeling monitors protein conformation and solvent accessibility by exposing the protein 
to hydroxyl radicals for a short (~ µs) time and measuring the modification extent. In an FPOP 
experiment, the sample is mixed with 15 mM of H2O2 and a chosen radical scavenger 
(conventionally 20 mM of Gln), and then flowed through a silica tube (ID: 150 µM) which has a 
clear window facing laser irradiation (Figure 5-4).  The laser is a pulsed 248 nm KrF laser and its 
frequency is adjusted along with the sample flow rate in order to avoid double shots of the same 
sample fraction. Upon irradiation, H2O2 is photolyzed to form hydroxyl radicals, which then 
reacts with the scavenger and the protein. The presence of the scavenger controls the radical life 
time to ~ µs, and, therefore, the protein sample is only shortly exposed to the hydroxyl radicals.  
Because of this short exposure and fast reaction, only one single state, which is often the native 
state, of the protein is “captured” and labeled. As a result of the sampling of a single 
conformation of the protein, the labeling products (+0, +16, +32 etc. Da states) present in a 
Poisson distribution(50). Other developments with FPOP involves using different radicals (e.g., 
SO4-• and I•) to react with different amino acids; such developments expanded the original 
design of FPOP and demonstrates its versatility. In this thesis, however, we only discuss FPOP 
labeling in protein-protein interaction characterization with the original •OH design.  
98 
 
The resulting modification of an amino acid reacting with hydroxyl radicals is generally thought 
to be independent of the technique used for radical production(51-53). Intrinsic reactivity of the 
functional groups in proteins with hydroxyl radicals have been extensively studied over the 
years(43-46). Previous studies showed that 14 of the 20 common amino acids in the protein react 
with hydroxyl radicals(43) (these commonly modified residues and their corresponding reaction 
rate constants are listed in Table 5-1. The oxidation products are numerous, but the most 
common modification is +16 (+oxygen or substitution of an H by an OH). One example of a 
hydroxyl radical reaction with an amino acid is shown in Figure 5-5. Besides labeling the side 
chain of the protein amino-acid residues, hydroxyl radicals can also nonspecifically cleave 
protein backbones. However, such cleavages occur 10-1000 times slower than side-chain 
modifications(43, 44, 46), and they can be further minimized by modifying labeling conditions.  
Table 5- 1. Rate Constants for Reaction 
of 14 Amino Acids with Hydroxyl 
Radical at near Neutral pH. Take from 
Chance et al. 2005 Anal. Chem. 
substrate rate (M-1s-1) pH 
Cys 3.5 × 1010 7.0 
Trp 1.3 × 1010 6.5-8.5 
Tyr 1.3 × 1010 7.0 
Met 8.5 × 109 6-7 
Phe 6.9 × 109 7-8 
His 4.8 × 109 7.5 
Arg 3.5 × 109 6.5-7.5 
Ile 1.8 × 109 6.6 
Leu 1.7 × 109 ~ 6 
Val 8.5 × 108 6.9 
Gln 5.4 × 108 6.0 
Lys 3.5 × 108 6.6 
Ser 3.2 × 108 ~ 6 
Glu 2.3 × 108 6.5 
 
 
Figure 5- 5. Reaction of hydroxyl radical 
with phenylalanine. Taken from Chance et 
al 2007 Chem. Rev. 
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FPOP experiments rely on peptide mapping with high-resolution LC/MS and MS/MS to identify 
the site of modification in a protein/peptide. Unlike HDX, hydroxyl radical labeling is 
complicated and heterogeneous at different residues and/or sites of a protein; therefore, 
performing MS/MS on the digested modified peptides is important for identifying the 
modification. Because •OH labeling is irreversible, complex sample handling, such as long 
digestions and LC/MS analysis, can be performed. Nevertheless, data interpretation remains 
difficult. There is now some commercial software available for identifying modification type and 
calculating the modification extent; however, they are far from perfect and a lot of manual 
examination is still required after software data processing.  
5.6 The Complementary Roles of HDX and FPOP 
Both HDX and FPOP footprinting have the advantage of probing protein conformations in the 
solution-phase with no known protein size limit. These experiments can provide a 
comprehensive picture of biological change related to conformational changes as affected by 
mutation(54, 55), aggregation(56, 57), and ligand binding(58-60).  
Both HDX and FPOP labeling methods have their relative strengths and weaknesses. For 
example, HDX labeling is reversible and, therefore, requires rapid, low-temperature digestion, 
separation and MS analysis, which sometimes limits the number of protein identifications 
especially with complex samples having undergone post-translational modification. On the other 
hand, FPOP labeling does not require specialized LC-MS-based strategies to preserve the label 
because it is irreversible and, therefore, is more flexible to accommodate complex sample 
treatment and LC-conditions tuning to achieve as complete as possible peptide identification and 
good sequence coverage. However, FPOP labeling has the difficulty of being heterogeneous in 
both labeling subjects and products, generating products with varied molecular weights and 
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retention times in the LC-MS readout.  Thus, FPOP imposes considerable more difficulty on data 
analysis. HDX labeling is homogeneous, and its data analysis is much easier. 
HDX and FPOP labeling provide complementary information to each other on protein 
conformations. For example, FPOP labeling is very fast whereas HDX labeling is relatively 
slow. In footprinting, short labeling time can be advantageous in probing low-amplitude motions 
that occur on fast timescales, but at the same time, short labeling limits the range of solution-
phase conformations that can be probed, which becomes less of a problem for longer labeling 
times. Besides labeling speed, HDX and FPOP labeling also provide orthogonal information 
regarding the labeling subjects. HDX labeling occurs on the protein backbone, while FPOP 
targets the protein side-chains. Therefore, they may identify conformational changes caused by 
different interactions.  
In the second part of this thesis, we present the application of both HDX and FPOP labeling to 
study protein structure and dynamics.   In chapter 6, we studied the dimerization of SecA protein 
with HDX MS. The controversial interface was solved along with new findings of accompanying 
conformational changes upon dimerization, which provided leads for the active form of SecA. In 
chapter 7, we focus on mapping the epitope of Adnectin1-EGFR interaction at amino acid 
residue level by FPOP. The epitope identified agrees with that from both HDX study and 
crystallography results, presenting more evidence of the capability of FPOP in epitope mapping. 
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Chapter 6* 
Hydrogen Deuterium Exchange Mass Spectrometry for the 
Analysis of SecA Dimerization in Solution  
 
 
 
 
 
 
 
 
 
 
*This chapter is based on recent publication: Wowor, A. J., Yan, Y., Auclair, S. M., Yu, D., 
Zhang, J., May, E. R., Gross, M. L., Kendall, D. A., Cole, J. L.. Analysis of SecA Dimerization 
in Solution. Biochemistry, 2014, 53(19), 3248-3260. (Yan, Y. and Wowor, A. J. contributed 
equally to this work.) 
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6.1 Abstract  
The Sec pathway mediates protein translocation across the inner membrane of bacteria. SecA is a 
motor protein that drives preprotein translocation through the SecYEG channel. SecA reversibly 
dimerizes under physiological conditions but different dimer interfaces have been observed in 
SecA crystal structures. Here, we have used biophysical approaches to address the nature of the 
SecA dimer that exists in solution. We have taken advantage of the extreme salt sensitivity of 
SecA dimerization to compare the rates of hydrogen-deuterium exchange of the monomer and 
dimer and compared the result to the study of effects of single alanine substitutions on 
dimerization affinity performed by our collaborators in U Connecticut. Our results support the 
antiparallel dimer arrangement observed in the crystal structure of Bacillus subtilis SecA. 
Additional residues lying within the preprotein binding domain and the C-terminus are also 
protected from exchange upon dimerization, indicating linkage to a conformational transition of 
the preprotein binding domain from an open to a closed state. In agreement with this 
interpretation, normal mode analysis demonstrates that the SecA dimer interface influences the 
global dynamics of SecA such that dimerization stabilizes the closed conformation. 
  
111 
 
6.2 Introduction 
In bacteria, the majority of secretory preproteins are translocated through a general secretion 
(Sec) pathway that contains a Sec translocase complex comprising the integral membrane 
channel, SecYEG, and the cytosolic ATPase motor protein, SecA(1, 2). SecA binds preproteins, 
associates with the SecYEG channel, and harnesses energy from ATP hydrolysis to drive 
conformational changes that lead to preprotein 
translocation(3-6). SecA is a large, 102 kDa 
multifunctional protein that is comprised of several 
domains: nucleotide binding domains I and II (NBD I 
and II), a preprotein binding domain (PBD), and a C-
domain that is comprised of an α-helical scaffold 
domain (HSD), an α-helical wing domain (HWD) and 
a carboxyl-terminal linker (CTL) (Figure 6-1)(7). The 
PBD and HWD contribute to the formation of a 
binding groove for the signal peptide region of the 
preprotein(8-12). 
SecA exists in a monomer-dimer equilibrium that is 
sensitive to salt concentration and temperature(13-16). The cellular concentration of SecA is 5-8 
µM(17, 18), and its dissociation constant is 0.28 µM in 200 mM KCl(16). Thus, in the absence of 
ligands, SecA likely exists as a dimer in the cytoplasm(13, 16). It has been suggested that SecA 
functions as a dimer during preprotein translocation because a cross-linked SecA dimer(19, 20) and 
a genetically produced SecA dimer(21) are active for translocation. Nevertheless, the oligomeric 
state of SecA during preprotein translocation remains controversial. Some studies indicate that 
 
 
Figure 6- 1. Structural domains of 
SecA.  The structure of E. coli SecA 
(PDB 2VDA(8)) with domains 
indicated by color: NBD I (blue), 
PBD (purple), NBD II (green), HSD 
(red) and HWD (cyan). In this 
monomer structure the PBD adopts 
an open conformation. 
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dissociation of SecA is favored in the presence of phospholipids(18, 22) or synthetic signal 
peptides(23), and upon SecYEG binding(24). Other reports support an active monomeric form of 
SecA, indicating that the monomeric SecA mutant is functional(25) whereas a disulfide cross-
linked dimer is nonfunctional and its reduced monomeric counterpart is functional(26). 
The relative positioning of the two protomers in the SecA dimer is also unclear. Although the 
structure of the SecA protomer obtained from different bacterial species is highly conserved in 
crystal structures, multiple dimeric interfaces have been identified(27-31) among the five crystal 
structures of the SecA dimer reported to date (Figure 6-2). Both parallel(29) and antiparallel(27, 28, 
30, 31) dimer orientations are observed and these structures contain different dimerization 
interfaces. For example, the dimer interface of Escherichia coli SecA (PDB 2FSF(31)) lies on the 
opposite side relative to the dimer interface in one of the Bacillus subtilis SecA structures (PDB 
1M6N(27)). It is difficult to distinguish crystal packing contacts from biologically relevant 
protein-protein interfaces(7, 32, 33), and it remains unclear which of these crystal structures, if any, 
 
Figure 6- 2. Alternative dimer interfaces in SecA. The dimer interfaces in different structures 
of SecA are indicated in blue with the protomers in two orientations. A) E. coli SecA (PDB 
2FSF)(31), B) T. thermophilus (PDB 2IPC)(29), C) B. subtilis (PDB 1M6N)(27), D) B. subtilis 
(PDB 2IBM)(30), and E) M. tuberculosis (PDB 1NL3)(28). The cyan circles in B and C indicate 
the location of the N-terminal region. 
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corresponds to the physiologically relevant SecA dimer. Single particle cryo-electron 
microscopy measurements support an antiparallel dimer structure(14) and fluorescence resonance 
energy transfer distance measurements show the greatest agreement with the 1M6N antiparallel 
dimer(34, 35). A cross-linking study led to the proposal of a novel interface that involves residues 
from the NBD I, PBD, and HSD(36). 
Interestingly, the PBD is found to adopt multiple conformations. A closed form that brings the 
PBD and HWD in close proximity is found in several SecA dimer crystal structures(27-29) and in a 
structure of a SecA monomer complexed with ADP(37), whereas an open conformation where the 
PBD is solvent accessible exists in a crystal structure of a monomeric form(38) and in one dimer 
structure(31). In the open state, the groove between the PBD and NBD II forms a polypeptide-
binding clamp(24, 39). Binding of a non-signal sequence peptide in this region results in movement 
of the PBD towards NBD II(37). Interaction of SecA with SecYEG induces further movement of 
the PBD towards NBD II, closing the clamp(24). NMR analysis indicates that SecA interconverts 
between open and closed states in solution, with the equilibrium favoring the open state(8). 
Cysteine cross-linking indicates that movement of the PBD from the open state to the closed 
clamp state is required for initiation of translocation(40). 
To resolve these conflicting interpretations, we collaborated with Prof. James Cole’s group in U. 
Connecticut and combined three biophysical strategies to identify the dimer interface of SecA in 
solution and to characterize the conformational changes associated with dimerization. First, we 
used hydrogen/deuterium exchange mass spectrometry (HDX MS) to identify regions on SecA 
that are protected from exchange upon dimerization and to probe conformational changes 
associated with dimerization. Second, to complement our result from HDX and achieve site-
specific information on the dimer interface, our collaborators from U. Connecticut selected 
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amino acids for alanine substitution that are predicted to have significant energetic contributions 
to SecA dimerization based on alternative dimer interfaces. Each alanine-substituted protein was 
then analyzed by sedimentation velocity analytical ultracentrifugation (AUC) to measure SecA 
dimerization affinity. Third, Prof. Eric May from U. Connecticut performed normal mode 
analysis of SecA monomer and dimer and defined conformational changes linked to 
dimerization. This combined strategy locates the likely SecA dimer interface and provides a link 
between closure of the PBD/HWD groove and SecA dimerization. In this chapter, we will focus 
on the discussion of our study on HDX MS. For details of the other two methods, one can refer 
to the publication. 
6.3 Materials and Methods 
6.3.1 Wild-Type SecA Expression and Purification  
Wild-type, native E. coli SecA was expressed and purified as previously described(16). SecA 
samples were exchanged by using spin columns into a working buffer containing 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.5), 0.5 mM 
ethylenediaminetetraacetic acid (EDTA), 0.1 mM tris(2-carboxyethyl)phosphine (TCEP), and 
100 to 500 mM KCl. The SecA concentration was determined by absorbance at 280 nm, using a 
molar absorptivity (ɛ280) of 75,750 M−1 cm−1 calculated with Sednterp(41).  
6.3.2 HDX MS Protocol 
Given the high sensitivity of SecA dimerization to salt concentration (Kd increases from 0.014 
µM at 100 mM KCl to 40.4 µM in 500 mM KCl(16)) , this effect was exploited to permit 
comparison of HDX of SecA dimer (low salt) and monomer (high salt). Stock solutions of 
untagged, wild-type SecA were prepared at 6 µM in either low salt (100 mM KCl) or high salt 
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(500 mM KCl) pH 7.5 buffer, each containing 20 mM HEPES, 0.5 mM EDTA, and 0.1 mM 
TCEP. Samples were equilibrated at 25 °C for 1 h before HDX analysis. Continuous labeling 
with deuterium was initiated by diluting 4 µL of the stock solution into 16 µL of D2O with an 
identical KCl concentration. Based on the measured dissociation constants, the low salt samples 
were 93% dimer, and the high salt samples were 95% monomer. HDX was measured at 10 s, 30 
s, 1 min, 2 min, 15 min, 1 h, and 4 h. Two proteases, pepsin and fungal XIII, were used for 
protein digestion to achieve high peptide coverage. For measurement, the exchange reaction was 
quenched at various times by mixing with 30 μL of 3 M urea, 1% trifluoroacetic acid (TFA) at 
~1 °C. The mixture was then passed over a custom-packed pepsin column (2×20 mm) at 200 
µL/min. For fungal XIII digestion, the exchange reaction was quenched with 30 μL of 1.2 
mg/mL fungal XIII, 1% formic acid (FA) in water and set on ice for 2 min. Prior to LC/MS 
analysis, the digested peptides were captured on a 2×15 mm C8 trap column (Agilent, Santa 
Clara, CA, USA) and desalted with a 3 min flow at 200 μL/min of H2O containing 0.1% TFA. 
Peptides were then separated by using a 2.1×50 mm reversed-phase C18 column (1.9 μm 
Hypersil Gold; Thermo Fisher Scientific, Waltham, MA, USA) with an 11.5 min linear gradient 
of 4%–40% CH3CN in 0.1% FA at 50 µL/min with a nanoACQUITY UPLC (Waters, Milford, 
MA, USA). Protein digestion and peptide separation were carried out in water-ice bath to 
minimize back exchange. MS detection was performed on an LTQ-Orbitrap (Thermo Fisher 
Scientific, Santa Clara, CA, USA) with the following instrument parameters: spray voltage 4 kV, 
capillary temperature 225 °C, capillary voltage 44 V, and tube lens 100 V. Data were collected 
with mass resolving power of 100,000 at m/z 400. Each experiment was carried out in duplicate. 
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6.3.3 HDX Data Analysis 
To identify the products of pepsin or fungal XIII digestions and to provide a list of peptides to be 
followed during HDX, product-ion mass spectra were acquired in a data-dependent mode, with 
the six most abundant ions from each scan selected for MS/MS. The MS/MS *.raw files were 
then converted to mzXML files and submitted to MassMatrix for peptide identification(42). This 
search was also performed against a decoy (reversed) sequence, and ambiguous identifications 
were discarded. The final peptide list generated from MassMatrix was output as *.csv files. 
The peptide list *.csv files and Thermo *.raw files were then input into HDX workbench(43) to 
calculate the centroid masses of isotopic envelopes (m) and deuterium level (D%). As described 
previously(44), D% = {[m(P) – m(N)]/[m(F) – m(N)]} × 100%, where m(P), m(N) and m(F) are 
the centroid values of partially deuterated peptide, nondeuterated peptide, and fully deuterated 
peptide, respectively. The retention time window used for calculation of m of each peptide in 
each sample was manually inspected and adjusted for accurate calculation of D%, and peptides 
that showed interference by isotopic peaks from other peptides were discarded. The deuterium 
level was finally adjusted because the exchange media had 80% deuterium content. The data 
were not corrected for back exchange because two states were compared.  
For details on SecA mutagenesis, analytical ultracentrifugation, and normal mode analysis, 
please see Biochemistry, 2014, 53(19), 3248-3260. 
6.4 Results 
6.4.1 Experiment Condition Control for HDX 
Because the oligomeric state of SecA depends on the KCl concentration, and the intrinsic 
exchange rate of amide protons are largely unaffected by different salt concentrations(45), we 
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prepared samples of SecA containing predominantly monomer or dimer—at the same protein 
concentration—by simply varying the KCl concentration.  Any measured changes in HDX rates 
would then reliably reflect any dimerization-induced changes in the protein. We previously 
determined that the Kd for SecA dimerization at 20 °C varies from 0.014 µM at 100 mM KCl to 
40.4 µM at 500 mM KCl(16). We also found that Kd decreases monotonically by approximately a 
factor of two for every 5 °C increase in temperature; thus, at 25 °C, where we conducted HDX, 
the Kd values of SecA in 100 mM KCl and 500 mM KCl are approximately 0.007 and 20.2 µM, 
respectively. For each incubation in our continuous HDX experiments, the SecA stock solution 
was diluted from 6 µM to 1.2 µM with D2O buffer. Under these conditions, 93% of the SecA is 
dimeric at 100 mM KCl and 95% is monomeric in 500 mM KCl. 
To obtain high coverage of SecA in the digestion following HDX, we supplemented the 
traditional pepsin digestion with a separate one using acidic protease, fungal XIII. Pepsin 
digestion alone gave 86% coverage; missing were 35 residues at the N-terminus and 30 residues 
at the C-terminus. Fungal XIII digestion, however, allowed us to recover many peptides covering 
the N-terminus. Combining the peptides from the two digestions provided high (96%) coverage 
for the total 901 amino acid residues in this large protein. 
6.4.2 HDX Analysis of SecA Monomer 
We expect that regions on the protein with defined secondary structures will undergo slower 
HDX than unstructured regions or those in loops. This is because protein backbone amide 
hydrogen exchange rates are highly dependent on local fluctuations in structure and solvent 
accessibility(46). We mapped for visual convenience the HDX results for the SecA monomer onto 
the NMR structure of E. coli SecA (PDB 2VDA). The time-dependent deuterium uptake for the 
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SecA peptides from pepsin and fungal XIII digestion, measured at seven time points, was used in 
the mapping (Figure 6-3).  
In general, the peptides located completely in α-helical or β-sheet regions exhibit slower HDX (< 
40% at short time points) and are more protected than those at loops and termini. One exception 
is the peptide covering residues 602-609. Although this region is an α-helix in the NBD II 
domain, it is dynamic with over 70% of the amide hydrogens exchanged after 10 s. Judging from 
the NMR structure, we see that this helix is located at the periphery of the NBD II domain and is 
detached from the main body by two loops, imparting greater solvent accessibility and more 
frequent local conformation fluctuations to this region. Noticeably, the N-terminus peptides 
covering residues 1-6 and 7-15 were also found to be highly dynamic, with maximal exchange 
within 10 s. When looking at different exchange behavior from 10 s to 4 h, most of the peptides 
contained within α-helical or β-sheet regions underwent increases of less than 40%. Interestingly, 
 
Figure 6- 3. HDX dynamics of SecA monomer. Different color indicates 
different amount of D uptake.  
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unlike most others, peptides derived from the long α-helix in HSD covering residues 627-666, 
showed an increase to more than 80% in deuterium uptake. This may reflect the relatively higher 
dynamics of this α-helical region, also named the “transducer helix(47)” , which, as indicated by 
its name, is important for allosteric communication between NBD I , NBD II,  PBD, and the C-
domain(37). 
6.4.3 Differential HDX Analysis of SecA Monomer and Dimer 
To determine the dimerization interface of SecA, we applied comprehensive differential HDX 
analysis of the monomer and dimer. In this approach, the HDX kinetics of peptic/fungal peptides 
derived from the SecA monomer and dimer were compared (percentage-of-deuterium-
incorporated, D%, versus time (log scale) plots are made for all peptides). As expected, some 
regions in the dimer became more protected against exchange than in the monomer. The average 
differences in D% (ΔD%) for the duplicate analysis of seven exchange time points were 
calculated, and regions with significant differential deuteration levels are identified in Table 6-1. 
The differences between the monomer and dimer in these regions are considered significant 
because all peptic and fungal peptides covering the same region showed consistent HDX 
kinetics, smooth curves, and similar ΔD% values. These regions are categorized into two groups: 
those that show a large difference (ΔD% ≥ 6, red) and those that show a small difference (3 < 
ΔD% ≤ 5, magenta). It is worth mentioning that most regions in SecA have insignificant ΔD% 
values (less than 3; not listed in Table 6-1). For example, Figure 6-4D shows some HDX kinetic 
plots of regions that are unaffected by SecA dimerization. This consistency over most regions in 
SecA serves as a negative control in showing that the HDX rate is unaffected by KCl 
concentration and indicates there are large regions of the protein that show little change in HDX 
upon dimerization.  
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Table 6- 1. SecA peptides showing different deuterium level incorporation induced by dimerization. 
Region Structure 
Pepsin Digestion Fungal XIII Digestion 
AA Position Δ D% AA Position Δ D%
208-216 NBD 
208-215 (+1) 3 208-215 (+1), 210-215 (+1) 3 
  
211-217 (+1) 5 
313-319 PBD 314-319 (+2) 4 313-319 (+2) 3 
320-338 PBD 
315-320 (+2) 6 320-325 (+2) 13 
320-325 (+2), 320-326 (+1)(+2) 13 320-326 (+1)(+2) 13 
321-326 (+1)(+2) 15 327-338 (+2) 7 
327-333 (+1)(+2), 327-334 (+2) 8 
  
350-374 PBD 
359-372 (+2), 360-372 (+2) 13 352-358 (+2), 350-362 (+2)(+3) 15 
359-368 (+2), 359-374 (+2) 13 350-358 (+2),363-368 (+1) 12 
375-380 NBD 
373-380 (+1)(+2) 5 369-379 (+2) 5 
375-380 (+1) 3 373-379 (+1) 5 
398-408 NBD 
399-404 (+1) 9 398-408 (+2), 399-407 (+2) 6 
401-409 (+2) 6 399-408 (+2) 6 
404-409 (+2) 4 402-407 (+2), 402-408 (+1)(+2) 7 
427-437 NBD2 
432-437 (+1) 4 427-434 (+2), 427-436 (+2) 5 
432-437 (+2) 4 430-436 (+2) 3 
562-574 NBD2   
562-568 (+3) 6 
  
569-574 (+2) 12 
575-587 NBD2 
572-586 (+3)(4) 5 567-587 (+4), 569-587 (+3)(+4) 5 
  
569-585 (+3), 569-586 (+3)(+4) 5 
626-671 HSD 
627-638 (+2), 627-638 (+4) 8 626-633 (+2), 626-635 (+2)(+3) 10 
627-638 (+3) 11 634-639 (+1)(+2), 654-660 (+2) 11 
627-639 (+3) 8 636-642 (+3), 661-666 (+2) 8 
639-647 (+2)(3), 648-666 (+4) 6 659-665 (+2) 10 
627-647 (+3)(+4), 649-666 (+4) 5 664-671 (+1) 6 
672-690 HWD   
672-677 (+1) 4 
685-690 (+1)(+2) 4 683-689 (+1)(+2), 683-690 (+2) 4 
701-708 HWD 
701-706 (+1), 701-708 (+1)(+2) 3 
  
701-707 (+1)(+2) 4 
  
723-737 HWD 
723-730 (+1)(+2), 731-737 (+2) 4 724-732 (+3) 3 
724-730 (+2) 7 724-733 (+2)(+3) 4 
744-757 HWD 
744-755 (+2)(+3), 746-758 (+2)(+3) 5 744-750 (+2)(+3) 7 
746-755 (+2)(+3), 748-755 (+2)(+3) 7 744-751 (+3) 5 
747-755 (+2)(+3), 746-757 (+2)(+3) 6 
  
758-774 HSD 
758-767 (+3), 759-767 (+2)(+3) 3 762-768 (+2), 765-771 (+1) 4 
759-765 (+3) 4 762-771 (+2), 764-771 (+2) 3 
768-774 (+1) 3 772-778 (+2)(+3) 3 
775-783 HSD 
775-781 (+2), 775-782 (+2)(+3) 6 772-783 (+3) 8 
775-783 (+2) 8 
  
815-830 HSD 
815-820 (+2) 4 812-819 (+2), 814-819 (+2) 4 
815-826 (+2), 816-826 (+2) 4 820-826 (+1) 2 
821-826 (+1) 5 820-828 (+1)(+2), 820-830 (+2) 3 
The ΔD% values represent the average difference in percentage of deuterium incorporation across all HDX exchange 
points of SecA monomer and dimer. The red and magenta colors represent two groups categorized based on ΔD%
values: large and small, respectively. The values in parentheses represent the charge state of each peptide ion; two values 
indicate two charge states for the same peptide.  
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In contrast, several regions that show significant ΔD% values (Table 6-1) must have different 
structures or interactions in monomer and dimer states. The largest differences are observed for 
peptides within the region 627-671 in the HSD (Figure 6-4A) and within the regions 313-338 
and 350-374 in the PBD (Figure 6-4B). Peptides encompassing 758-774 and 815-830 in the HSD 
show small changes of ΔD% but a large difference is detected for 775-783 (Figure 6-4C). The 
kinetic curves for monomer and dimer typically come together at long times, suggesting that the 
dimer has a relatively large off rate, allowing the protomer to be freed from the dimer and 
undergo HDX as the monomer. 
To help understand the interface that forms upon SecA dimerization, we mapped the regions 
 
Figure 6- 4. Peptide-level HDX kinetics of SecA. A comparison between monomer 
(black) and dimer (red) shows significant changes in HDX at the transducer helix 
from HSD (A), regions in PBD (B), two helix fingers from HSD (C), and no 
differences in HDX at regions undergoing little structural change (D). The 
corresponding regions for A, B, and C are marked on Figure 6-5A. 
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identified in Table 6-1 onto the NMR structure of SecA using the same color code (Figures 6-5A 
and B). The three locations exhibiting the greatest difference in HDX (Figures 6-4A, B, and C), 
are marked with a’, b’ and c’, respectively, on the structure shown in Figure 6-5A. Region a' 
corresponds to the long transducer helix in HSD. Region b' lies within the PBD and includes two 
antiparallel β-strands and the following α-helix. Region c’ contains the two-helix finger from 
HSD. Other regions within HWD, NBD I, and NBD II also show some differential ΔD% and are 
highlighted in Figure 6-5.  
The regions of SecA that show reduced HDX upon dimerization lie on multiple faces of the 
 
Figure 6- 5. Structural analysis of SecA HDX kinetics. A and B: exchange rates 
mapped onto the E. coli SecA (PDB 2VDA) structure. Regions exhibiting a large 
difference (ΔD% ≥ 6) are colored red and regions exhibiting a small difference (3 < 
ΔD% ≤ 5) are colored magenta, as in Table 6-1. A) Ribbon diagram. Regions marked 
as a’, b’, and c’ correspond to peptides in Figures 6-4A, B, and C, respectively. B) 
Surface representation. C and D: exchange rates mapped onto the closed-form model 
of E. coli SecA. C) Dimer structure. Coloring of the left protomer corresponds to A 
and B. D) Interface of the PBD and the C-domain. 
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protomer surface, suggesting that large conformational changes accompany dimerization. Using 
the crystal structure 1M6N as a reference, we attribute the decreased HDX in the transducer helix 
(region a') to dimer-interface formation; this is also consistent with our AUC results described 
below. We assign the decreased HDX in the PBD (region b') to an induced allosteric effect 
caused by dimerization.  Corresponding HDX changes are also evident within region c' and the 
HWD, supporting a model where SecA dimerization induces movement of the PBD into a closed 
conformation where it interacts with the C-terminal portion of SecA. This model is consistent 
with the previous observation of open and closed conformations of the PBD(14, 27, 30, 37, 38, 48, 49). In 
the closed conformation, the PBD interacts extensively with the C-terminal domain and forms a 
compact structure, whereas in the open conformation, the PBD is more solvent exposed and 
would, therefore, undergo a greater extent of HDX. Owing to its vicinity to the transducer helix, 
the altered HDX in the two-helix finger may arise from dimerization or altered interactions with 
the PBD. The small ΔD% of the short peptide 427-437 located in NBD II opposite the HSD may 
be due to an allosteric effect.  
6.4.4 Analysis of the SecA Dimer Interface by AUC 
To complement our analysis of the dimer interface by HDX, our collaborators from U. 
Connecticut used AUC to probe the energetic contribution of individual surface residues to SecA 
dimerization.  Residues observed within the dimer interfaces of SecA crystal structures from 
multiple bacterial species(27-31) were chosen to be substituted with alanine. The program 
Robetta(50) was used to identify residues lying within potential dimerization interfaces and to 
guide selection of single alanine substitutions that are expected to strongly destabilize the SecA 
dimerization. AUC was then used to measure the dissociation constants of the alanine mutants. 
The result showed consistency with our HDX data, indicating two residue from HSD, Q662 and 
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E665, significantly affect SecA dimerization. Besides that, the AUC result also showed that 
another residue from the N-terminus, K8, is important to SecA dimerization as well, which was 
unrevealed in HDX results.  
To analyze further the effect of N-terminus on SecA dimerization, deletion constructs, including 
∆2-8, ∆2-9, and ∆2-10, were examined. And the result showed that SecA dimerization decreases 
with the number of residues deleted from the N-terminus. SecA constructs containing multiple 
alanine substitutions at the N-terminus were also generated and examined. And they found that 
dimerization affinity decreases as additional alanine substitutions are introduced.  
For more details on this section, please see Biochemistry, 2014, 53(19), 3248-3260. 
6.4.5 Normal Mode Analysis 
To explore the possibility of an allosteric 
mechanism in which SecA dimerization mediates 
structural changes, Prof. Eric May from U. 
Connecticut performed normal mode analysis on 
the monomer and dimer in the open and closed 
states. The analysis showed that the major 
structural difference is related to the separation 
between the PBD and HWD regions (Figure 6-6), 
and the dimer has a mode that couples much more 
strongly to the PBD-HWD domain separation than 
any mode in the monomer. The presence of this 
mode, which does not appear (as a single mode) in 
 
Figure 6- 6. Normal mode analysis of 
SecA monomer and proposed dimer 
configurations. The open state (PDB 
2VDA) is shown as a surface 
representation in gray and the modeled 
closed state is shown in a ribbon 
diagram in red. 
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the monomer, indicates our proposed dimer interface is influencing the global dynamics of SecA, 
and providing flexibility to the PBD and HWD regions of the structure. These regions are distal 
to the proposed dimer interface and the observation is consistent with an allosteric mechanism 
where dimerization is linked to an open to closed transition.  
For more details on this section, please see Biochemistry, 2014, 53(19), 3248-3260. 
6.5 Discussion 
In the research described in this chapter, we utilized HDX MS in combination with site-directed 
mutagenesis/AUC performed by our collaborators, to probe the dimer interface of SecA in 
solution. HDX examines the effects of dimerization based on changes in peptide backbone 
solvent accessibility, with spatial resolution limited by digestion coverage and peptide size, 
whereas site-directed mutagenesis/AUC measures the energetic contributions of individual 
residues to dimerization. The HDX measurements were performed with a limited (10 s) time 
resolution and are, thus, insensitive to faster processes.  
The HDX MS and AUC data together indicate that the HSD is a component of the dimer 
interface. Site-directed mutagenesis/AUC shows that residues Q662 and E665 lying at the C-
terminus of the long transducer helix in the HSD are involved in dimerization. The HDX results 
implicate a larger region within the HSD, including the entire transducer helix and the two-helix 
finger. The difference in the extent of HSD involvement in the dimer interface detected by these 
methods may arise because some of the interfacial residues do not provide a large energetic 
contribution to dimerization. Alternatively, the transducer helix is known to be mobile(37), and 
changes in the accessibility of this helix upon dimerization may be communicated to regions 
lying distal from the dimer interface. With the exception of the E. coli structure (PDB 2FSF), 
each of the SecA crystal structures includes N-terminal portions of the transducer helix within 
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the dimer interface (Figure 6-2). However, only the B. subtilis 1M6N interface also encompasses 
the C-terminal region of this helix identified by AUC.  
The AUC data indicate that the N-terminus contributes to the SecA dimer interface whereas 
HDX does not detect differences in this region between the monomer and dimer states. This 
discrepancy is likely associated with the flexible nature of the N-terminus. In this region, the 
deuterium uptake reaches a maximum at the shortest exchange time point (10 s), precluding 
detection of an interface by HDX, consistent with high on and off rates for the interaction. Our 
data demonstrating the involvement of the N-terminus in the SecA dimer interface disagrees with 
three dimer structures (PDB: 2FSF, 1NL3, and 2IBM) that do not include the N-terminus as part 
of the dimer interface. Note that these three structures were solved using SecA deletion mutants. 
Specifically, the E. coli SecA (PDB 2FSF) structure was solved using an N-terminus deletion 
mutant (Residues 9-861). In contrast, the dimer interfaces from T. thermophilus (PDB 2IPC) and 
B. subtilis (PDB 1M6N) structures contain the N-terminus. 
Overall, the HDX and AUC data appear most consistent with the B. subtilis SecA 1M6N 
antiparallel dimer arrangement(27). However, only 5 out of 14 alanine substitutions predicted to 
diminish dimerization affinity based on the 1M6N interface actually reduced dimerization of E. 
coli SecA, despite the 50% sequence identity between these orthologs. This discrepancy may 
indicate that the solution interface dimer is similar, but not identical, to that found in the 1M6N 
structure and, thus, none of the crystal structures may correspond to the interface adopted by 
cytoplasmic SecA. Also, another possible explanation is that different salt concentrations and 
buffer conditions may lead to the formation of slight different dimer interfaces. Alternatively, it 
was recently reported that SecA adopts multiple dimeric interfaces during translocation(51) and 
these may exist in equilibrium in solution. Both proposed dimer interfaces, based on the 1M6N 
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structure and an interface found in the M. tuberculosis 1NL3 crystal form (but different from the 
one depicted in Figure 6-2E), include the N-terminal region and portions of the HSD and HWD. 
However, the latter interface does not include residues Q662 and E665 that we found to affect 
SecA dimerization or the N-terminal portions of the transducer helix that are protected from 
HDX by dimerization. In agreement with our results, inter-protomer distances derived from 
fluorescence resonance energy transfer measurements are also most consistent with the 1M6N 
interface(34, 35). 
The HDX data also reveal that dimerization induces movement of the PBD into a closed 
conformation where it interacts with the HWD. Normal mode analysis supports such an allosteric 
mechanism where dimerization is linked to an open to closed transition. We identified a low 
frequency mode in the dimer but not in the monomer that is coupled to the PBD-HWD 
separation. Consistent with correlation of SecA dimerization with a closing transition of the 
PBD, B. subtilis SecA adopts an open conformation in a monomeric crystal form (1TF5)(38) 
whereas closed forms are found in two dimeric crystal forms of the same enzyme(27, 30). Cryo-
electron microscopy analysis of dimeric E. coli SecA reveals a closed state(14). However, this 
correlation is not always observed, as a monomeric complex of T. maritima SecA with ADP can 
be crystalized in a closed state(37) and a crystal structure of dimeric E. coli SecA (PDB 2FSF) 
reveals an open state(31). Crystal packing forces may influence the conformation of the PBD. 
Consistent with a low barrier for this transition, solution NMR suggests that dimeric SecA 
rapidly interconverts between a closed state and a predominant open state(8). FRET 
measurements indicate that signal peptide binding induces dimeric SecA to adopt a more open 
conformation(35). Binding of a non-signal sequence peptide in the groove between PBD and NBD 
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II results in rotation of the PBD towards NBD II(37) and interaction of SecA with SecYEG 
induces further movement of the PBD to close the clamp(24).    
Our analysis can be interpreted in the context of the closed state model of the E. coli SecA dimer 
based on the 1M6N structure (Figure 6-5C). The dimer interface is primarily contributed by the 
HSD and the N-terminus, two regions that lie on the same side of the protomer. The C-terminal 
domain regions that form an interface with the PBD become less dynamic upon dimerization 
(Figure 6-5D). However, the corresponding colored regions in the PBD are not in close contact 
with the C-terminal domain. Most of the colored residues in the PBD are also removed from the 
inter-protomer interface, but a short loop does contribute to dimerization (residues 338-342) and 
a portion of the reduced HDX in the PBD may be directly associated with dimerization. The two 
regions in the PBD making close contact with the C-terminal domain, residues 263-268 (loop) 
and 304-314 (α helix), do not show significant ΔD% between monomer and dimer. Region 263-
268 is a flexible loop that reaches 60% deuterium exchange at the shortest HDX time point, 10 s, 
and 80% at 4 h. In contrast, the helix in region 306-314 is rigid and shows less than 5% 
deuterium exchange at the longest HDX time point, 4 h. Thus, the absence of a detectable 
difference in monomer and dimer HDX for these regions can be ascribed to very fast and very 
slow exchange, respectively, that lie outside the time resolution of the present study. 
Several studies show that SecA is dimeric when driving preprotein translocation across 
SecYEG(15, 19, 20, 37, 52, 53) whereas others report that the functional form of SecA is monomeric(18, 
24, 25). Regions within the PBD and C-domain of SecA interact with the C-terminal region of 
SecY(24). When SecA binds to SecYEG, the PBD moves away from HWD and closer to the NBD 
II(24). The B. subtilis (PDB 1M6N) dimer interface supported by the data presented here does not 
overlap with the SecA-SecYEG interface so that the intact dimer could interact with SecYEG. 
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Interaction with SecYEG and subsequent ATP hydrolysis may induce SecA dimer dissociation 
during the translocation cycle(1, 51). In this context, the movement of the PBD to an open 
conformation upon SecA dimer dissociation may facilitate transfer of the preprotein to the SecY 
pore. 
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Chapter 7* 
Fast Photochemical Oxidation of Proteins (FPOP) Maps the 
Epitope of EGFR Binding to Adnectin 
 
 
 
 
 
 
 
 
 
 
 
* This chapter is based on recent publication: Yan, Y., Chen, G., Wei, H., Huang, R. Y. C., Mo, J., 
Rempel, D. L., Tymiak, A. A., Gross, M. L..  Fast Photochemical Oxidation of Proteins (FPOP) 
Maps the Epitope of EGFR Binding to Adnectin. Journal of The American Society for Mass 
Spectrometry, 2014.  
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7.1 Abstract 
Epitope mapping is an important tool for the development of monoclonal antibodies, mAbs, as 
therapeutic drugs. Recently, a class of therapeutic mAb alternatives, adnectins, has been 
developed as targeted biologics.  They are derived from the tenth type III domain of human 
fibronectin (10Fn3). A common approach to map the epitope binding of these therapeutic proteins 
to their binding partners is X-ray crystallography. Although the crystal structure is known for 
Adnectin 1 binding to human EGFR, we seek to determine complementary binding in solution 
and to test the efficacy of footprinting for this purpose.  As a relatively new tool in structural 
biology and complementary to X-ray crystallography, protein footprinting coupled with mass 
spectrometry is promising for protein-protein interaction studies. We report in this chapter the 
use of fast photochemical oxidation of proteins (FPOP) coupled with MS to map the epitope of 
EGFR-Addnectin 1 at both the peptide and amino-acid residue levels. The data correlate well 
with the previously determined epitope from the crystal structure and are consistent with HDX 
MS data.  The FPOP-determined binding interface involves various amino-acid and peptide 
regions near the N terminus of EGFR. The outcome adds credibility to oxidative labeling by 
FPOP for epitope mapping and motivates more applications in the therapeutic protein area as a 
stand-alone method or in conjunction with X-ray crystallography, NMR, site-directed 
mutagenesis, and other orthogonal methods. 
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7.2 Introduction 
Epitope mapping is an important step in the characterization of monoclonal antibodies (mAb) for 
their use as therapeutic drugs. Therapeutic applications of mAbs are emerging or under 
development for oncology, autoimmune diseases, inflammatory disorders, and organ 
transplantation. Recently, a new class of biologics that mimic the binding region of mAbs, 
Adnectins, has been developed as therapeutic mAbs analogs(1-3).  
Adnectins are a class of biologics developed from the tenth human fibronectin type III domain 
(10Fn3), and they bind target proteins as potential therapeutic agents(1-6). 10Fn3 is a small (10 
kDa), highly stable and soluble β-sandwich protein that resembles an immunoglobulin variable 
domain but has no disulfide bonds(7-10). The protein fold contains three solvent-exposed loops, 
termed BC, DE and FG, which are structurally analogous to antibody complementarity-
determining regions (CDRs) and tolerant to extensive mutations(4). Mutations in the loops can 
impart different binding capacities to the 10Fn3-based variants.  Therefore, adnectins can have 
similar functions as therapeutic monoclonal antibodies by binding with high affinity to their 
targets. The first adnectin tested in preclinical and phase I studies, CT-322, targets vascular 
endothelial growth factor receptor-2, giving some desired pharmacological effects(11-14).   
Epidermal growth factor receptor (EGFR), a member of the ErbB receptor family, mediates cell 
proliferation, differentiation, survival, angiogenesis, and migration(15).  EGFR  has been 
implicated in many human cancers(16). Its structure consists of an extracellular domain 
(exEGFR), a transmembrane domain, and an intracellular tyrosine-kinase domain. Cell signaling 
is initiated by binding of ligands, such as EGF, to exEGFR, followed by dimerization of EGFR 
and phosphorylation of specific EGFR tyrosine residues(15). We recently studied the effects of  
dimerization and subsequent phosphorylation by mass spectrometry (MS)-based footprinting of 
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one family member attached to a membrane(17). Tyrosine-phosphorylated receptors serve as 
docking sites for intracellular signaling proteins, which initiate many signaling cascades to 
produce a physiological outcome(18). This EGFR signaling network is often dys-regulated in 
cancer and motivates a strategy for cancer therapy with EGFR-blocking agents, including mAbs 
targeting exEGFR and small molecules targeting the EGFR intracellular domain(19-21).   
To develop mAb alternatives for cancer therapy, a representative adnectin (Adnectin 1) that 
specifically binds EGFR was generated using the mRNA display technique(22, 23). As a 
requirement in therapeutic drug development, the EGFR-Adnectin 1 interaction was previously 
characterized, in this case by X-ray crystallography, revealing the binding epitope to be distinct 
from those of approved mAbs(22).  Although X-ray crystallography is often regarded as the “gold 
standard” for structure determination, it has limitations. For example, crystallization is 
sometimes difficult for certain antigen-antibody complexes and requires a relatively large 
amount of protein.  Furthermore, whether contacts from crystal structures faithfully represents 
biologically relevant protein-protein interfaces is questionable(24, 25).  Another approach, site-
directed mutagenesis(26), is labor intensive and could cause false positives because the protein is 
submitted to modifications, some of which could affect structure.  Binding assays(27) and 
PEPSCAN(28) are often restricted to linear (continuous) epitopes, and are likely to fail when 
facing conformational (discontinuous) epitopes, characterization of which requires maintaining 
the native structure of both antigen and antibody. Limited proteolysis(29) followed by MS 
analysis is another approach but of low resolution.   
There is a growing interest in mass-spectrometry-based methods for mapping epitopes and other 
protein-ligand interactions.  Two appropriate approaches are hydrogen-deuterium exchange 
(HDX)(30-36) and oxidative labeling (e.g., OH radicals, FPOP)(37-40). These methods are sensitive, 
141 
 
can accommodate large proteins, and can be used with the protein in native or near-native states. 
For example, the epitope of EGFR binding to Adnectin 1 was mapped by Iacob and Engen using 
HDX MS(41), and the results correlate well with the structure from X-ray crystallography. 
Oxidative labeling has advantages because the labeling is fast, irreversible, and residue-level 
information can often be generated. Fast oxidative labeling (millisec time scale) was first 
established by Chance and coworkers(42) by radiolytic modification.  Photochemical labeling 
initiated by laser irradiation of H2O2 was later developed by different groups(43-45). Of those 
methods, photochemical oxidation of proteins (FPOP), developed by Hambly and Gross(45), uses 
a flow system and controls the radical life to ~ 1 µs by introducing a radical scavenger to prevent 
excessive labeling. Recently, Jones and Gross(40) reported the use of FPOP coupled to MS  to 
map the conformational epitope of the serine protease thrombin and showed results that are 
consistent with those from HDX.  
In this chapter, we describe the use of FPOP to map the epitope of exEGFR-Adnectin 1 complex. 
To accomplish the mapping, we modified the experimental conditions from traditional FPOP 
settings to allow measurement in formulation-relevant conditions and to produce moderate 
amount of oxidation of exEGFR even in the presence of the adnectin. The FPOP data are largely 
consistent with the X-ray crystallography results, which show that the epitope binds at the N 
terminus in Domain I, as shown by decreased modifications upon Adnectin 1 binding. In 
addition, FPOP also revealed changes of a residue located outside the previously determined 
binding interface, F24, which may be due to an allosteric change in side-chain orientation that 
produces decreased solvent accessibility.  
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7.3 Experimental 
7.3.1 Materials and Reagents 
30% hydrogen peroxide, formic acid, trifluoroacetic acid, L-histidine, L-glutamin, L-methionine, 
catalase, phosphate-buffered saline, ammonium bicarbonate, dithiothreitol (DTT), iodo-
acetamide (IAA), and HPLC-grade solvents were purchased from Sigma Aldrich (St. Louis, 
MO). Trypsin/Lys-C Mix was obtained from Promega Corp. (Madison, WI). PNGase F was 
purchased from New England Biolabs inc (Ipswich, MA). RapiGest SF was from Waters Corp. 
(Milford, MA). West Nile Virus E protein Domain III (WNV E DIII) was provided by D. 
Fremont from Department of Pathology and Immunology at Washington University, school of 
medicine. Human exEGFR (residues 1-642) was expressed in Sf9 cells mammalian cells with a 
C-terminal His tag and purified as described previously(22). It was supplied in phosphate buffer 
saline (PBS:137mM NaCl, 2.7mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 (pH 7.2). Adnectin 1 
was supplied in PBS buffer (pH 7.2). Its expression and purification were described 
previously(22). 
7.3.2 FPOP labeling of Proteins 
exEGFR and Adnectin 1 were mixed together at a 1:1 molar ratio at 50 µM concentration (Kd ~ 2 
nM(22)) and incubated for 1 h at room temperature. FPOP labeling of proteins was performed on 
the same day under the same conditions. Each sample started with 5 µM protein reconstituted in 
1×PBS containing 350 µM His and 20 mM H2O2. H2O2 was added just prior to infusing the 
solution into the tubing for FPOP. FPOP was performed as described previously(45, 46). The KrF 
excimer laser power (GAM Laser Inc., Orlando, FL) was adjusted to 44 mJ/pulse, and its pulse 
frequency set to 6.5 Hz. The width of the laser beam at the clear sample tube window was 1.8 
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mm. The flow rate was adjusted to 15 µL/min to ensure a 20% exclusion volume to avoid 
repeated HO‧exposure and reaction(44). All collections were in vials containing 10 mM catalase 
and 20 mM Met to reduce left-over H2O2. For each state, exEGFR with Adnectin 1 and exEGFR 
alone, three separate samples were made and submitted to FPOP labeling. In addition, three 
control samples for exEGFR alone were handled in the same manner, but they were not laser 
irradiated. All samples were stored at -80 °C after solvent evaporation if they were not directly 
subjected to trypsin digestion. 
7.3.3 Proteolysis 
A 20 µL aliquot of each FPOP-labeled exEGFR sample was mixed with 2 µL of RapiGest SF 
and incubated at 80 °C for 15 min. The samples were reduced with 10 mM dithiothreitol (2 µL of 
10 mM solution) at 55 °C for 30 min, alkylated with 23 mM iodoacetamide (2 µL of 300 mM 
solution) in the dark at RT for 30 min, and deglycosylated with 2 µL PNGsae F at 37 °C for 2 h.  
Solutions of 40 µL of 1×PBS and 24 µL of 0.1 M ammonium bicarbonate were then added to 
each aliquot to bring the pH to ~8. Samples were digested overnight with the Trypsin/Lys-C Mix 
at an enzyme:protein ratio of 1:25. The reaction was quenched with trifluoroacetic acid (TFA) to 
give a final concentration of 1%. An aliquot of 30 µL of the digested samples was cleaned up 
with NuTip C-18 zip tips (Glygen Corp., Columbia, MD) and eluted into 30 µL of 60% 
acetonitrile/40% H2O/0.1% formic acid (FA).  The eluent was dried and reconstituted in 30 µL 
of water with 0.1% FA for autosampler loading and subsequent analysis. 
7.3.4 Mass Spectrometry 
For peptide and residue level analysis of labeled exEGFR, samples were analyzed on a LTQ 
Orbitrap XL (Thermo Fisher, San Jose, CA) operated in data-dependent acquisition mode. An 
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aliquot of 5 µL of each sample was loaded by the autosampler onto and eluted from a 15 cm 
column with a PicoFrit tip (New Objective, Inc., Woburn, MA), custom-packed with C18 
reversed phase material (Magic, 0.075 mm × 150 mm, 5 µm, 100 Å; Michrom Bioresources Inc., 
Auburn, CA); the chromatograph was an Ultra 1D+ UPLC (Eksigent, Dublin, CA). Peptides 
were eluted by a 95 min, 260 nL/min gradient coupled to the nanospray source. The gradient 
started with a linear increase from 2% of solvent B (CH3CN/0.1%FA) to 32% in 65 min, and 
then to 90% in 13 min, held at 90% B for 5 min, and re-equilibrated to solvent A (H2O/0.1%FA) 
for 12 min. Mass spectra were obtained at high mass resolving power (60,000, FWHH, for ions 
of m/z 400), and the six most abundant ions eluting per scan were subjected to CID MS2 in the 
ion trap, with charge-state rejection of +1 ions enabled. Precursor ions were added to a dynamic 
exclusion list for 12 s to ensure good sampling of each elution peak.  
7.3.5 Adjustment of the Scavenger for FPOP 
FPOP used an excimer laser to photolyze hydrogen peroxide to give two OH radicals; the H2O2 
was added in low concentration to the protein solution, to form hydroxyl radicals(45, 47). To 
control the radical lifetime, a pulsed laser and selected scavenger of 20 mM Gln were used for 
protein labeling at a microsecond time scale, faster than protein unfolding(46). There were 
concerns, however, regarding the impact of high concentration of Gln on protein conformation 
and behavior and whether it faithfully mimicked the protein native state.  
Thus, His, a common reagent in protein formulation buffers, was selected to replace Gln as a 
scavenger in the FPOP experiments. Because the reaction rate constant of ‧OH with His is larger 
than that with Gln, His was expected to be a more efficient scavenger than Gln and to work at 
lower concentrations. To determine the concentration of His as an alternative to the previously 
used 20 mM Gln scavenger, each sample started with 10 µM WNV E DIII (a model protein), 20 
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mM H2O2 and different concentrations of His (200 µM, 350 µM, 500 µM) or 20 mM Gln in 
1×PBS. The traditional FPOP condition with 20 mM Gln was included to serve as a positive 
control. After FPOP labeling, protein-level analysis of labeled WNV E DIII was performed on a 
Bruker Maxis 4G MS (Bruker Biosciences Corporation, Billerica, MA). Samples were trapped 
on a 2×15 mm C8 trap column (Agilent, Santa Clara, CA, USA) and desalted with a 3 min flow. 
A 5 min linear gradient of 4-40% CH3CN in 0.1% formic acid was used to elute the sample for 
protein-level analysis. The peak corresponding to +8 charge state from the global mass spectrum 
was used for data analysis 
Global analysis with the custom program afforded the fraction of unmodified protein after FPOP 
for all four conditions, as shown in Table 7-1.  The table indicates that 350 µM His gave the 
closest scavenging ability comparing to 20 mM Gln. According to previous studies(48), one 
important criterion indicating the sampling of a single (native) conformation of the protein is the 
Poisson distribution of +0, +16, +32 species after FPOP labeling. Therefore, a more rigorous 
analysis was conducted, to model the product distribution for all four experiments. The goodness 
of the fit was indicated by the “Poisson distribution factor” in Table 7-1, for which a value closer 
to “1” indicated the better fit. The result also indicated the suitability of 350 µM His as a 
scavenger for FPOP experiments.  
Table 7- 1. Analysis of FPOP modification on WNV E DIII at protein level with 
different scavengers 
Scavenger Unmodified WNV E DIII% Poisson distribution factor 
20 mM Gln 24.9% 0.89 
500 µM His 26.4% 0.89 
350 µM His 26.2% 0.91 
200 µM His 17.4% 0.75 
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7.3.6 Data Analysis for FPOP labeling of exEGFR 
The raw MS files were converted to .mgf files and profile mzXML files by using MassMatrix 
Mass Spec Data File Converter. The .mgf files of control samples were searched using 
MASCOT (Matrix Science, London, U.K.) against a custom-built database containing the 
sequence of exEGFR for sequence coverage and including deamidation at Asn or Gln, which 
results from N-deglycosylation in the sample handling. Oxidation at Met was also added as a 
variable modification. The alkylation of the samples with iodo-acetamide added a 
carbamidomethyl group (MW= 57.0214) to cysteines; therefore, it too was set as a fixed 
modification in the search. Several Asn residues were found to be entirely deamidated to form 
Asp or isoAsp, and they were changed in the sequence from N to D for further FPOP 
modification analysis. The profile mzXML files of all samples were then searched against the 
modified sequence for labeled and unlabeled exEGFR tryptic peptides by using ProtmapMS 2.1 
(Case Western Reserve Univ., OH) with oxidative mode set to 2, meaning up to two variable 
modifications were allowed to occur on the same peptide. All known hydroxyl radical side-chain 
reaction products(49-51) were added to the modification database for searching as variable 
modifications. Carbamidomethyl group modification on Cys was added as a fixed modification. 
From the identified modifications on each tryptic peptide (Table 7-2), the intensities of signals 
for the modified (Iox) and the unmodified species (I) for each peptide were then read from the 
raw data files. The extents of modification at peptide level were calculated by using the 
following equation(52):  
		  ∑ !∑ ! 	+ 	 
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Table 7- 2. Modifications by FPOP on all peptides as identified by ProtmapMS 
peptide Modification species 
15.995 13.979 -10.032 -22.032 31.99 -30.011 4.979 -22.032 -31.99 
14-29 + + - - - - - - - 
30-48 + - - - - - - - - 
49-56 + - - - - - - - - 
57-74 + - - - - - - - - 
75-84 + - - - - - - - - 
85-105 + - - - - - - - - 
106- - - - - - - - - - 
110- - - - - - - - - - 
115- + - + + - - - - - 
126- + - - - + - - - - 
142- + - - - + - - - - 
166- + - - - - - - - - 
189- + - - - - - - - - 
201- + - - - - - - - - 
203- + - - - - + + - - 
221- + - - - - - - - - 
230- + - - - + - - - - 
238- + - - - + - - - - 
261- + - - - - + + - - 
261- + - - - - - - - - 
274- + - - - + + + + - 
286- + - - - - - - - - 
286- + + - - + - - - + 
311- + - - - - - - - - 
312- + - - - - - - - - 
323- + + - - - - - - - 
334- - - - - - - - - - 
337- + - - - + - - - - 
354- + + + + + - - - - 
376- + - - - + - - - - 
391- + + - - - - + - - 
408- - - + - - - + - - 
428- + - - - - - - - - 
431- + + - - - - - - - 
444- + - - - + - - - - 
444- + - - - + - - - - 
456- + + - - - - - - - 
477- + - - - + + + - - 
515- + - - - - - - - - 
524- + - - - + + - - - 
 “+” indicates the modification is detected and “-” indicates the modification is not detected 
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Quantitative analysis of oxidative labeling at residue level was also performed for regions that 
showed differences in extent of modification at the peptide level between exEGFR alone and 
exEGFR with Adnectin 1. Modification sites on the peptide were assigned with MS2 
information. In a few cases, where location of a modification to a single residue wasn’t possible 
owing to limited fragmentation information from MS2 or to the presence of interference from co-
elution of peptide isomers, the modification was indicated to occur on a set of possible residues.  
7.4 Results and Discussion 
7.4.1 FPOP labeling and analysis of exEGFR 
FPOP is a chemical footprinting approach that uses short-lived ‧OH radicals to “snapshot” the 
state of a protein or a protein-complex. Hydroxyl radicals probe the solvent accessibility of the 
protein because its size is similar to that of water molecules, and its high reactivity allows 
modification of up to 14 of 20 amino acids. In the presence of a scavenger, the radical lifetime is 
controlled to the µs timescale, which allows fast labeling presumably of a single state of the 
protein. In most FPOP footprinting experiments, the comparison is two-state; that is, of the same 
site of a protein existing in two states to reveal changes in solvent accessibility.  
By introducing an irreversible modification, the FPOP-introduced label is maintained during 
post-labeling sample handling, making it adaptable to a typical “bottom-up” proteomics 
methodology of proteolysis and LC/MS/MS. This robustness is important for membrane and 
secreted proteins containing complex glycosylation and other modifications, which are important 
for the structural and functional roles of the protein(53). The diversity of glycan modifications 
often adds to the difficulty of data processing in proteomics studies. In the case of exEGFR, we 
found that, without a deglycosylation step, trypsin digestion followed by typical database 
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searching gave only 74% of sequence coverage. Missing were several regions between AA320 to 
AA550. Interestingly, these missing regions all contain a “NXT” sequence, which is the common 
site for N-glycosylation. Therefore, we added a deglycosylation step before trypsin digestion to 
bring the coverage up to 89%, yet still missing several short regions containing multiple Lys or 
Arg residues (Figure 7-1).  
 
Figure 7- 1. Coverage map obtained for the tryptic digest of exEGFR. 
7.4.2 Epitope mapping of exEGFR-Adnectin 1 
We first performed FPOP labeling of exEGFR with 350 µM His as scavenger in the absence of 
Adnectin 1 and analyzed the oxidation extent at the peptide level to evaluate the labeling 
efficiency. This is important because different proteins contain different reactive sites, and, 
therefore, may require different concentrations of scavengers to achieve a proper modification 
extent. Because exEGFR is much larger in size than WNV E DIII, it is unlikely to get over-
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oxidized but possibly under-oxidized under the same scavenger concentration. Therefore, we 
only studied the oxidation extent but didn’t perform distribution analysis for the peptides after 
FPOP labeling. The results showed that moderate oxidation, between 0% and 25%, can be 
achieved for all peptides (darker bars in Figure 7-2).  This outcome is the basis for a more 
detailed FPOP study of the two states.  
 
Figure 7- 2. Extent of modification of EGFR alone (dark bars) and Adnectin 1-bound EGFR 
(light bars) for tryptic peptides covering 89% of the sequence. The light bar in 57-74 is absent 
because the modification extent is less than 0.1%, and so are several other peptides. 
 When comparing the modification extent of the two states of exEGFR, we used the Student’s t 
test on the sets of triplicates of both states for each peptide to determine if the two sets of data are 
significantly different from each other. The two-sample, two-tailed t test was applied assuming 
unequal variances, and the resulting P values for each peptide are listed in Table 7-3. We found a 
decrease in modification extent at the N-terminus for 2 of the 42 tryptic peptides of exEGFR 
upon Adnectin 1 binding, namely, for peptides 14-29 and 57-74 (“**” in Figure 7-2), of which 
the P values are 0.006 and 0.007, respectively. On the contrary, most of the other peptides have 
larger P values (Table 7-3), indicating no significant difference in oxidation extent between the 
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free and bound states of exEGFR. Three 
other peptides, namely, 75-84, 115-125 
and 323-333, also have relatively small P 
values (0.03 < P < 0.05) compared to 
most of the data (“*” in Figure 7-2), 
showing a similar trend of increased 
protection in the bound state. These 
differences are too small, however, and 
might be caused by structure fluctuations 
upon Adnectin binding rather than by 
interactions at the direct binding site. 
Noteworthy is that the modification 
extents for both states presented here are 
already adjusted by deducting the 
modification percentage in the control 
samples from them, in an effort to exclude oxidation introduced during sample handling. The 
reduced reactivity at those two regions indicates reduced solvent accessibility upon binding, 
suggesting that they are at or near the location of the binding site with Adnectin 1, assuming no 
allosteric effects are occurring.  
To obtain residue-specific information of the binding site, we performed residue-level analysis 
on the two regions that showed different modification extents for the two states. For example, the 
extracted ion chromatograms (EIC) and the corresponding mass spectra of peptide 14-29 
(unmodified and +16 modified) are shown in Figure 7-3a and Figure 7-3b, respectively, 
Table 7- 3. Student’s t-tests for all triplicates 
of both EGFR free and EGFR-Adnectin1 
bound states. 
peptide P value Peptide P value 
14-29 0.006 286-300 0.641 
30-48 0.822 286-301 0.157 
49-56 0.421 311-322 0.143 
57-74 0.007 312-322 0.177 
75-84 0.044 323-333 0.048 
85-105 0.449 334-353 NA 
106-114 NA 337-353 0.069 
110-114 NA 354-372 0.352 
115-125 0.032 376-390 0.517 
126-141 0.123 391-403 0.122 
142-165 0.807 408-427 0.063 
166-185 0.617 428-443 0.186 
189-198 0.713 431-443 0.686 
201-220 0.087 444-454 0.052 
203-220 0.147 456-463 0.403 
221-228 0.598 477-497 0.231 
230-260 0.253 515-523 0.104 
238-260 0.453 524-550 0.541 
261-269 0.446 551-569 0.111 
261-270 0.902 570-585 0.635 
274-285 0.425 586-618 0.570 
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indicating a mass shift of 15.9936 Da after modification. To assign residue-specific information 
to peptides eluting at each peak in the EIC, a single MS/MS scan of the +16 species at one 
elution time is used. An example product-ion spectrum of peptide 14-29 with a +16 modification 
from a single sampling (peak 1 in Figure 7-3a) is shown in Figure 7-4a. Two product ions at m/z 
725.5 and 790.0, assigned to y12 and y13 +16, respectively, indicated the +16 modification is on 
L17. This assignment is also supported by other fragment ions, such as b3 and b4 +16. Similarly, 
Figure 7-4b shows an isomeric peptide with a +16 modification eluting at a different time (peak 
2 in Figure 7-3a) and demonstrating that another oxidative modification occurs at a different 
location, here shown to be F20. In some cases, the product-ion spectrum was insufficiently 
informative for the assignment of the modification to a single residue.  In that case, the 
modification was assigned to the narrowest region determined by fragment ions (e.g., region 
L17-H23). Worth mentioning is that positional isomers of the same residue modification are also 
separated in the EIC, and such peaks corresponding to the same site modification are added 
together for calculation. 
 
Figure 7- 3. (a) Extracted ion chromatograms of peptide 14-29 unmodified (top) and +16 
modified (bottom). (b) Mass spectra of peptide 14-29 normalized to 100% unmodified (top) and 
modified (bottom).  
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Figure 7- 4. Product-ion (MS/MS) spectrum of peptide 14-29 with +16 modification on (a) L17, 
colored in red and (b) F20, colored in red. 
A total of seven specific residues or short regions were identified to bear the oxidations in the 
regions represented by peptides 14-29 and 57-74; all but one showed protection upon Adnectin 1 
binding (Figure 7-5). A similar Student’s t-test also performed on the seven residues evaluated 
the significance of the observed differences between the two states (Table 7-4). For peptide 14-
29, residues L14, L17, F20, F24 were modified and showed different modification extents 
between the bound and unbound states (P ≤ 0.02), whereas another modification assigned to 
region L17-H23 showed no change between the two states (P = 0.2). In addition to the N-
terminal residues, L69 from peptide 57-74, assigned with MS/MS, was also found to undergo 
decreased solvent accessibility and labeling extent upon Adnectin 1 binding (P = 0.03). There is 
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another +16 modification of peptide 57-74, but we were unable to determine its location from the 
MS/MS information. 
 
Figure 7- 5. Extent of modification of EGFR alone (dark bars) compared to Adnectin 1-bound 
EGFR (light bars) at the residue level for regions that showed labeling differences between the 
two states at peptide level. 
Table 7- 4. Student’s t-tests for all seven residues or short regions labeled in peptide 
14-29 and 57-74 of both EGFR free and EGFR-Adnectin1 bound states. 
residue L14 L17 F20 F24 L17-H23 57-74unknown L69 
p value 0.003 0.017 0.014 0.021 0.204 0.03 0.032 
 
7.4.3 Epitope detected by FPOP labeling vs. by other methods 
To compare the epitope of EGFR bound to Adnectin 1 as determined by FPOP labeling and 
crystallography, we mapped the five residues identified to undergo decreased labeling upon 
Adnectin 1 binding on the crystal structure of exEGFR-Adnectin 1 (PDB: 3QWQ, Figure 7-6). 
Four of the five residues, L14, L17, F20 and L69, lie at the interface of the two species when 
mapped onto the exEGFR-Adnectin 1 crystal structure (Figure 7-6). Specifically, the differential 
modification of L17 from FPOP labeling is consistent with the crystallography study(22), which 
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shows that L17 interacts with K79 of Adnectin 1 via H-bonding. The crystallography also 
pinpoints several neighboring residues (T15, Q16 and G18) that interact with Adnectin 1 via H-
bonding, and others (L14, L69, S99 and Y101) that interact via van der Waals forces. 
Information on T15, Q16 and G18 was not obtained, however, by FPOP labeling owing to a lack 
of reactivity of these residues. Although FPOP resolved interactions involving L14 and L69, it 
was silent concerning S99 and Y101 because these residues showed little reactivity; evidence for 
oxidation on those two residues was unclear because of interference from the highly oxidized 
M87 (located in an exposed loop) on the same peptide in the LC chromatogram. F20, although 
not thought to interact with ligands of EGFR, is at the buried surface of Adnectin 1 binding 
determined by crystallography, and, therefore, shows decreased solvent accessibility in the 
complex. The last residue, F24, changing its solvent accessibility as identified by FPOP, 
however, is distant to the putative EGFR-
Adnectin 1 interface according to the 
crystal structure. The decrease in labeling 
extent on F24 may be due to a change of 
side-chain orientation that leads to 
decreased solvent accessibility or a slight 
change in solvent accessibly (from small 
to smaller) allosterically controlled by 
Adnectin binding. 
When comparing the epitope mapped by 
HDX(41) and by FPOP labeling, we also 
found good consistency. HDX MS 
 
Figure 7- 6. Structural model of EGFR-Adnectin 
1 (PDB file 3QWQ) with the interacting residues 
from Adnectin 1 colored in magenta, and domain 
I of exEGFR, in other colors. Residues from 
regions 14-29 and 57-74 that showed different 
modification extents are in green. 
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coupled with ETD achieved epitope mapping at residue level and the most important interaction 
site was assigned as K13 to Q16. Noteworthy is that, unlike HDX, FPOP labeling is a measure of 
solvent accessibility of a side chain whereas HDX responds to changes in H-bonding of the 
protein backbone. Therefore, the two methods provide orthogonal information in epitope 
mapping, and both can complement other epitope mapping methods, such as X-ray 
crystallography, but reveal more relevant solution binding. 
7.5 Conclusions 
As a relatively new protein footprinting method, FPOP is less studied than HDX in applications 
involving mapping epitopes of protein antigens. In this application, we make two-state (bound 
and unbound) comparisons of labeling extents at identical sites.  The comparisons reflect 
changes in solvent accessibility accompanying intermolecular interactions or allosteric 
changes(48). The irreversible nature of FPOP labeling allows for complicated sample handling 
before MS detection, including deglycosylation, digestion, and long chromatography. This 
attribute is particularly important when dealing with complex samples and achieving good 
coverage and detailed CID analysis for residue-specific information. Here, we demonstrated the 
successful application of FPOP in mapping the epitope of EGFR-Adnectin 1 complex, showing 
largely consistent results with that from X-ray crystallography and HDX studies but revealing an 
additional interaction site. Five residues or short regions show decreased modification extent 
upon Adnectin 1 binding; of these, four lie in the binding interface determined by the crystal 
structure. The other (F24) is possibly caused by a change in side-chain orientation or a decrease 
in solvent accessibility of Adnectin 1 when bound. One advantage of MS-based protein 
footprinting is that it can sample physiologic mixtures. Therefore, FPOP and/or HDX can be 
157 
 
used as stand-alone methods or in conjunction with crystallography to elucidate confidently 
specific binding sites of antigens in a physiological-relevant solution state.  
7.6 Acknowledgements 
This research was supported by the NIH, NIGMS P41 grant (P41GM103422) to MLG. The 
authors thank Dr. Reb Russell, Dr. Sharon Cload and Dr. Bruce Car from Bristol-Myers Squibb 
for their support of this project. 
  
158 
 
7.7 References 
1. Xu, L., Aha, P., Gu, K., Kuimelis, R. G., Kurz, M., Lam, T., Lim, A. C., Liu, H., Lohse, 
P. A., Sun, L., Weng, S., Wagner, R. W., and Lipovsek, D. (2002) Directed evolution of 
high-affinity antibody mimics using mRNA display, Chemistry & biology 9, 933-942. 
2. Hackel, B. J., Kapila, A., and Wittrup, K. D. (2008) Picomolar affinity fibronectin 
domains engineered utilizing loop length diversity, recursive mutagenesis, and loop 
shuffling, Journal of molecular biology 381, 1238-1252. 
3. Wojcik, J., Hantschel, O., Grebien, F., Kaupe, I., Bennett, K. L., Barkinge, J., Jones, R. 
B., Koide, A., Superti-Furga, G., and Koide, S. (2010) A potent and highly specific FN3 
monobody inhibitor of the Abl SH2 domain, Nature structural & molecular biology 17, 
519-527. 
4. Koide, A., Bailey, C. W., Huang, X., and Koide, S. (1998) The fibronectin type III 
domain as a scaffold for novel binding proteins, Journal of molecular biology 284, 1141-
1151. 
5. Koide, A., Abbatiello, S., Rothgery, L., and Koide, S. (2002) Probing protein 
conformational changes in living cells by using designer binding proteins: application to 
the estrogen receptor, Proceedings of the National Academy of Sciences of the United 
States of America 99, 1253-1258. 
6. Karatan, E., Merguerian, M., Han, Z., Scholle, M. D., Koide, S., and Kay, B. K. (2004) 
Molecular recognition properties of FN3 monobodies that bind the Src SH3 domain, 
Chemistry & biology 11, 835-844. 
159 
 
7. Main, A. L., Harvey, T. S., Baron, M., Boyd, J., and Campbell, I. D. (1992) The three-
dimensional structure of the tenth type III module of fibronectin: an insight into RGD-
mediated interactions, Cell 71, 671-678. 
8. Dickinson, C. D., Veerapandian, B., Dai, X. P., Hamlin, R. C., Xuong, N. H., Ruoslahti, 
E., and Ely, K. R. (1994) Crystal structure of the tenth type III cell adhesion module of 
human fibronectin, Journal of molecular biology 236, 1079-1092. 
9. Leahy, D. J., Erickson, H. P., Aukhil, I., Joshi, P., and Hendrickson, W. A. (1994) 
Crystallization of a fragment of human fibronectin: introduction of methionine by site-
directed mutagenesis to allow phasing via selenomethionine, Proteins 19, 48-54. 
10. Leahy, D. J., Aukhil, I., and Erickson, H. P. (1996) 2.0 angstrom crystal structure of a 
four-domain segment of human fibronectin encompassing the RGD loop and synergy 
region, Cell 84, 155-164. 
11. Mamluk, R., Carvajal, I. M., Morse, B. A., Wong, H., Abramowitz, J., Aslanian, S., Lim, 
A. C., Gokemeijer, J., Storek, M. J., Lee, J., Gosselin, M., Wright, M. C., Camphausen, 
R. T., Wang, J., Chen, Y., Miller, K., Sanders, K., Short, S., Sperinde, J., Prasad, G., 
Williams, S., Kerbel, R., Ebos, J., Mutsaers, A., Mendlein, J. D., Harris, A. S., and 
Furfine, E. S. (2010) Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular 
endothelial growth factor receptor-2, mAbs 2, 199-208. 
12. Bloom, L., and Calabro, V. (2009) FN3: a new protein scaffold reaches the clinic, Drug 
discovery today 14, 949-955. 
13. Molckovsky, A., and Siu, L. L. (2008) First-in-class, first-in-human phase I results of 
targeted agents: highlights of the 2008 American society of clinical oncology meeting, 
Journal of hematology & oncology 1, 20. 
160 
 
14. Tolcher, A. W., Sweeney, C. J., Papadopoulos, K., Patnaik, A., Chiorean, E. G., Mita, A. 
C., Sankhala, K., Furfine, E., Gokemeijer, J., Iacono, L., Eaton, C., Silver, B. A., and 
Mita, M. (2011) Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted 
Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin, Clinical cancer 
research : an official journal of the American Association for Cancer Research 17, 363-
371. 
15. Janmaat, M. L., and Giaccone, G. (2003) The epidermal growth factor receptor pathway 
and its inhibition as anticancer therapy, Drugs of today 39 Suppl C, 61-80. 
16. Yarden, Y., and Sliwkowski, M. X. (2001) Untangling the ErbB signalling network, 
Nature reviews. Molecular cell biology 2, 127-137. 
17. Zhang, H., Shen, W., Rempel, D., Monsey, J., Vidavsky, I., Gross, M. L., and Bose, R. 
(2011) Carboxyl-group footprinting maps the dimerization interface and phosphorylation-
induced conformational changes of a membrane-associated tyrosine kinase, Mol Cell 
Proteomics 10, M110 005678. 
18. Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases, Cell 103, 211-225. 
19. Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. (1984) 
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor 
receptor monoclonal antibodies, Cancer research 44, 1002-1007. 
20. Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J., Polikoff, J., and Sato, G. H. (1983) 
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor 
receptors, Molecular biology & medicine 1, 511-529. 
21. Flynn, J. F., Wong, C., and Wu, J. M. (2009) Anti-EGFR therapy: mechanism and 
advances in clinical efficacy in breast cancer., J. Oncol. 10.1155/2009/526963. 
161 
 
22. Ramamurthy, V., Krystek, S. R., Jr., Bush, A., Wei, A., Emanuel, S. L., Das Gupta, R., 
Janjua, A., Cheng, L., Murdock, M., Abramczyk, B., Cohen, D., Lin, Z., Morin, P., 
Davis, J. H., Dabritz, M., McLaughlin, D. C., Russo, K. A., Chao, G., Wright, M. C., 
Jenny, V. A., Engle, L. J., Furfine, E., and Sheriff, S. (2012) Structures of 
adnectin/protein complexes reveal an expanded binding footprint, Structure 20, 259-269. 
23. Emanuel, S. L., Engle, L. J., Chao, G., Zhu, R. R., Cao, C., Lin, Z., Yamniuk, A. P., 
Hosbach, J., Brown, J., Fitzpatrick, E., Gokemeijer, J., Morin, P., Morse, B. A., Carvajal, 
I. M., Fabrizio, D., Wright, M. C., Das Gupta, R., Gosselin, M., Cataldo, D., Ryseck, R. 
P., Doyle, M. L., Wong, T. W., Camphausen, R. T., Cload, S. T., Marsh, H. N., Gottardis, 
M. M., and Furfine, E. S. (2011) A fibronectin scaffold approach to bispecific inhibitors 
of epidermal growth factor receptor and insulin-like growth factor-I receptor, mAbs 3, 38-
48. 
24. Carugo, O., and Argos, P. (1997) Protein-protein crystal-packing contacts, Protein 
science : a publication of the Protein Society 6, 2261-2263. 
25. Xu, Q., Canutescu, A. A., Wang, G., Shapovalov, M., Obradovic, Z., and Dunbrack, R. 
L., Jr. (2008) Statistical analysis of interface similarity in crystals of homologous 
proteins, Journal of molecular biology 381, 487-507. 
26. Benjamin, D. C., Berzofsky, J. A., East, I. J., Gurd, F. R., Hannum, C., Leach, S. J., 
Margoliash, E., Michael, J. G., Miller, A., Prager, E. M., and et al. (1984) The antigenic 
structure of proteins: a reappraisal, Annual review of immunology 2, 67-101. 
27. Scott, J. K., and Smith, G. P. (1990) Searching for peptide ligands with an epitope 
library, Science 249, 386-390. 
162 
 
28. Geysen, H. M., Meloen, R. H., and Barteling, S. J. (1984) Use of peptide synthesis to 
probe viral antigens for epitopes to a resolution of a single amino acid, Proceedings of the 
National Academy of Sciences of the United States of America 81, 3998-4002. 
29. Jemmerson, R., and Paterson, Y. (1986) Mapping epitopes on a protein antigen by the 
proteolysis of antigen-antibody complexes, Science 232, 1001-1004. 
30. Yamada, N., Suzuki, E., and Hirayama, K. (2002) Identification of the interface of a large 
protein-protein complex using H/D exchange and Fourier transform ion cyclotron 
resonance mass spectrometry, Rapid communications in mass spectrometry : RCM 16, 
293-299. 
31. Baerga-Ortiz, A., Hughes, C. A., Mandell, J. G., and Komives, E. A. (2002) Epitope 
mapping of a monoclonal antibody against human thrombin by H/D-exchange mass 
spectrometry reveals selection of a diverse sequence in a highly conserved protein, 
Protein science : a publication of the Protein Society 11, 1300-1308. 
32. Lu, J., Witcher, D. R., White, M. A., Wang, X., Huang, L., Rathnachalam, R., Beals, J. 
M., and Kuhstoss, S. (2005) IL-1beta epitope mapping using site-directed mutagenesis 
and hydrogen-deuterium exchange mass spectrometry analysis, Biochemistry 44, 11106-
11114. 
33. Coales, S. J., Tuske, S. J., Tomasso, J. C., and Hamuro, Y. (2009) Epitope mapping by 
amide hydrogen/deuterium exchange coupled with immobilization of antibody, on-line 
proteolysis, liquid chromatography and mass spectrometry, Rapid communications in 
mass spectrometry : RCM 23, 639-647. 
34. Zhang, Q., Willison, L. N., Tripathi, P., Sathe, S. K., Roux, K. H., Emmett, M. R., 
Blakney, G. T., Zhang, H. M., and Marshall, A. G. (2011) Epitope mapping of a 95 kDa 
163 
 
antigen in complex with antibody by solution-phase amide backbone hydrogen/deuterium 
exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry, 
Analytical chemistry 83, 7129-7136. 
35. Pandit, D., Tuske, S. J., Coales, S. J., E, S. Y., Liu, A., Lee, J. E., Morrow, J. A., Nemeth, 
J. F., and Hamuro, Y. (2012) Mapping of discontinuous conformational epitopes by 
amide hydrogen/deuterium exchange mass spectrometry and computational docking, 
Journal of molecular recognition : JMR 25, 114-124. 
36. Jensen, P. F., Jorgensen, T. J., Koefoed, K., Nygaard, F., and Sen, J. W. (2013) Affinity 
capture of biotinylated proteins at acidic conditions to facilitate hydrogen/deuterium 
exchange mass spectrometry analysis of multimeric protein complexes, Analytical 
chemistry 85, 7052-7059. 
37. Takamoto, K., and Chance, M. R. (2006) Radiolytic protein footprinting with mass 
spectrometry to probe the structure of macromolecular complexes, Annual review of 
biophysics and biomolecular structure 35, 251-276. 
38. Pan, Y., Brown, L., and Konermann, L. (2009) Mapping the structure of an integral 
membrane protein under semi-denaturing conditions by laser-induced oxidative labeling 
and mass spectrometry, Journal of molecular biology 394, 968-981. 
39. Pan, Y., Stocks, B. B., Brown, L., and Konermann, L. (2009) Structural characterization 
of an integral membrane protein in its natural lipid environment by oxidative methionine 
labeling and mass spectrometry, Analytical chemistry 81, 28-35. 
40. Jones, L. M., J, B. S., J, A. C., and Gross, M. L. (2011) Fast photochemical oxidation of 
proteins for epitope mapping, Analytical chemistry 83, 7657-7661. 
164 
 
41. Iacob, R. E., Chen, G., Ahn, J., Houel, S., Wei, H., Mo, J., Tao, L., Cohen, D., Xie, D., 
Lin, Z., Morin, P. E., Doyle, M. L., Tymiak, A. A., and Engen, J. R. (2014) The influence 
of adnectin binding on the extracellular domain of epidermal growth factor receptor, 
Journal of the American Society for Mass Spectrometry 25, 2093-2102. 
42. Maleknia, S. D., Brenowitz, M., and Chance, M. R. (1999) Millisecond radiolytic 
modification of peptides by synchrotron X-rays identified by mass spectrometry, 
Analytical chemistry 71, 3965-3973. 
43. Sharp, J. S., Becker, J. M., and Hettich, R. L. (2004) Analysis of protein solvent 
accessible surfaces by photochemical oxidation and mass spectrometry, Analytical 
chemistry 76, 672-683. 
44. Aye, T. T., Low, T. Y., and Sze, S. K. (2005) Nanosecond laser-induced photochemical 
oxidation method for protein surface mapping with mass spectrometry, Analytical 
chemistry 77, 5814-5822. 
45. Hambly, D. M., and Gross, M. L. (2005) Laser flash photolysis of hydrogen peroxide to 
oxidize protein solvent-accessible residues on the microsecond timescale, Journal of the 
American Society for Mass Spectrometry 16, 2057-2063. 
46. Gau, B. C., Sharp, J. S., Rempel, D. L., and Gross, M. L. (2009) Fast photochemical 
oxidation of protein footprints faster than protein unfolding, Analytical chemistry 81, 
6563-6571. 
47. Hambly, D., and Gross, M. (2007) Laser flash photochemical oxidation to locate heme 
binding and conformational changes in myroglobin, Int J Mass Spectrom 259, 124-129. 
48. Gau, B. C., Chen, H., Zhang, Y., and Gross, M. L. (2010) Sulfate radical anion as a new 
reagent for fast photochemical oxidation of proteins, Analytical chemistry 82, 7821-7827. 
165 
 
49. Xu, G., and Chance, M. R. (2004) Radiolytic modification of acidic amino acid residues 
in peptides: probes for examining protein-protein interactions, Analytical chemistry 76, 
1213-1221. 
50. Xu, G., and Chance, M. R. (2007) Hydroxyl radical-mediated modification of proteins as 
probes for structural proteomics, Chemical reviews 107, 3514-3543. 
51. Zhu, W., Smith, J. W., and Huang, C. M. (2010) Mass spectrometry-based label-free 
quantitative proteomics, Journal of biomedicine & biotechnology 2010, 840518. 
52. Zhang, H., Gau, B. C., Jones, L. M., Vidavsky, I., and Gross, M. L. (2011) Fast 
photochemical oxidation of proteins for comparing structures of protein-ligand 
complexes: the calmodulin-peptide model system, Analytical chemistry 83, 311-318. 
53. Edited by Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, 
C. R., Hart, G. W., and Etzler, M. E. (2009) Essentials of Glycobiology (2nd edition), 
Cold Spring Harbor Laboratories Press (NY). 
 
 
 
166 
 
Yuetian Yan’s Resume 
665 S Skinker Blvd., APT 15H                                      314-603-7681 (Cell) 
Saint Louis, MO 63105                                                                                                karyyan@gmail.com 
 
Education: 
Ph.D.: Washington University in St. Louis, United States 
Analytical Chemistry (Mass Spectrometry)           Cumulative GPA: 3.92/4.00                       January 2015 
BS: Nanjing University, China 
Department for Intensive Instruction (major: chemistry)       Cumulative GPA: 90.1 /100            May 2008 
 
Industry Experience: 
Bristol-Myers Squibb 
Biologics Development and Operations/PCO BDAS            Princeton, New Jersey 
Research Co-op, Groups of Li Tao and Guodong Chen                                    July 2014 – December 2014 
● Utilized HDX MS to study the local and global conformational impact of non-enzymatic degradation in 
the CDRs of a therapeutic antibody, including isomerization and oxidation.  
● Utilized HDX MS to study the relationship between structure and the degradation pattern of a 
PEGylated Adnectin. 
● Utilized native ESI MS and HDX MS to study an intermediate state of an antibody, which is composed 
of an extra light chain and a monomer. This study was performed on a Waters Synapt G2 instrument. 
Native ESI MS was used to confirm the non-covalent interaction between the light chain and the 
monomer. Separation of Fab and Fc followed by Native ESI MS indicated that the extra light chain binds 
to the Fab. HDX MS then reported on the interaction site of Fab and the light chain, with support from 
structural modeling. 
Reliable Biopharmaceutical Corporation                                                                 Saint Louis, Missouri 
Collaboration service                                                                                         December 2011 – May 2014 
● Provided MS analysis in carbohydrates drug and small molecule drug development, and generated 
scientific reports and communicate with customers. 
 
Academic Experience: 
Washington University in St. Louis          Saint Louis, Missouri 
Research Assistant, Laboratory of Michael L. Gross             June 2010 – Present 
● Studied the dimerization of SecA (a 102 kDa protein) by HDX MS. SecA is motor protein in bacteria 
preprotein translocation, and both its dimeric interface and active state remain controversial. We 
controlled the oligomeric state of SecA by varying salt concentrations, and used HDX MS to characterize 
the dimer interface. The determined interface is consistent with Alanine mutation/Analytical 
Ultracentrifugation results, and majorly agrees with one of the five controversial crystal structures. A 
conformational change from open to closed forms was also identified at the pre-protein binding domain 
upon dimerization. This study also provided leads for the active form of SecA.  
● Mapped the epitope of Adnectin1-EGFR interaction at the amino-acid residue level by fast 
photochemical oxidation of proteins (FPOP) Mass Spectrometry, in collaboration with BMS. The epitope 
identified agrees with that from both HDX study and crystallography results, presenting more evidence 
of the capability of FPOP in epitope mapping.  
167 
 
● Built a tool box with LC/MS and GC/MS for structural characterization of steroid metabolites that are 
active pheromones in mice.  
● Implemented charge-remote fragmentation using high-energy CID on a MALDI TOF/TOF instrument 
to characterize the structures of steroid metabolites.  
● Developed a method involving MS to characterized the structure of an unknown steroid metabolite that 
activates mouse pheromone-sensing neurons from mouse urine. The proposed structure was confirmed 
by customer-synthesis.  
 ● Performed MS/LC-MS analysis of small molecules, polymers, proteins and peptides for internal and 
external customers, as a requirement on members of an NIH Research Resource. 
 
Technical Experience: 
● Mass spectrometers: Thermo LTQ-Orbitrap/FT; Waters Synapt G2/G2-Si; Brukers Maxis Q-TOF; 
and Agilent 7200 Q-TOF GC/MS, etc.) 
● LC systems: Waters ACQUITY/ nanoACQUITY systems, Agilent 1100/1200 systems, Eksigent 
1D/1D+ systems, and Dionex Ultimate 3000 
● Waters HDX system.  
● Separation/biochemical techniques: Reverse-phase chromatography; 1D-Electrophoresis; Solid phase 
extraction; Buffer exchange; Protein enzyme digestion, etc. 
● Bioinformatics tools: Xcalibur, MassLynX, BioPharmaLynx, ProteinLynx Global Server, DynamX, 
HDX Workbench, HDX Examiner, MASCOT, ProtMapMS, etc..  
 
Publications: 
● Yan Y., Wowor A.J., Auclari S.M., Yu D., Zhang J., May E.R., Gross M.L., Kendall D.A., Cole J.L., 
Analysis of SecA Dimerization in Solution, Biochemistry, 53(19), 3248-3260 (2014) 
● Yan Y., Chen G., Wei H., Huang R.Y., Mo J., Rempel D.L., Tymiak A.A., and Gross M.L., Fast 
Photochemical Oxidation of Proteins (FPOP) Maps the Epitope of EGFR Binding to Adnectin, JASMS, 
25(12), 2084-2092 (2014) 
● Yan Y., Rempel, D.L., Holy T.E., Gross M.L., Mass Spectrometry Combinations for Structural 
Characterization of Sulfated-Steroid Metabolites, JASMS, 25(5), 869-879 (2014)  
● Yan Y., Ubukata M., Cody R.B., Holy T.E., and Gross M.L., High-energy Collision-induced-
dissociation Causes Charge-remote-fragmentation of Steroid Sulfates on MALDI TOF/TOF, JASMS, 
25(8), 1404-1411 (2014) 
● Fu X., Yan Y., Xu S.P., Geerlof-vidavsky I., Chong W., Gross M.L. and Holy T.E., A Natural Ligand 
for Mouse Vomeronasal Sensory Neurons Revealed by Systematic Correlation Analyses. Reviewed by 
Cell. 
● Yefremova Y., Al-Majdoub M., Opuni K. F., Koy C., Cui W., Yan Y., Gross M. L., and Glocker M. O., 
“De-novo” amino acid sequence elucidation of protein G′e by combined “Top-Down” and “Bottom-Up” 
mass spectrometry, JASMS, DOI: 10.1007/s13361-014-1053-2 
 
Presentations: 
● Yan Y., Chen G.., Wei H., Huang R., Mo J., Rempel D.L., Tymiak A.A., Gross M.L., Epitope Mapping 
of EGFR Binding to an Adnectin by Fast Photochemical Oxidation of Proteins, ASMS 2014 Annual 
Conference 
168 
 
● Yan Y., Chen G.., Wei H., Huang R., Mo J., Rempel D.L., Tymiak A.A., Gross M.L., Epitope Mapping 
of EGFR Binding to an Adnectin by Fast Photochemical Oxidation of Proteins, 3rd International 
Symposium on Higher order structure of Protein Therapeutics (2014). Oral presentation. 
● Yan Y., Wowor A.J., Zhang J., Cole J.L., Kendall D.A., Gross M.L., H/DX MS Reveals Features of 
SecA Dimeric Interface and a Conformational Change from Open to Closed Forms upon Dimerization, 
ASMS 2013 Annual Conference 
● Yan Y., Fu X., Holy T.E., Gross M.L., Mass Spectrometric Structural characterization of Sulfated 
Steroids: Implications in Animal Communication, ASMS 2012 Annual Conference 
● Yan Y., Holy T.E., Gross M.L., Method Development for Structural Characterization of Sulfated 
Steroids with Mass Spectrometry: Applications in Animal Communication, ACS 2011 Regional Meeting 
 
Honors and Awards: 
● Dean Dissertation Fellowship, Washington University, United States           2014 
● Graduate Research Fellowships, Washington University, United States           2011 – 2013 
● Graduate Teaching Fellowships, Washington University, United States         2009 – 2011 
● Endeavour Australia Cheung Kong Scholarship, Melbourne University, Australia                    2007 
● National People’s Scholarship, 2nd class (top 5%), Nanjing University, China           2005, 2007 
● National People’s Scholarship, 3rd class (top 10%), Nanjing University, China            2006 
 
Professional Reference: 
Michael L. Gross, Ph.D.                                                       
Professor of Chemistry, Washington University in St. Louis 
Department of Chemistry, Campus Box 1134, Washington University in St. Louis 
One Brookings Drive, Saint Louis, MO 63130 
314-935-4814 (Office) 
mgross@wustl.edu 
 
Timothy E. Holy, Ph. D. 
Associate Professor of Anatomy and Neurobiology, Washington University School of Medicine 
Department of Anatomy & Neurobiology, Campus Box 8108, Washington University in St. Louis  
660 S. Euclid Avenue, Saint Louis, MO 63110-1093                                                     
314-362-0086 (Office) 
holy@wustl.edu 
 
Li Tao, Ph.D. 
Sr. Principal Scientist 
Global Manufacturing & Supply / Biologics Development & Operations  
Bristol-Myers Squibb 
Building 9, Room 123  
311 Pennington Rockey Hill Rd, Pennington, NJ, 08534 
609-818-5527 (Office) 
Li.Tao@bms.com 
 
